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ABSTRACT 
At present, little is known about the effect(s) of organophosphorous compounds (OPs) on 
cardiomyocytes. The present study aimed to investigate the effects of phenyl saligenin 
phosphate (PSP), two organophosphorothioate insecticides (diazinon and chlorpyrifos), and 
their acutely toxic metabolites (diazoxon and chlorpyrifos oxon) on rat H9c2 and human 
cardiomyocyte-like cells. The rat embryonic H9c2 myoblast cell line, which has the ability to 
differentiate into a cardiac muscle phenotype, can be instrumental in understanding OP 
cytotoxicity at different differentiation stages. Human induced pluripotent stem cell derived 
cardiomyocytes (hiPSC-CMs) were used for the validation of selected OP effects in a more 
human relevant system. The differentiation of both H9c2 and human cardiomyocytes 
resulted in increased expression of differentiated muscle markers such as troponin 1, 
tropomyosin and α-actin.  
OP-induced cytotoxicity was assessed by monitoring MTT reduction, LDH release, and 
caspase-3 activity. Cell death was not observed in mitotic or differentiated H9c2 cells with 
diazinon, diazoxon, or chlorpyrifos oxon (48 h exposure; 200 μM). Chlorpyrifos-induced cell 
death was only evident at concentrations >100 μM. In marked contrast, PSP displayed 
pronounced cytotoxicity towards both mitotic and differentiated H9c2 cells. PSP triggered 
the activation of JNK1/2, suggesting a role for this pro-apoptotic protein kinase in PSP-
induced cell death, which was attenuated by the JNK1/2 inhibitor SP 600125, confirming the 
role of JNK1/2 activation in PSP-induced cytotoxicity. Dansylated PSP was used to identify 
novel PSP binding proteins. 2D-gel electrophoresis profiles of cells treated with dansylated 
PSP (25 μM) were used to identify proteins fluorescently labeled with dansylated PSP. 
Proteomic analysis identified tropomyosin, heat shock protein β-1 and nucleolar protein 58 
as novel protein targets for PSP.  
The present study also examined the effect of sublethal concentrations of OP on 
differentiating H9c2 cells. This was assessed by monitoring morphological changes, levels of 
cardiac cytoskeleton protein expression and AChE activity in cells induced to differentiate in 
the presence and absence of OPs. Results showed that exposure to diazinon and chlorpyrifos 
induced morphological changes, AChE inhibition and decreases in troponin 1 expression. 
Morphological changes were observed with PSP treated cells concomitant with altered 
expression of cardiac cytoskeleton proteins, troponin 1, tropomyosin, α-actin and other 
novel proteins. When hiPSC-CMs were employed to validate differences in cardiac toxicity 
induced by OPs, a similar cardiotoxic pattern when compared to differentiated H9c2 cells. In 
summary, PSP induced cytotoxicity was associated with JNK activation and apoptrosis 
whereas little cytotoxicity was observed with the other OPs. However PSP, chlorpyrifos and 
diazinon induced sub-lethal effects in cultured H9c2 and hiPSC-CMs were associated with 
decrease levels of cardiac cytoskeleton protein expression.  
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1.1 Background 
Organophosphorous (OP) compounds were first synthesised in the 1800s by French chemists 
Jean Louis Lassaigne and Philip de Clermoun (Gallo & Lawryk, 1991). These chemical 
compounds were deployed as nerve agents in World War II (Chambers & Levi, 1992) and as 
chemical gas warfare weapons in the 1995 Tokyo subway terrorist attack (Suzuki et al., 
1995).  In the latter case, OPs were developed as pesticides by the German chemist Gerhard 
Schrader (Gallo & Lawryk, 1991). Since then, numerous OPs have been synthesised and 
commercialised worldwide.  
Nowadays, OP pesticides are widely used for a variety of purposes due to their wide ranging 
chemical and physical properties. For example, in developing countries they are used against 
microbial agents, plant pathogens and insects (Lotti, 2000). Some OPs are also used in jet 
engine lubricants as anti-wear additives, due to their fire-resistant properties (Solbu et al., 
2007). However in the last 25 years, numerous publications have reported passengers 
suffering from chronic symptoms such as cognitive problems and even paralysis 
(Montgomery et al., 1977; Winder et al., 2002). Moreover, neurotoxicity was reported in 
approximately 10–50,000 Americans who suffered from Tri-ortho-cresyl phosphate (TOCP) 
adulterant poisoning, an ethanolic organophosphate compound was first extracted from 
Jamaica ginger known as “Ginger Jake paralysis” (Smith & Lillie, 1931). 
 The increase in the global use of OPs has heightened concerns regarding their associated 
health problems. More than three million cases of OP pesticide poisoning have been 
reported and over 250,000 cases of mortality per year have occurred world wide (Carey et 
al., 2013). As a consequence, there is now considerable interest in determining the 
molecular mechanisms of OP-induced toxicity.  This study will investigate the effects of 
phenyl saligenin phosphate (PSP), the organophosphorothioate insecticides diazinon and 
chlorpyrifos and their acutely toxic metabolites diazoxon and chlorpyrifos oxon on mitotic 
and differentiated H9c2 cardiomyoblasts.   
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1.2 Mechanism of Organophosphate Toxicity 
The most well-known effect of organophosphate acute toxicity is due to the significant 
inhibition of acetylcholinesterase (AChE). AChE enzymes belong to the serine hydrolase 
family and mainly found at the neuromuscular junction, where it is responsible for 
acetylcholine (ACh) hydrolysis in the preganglionic and postganglionic neurons of the 
nervous system. Thus AChE terminates the transfer of signals to skeletal muscles, cardiac 
system and secretory glands (Ray & Richards, 2001). In recent years researchers have also 
shown that AChE activity may play a regulatory role in cell differentiation and cell-to-cell 
interactions; thus, blocking AChE activity may result in obstructed cellular dynamics (Jordaan 
et al., 2013), as shown in Figure 1.1.  
 
 
Figure 1. 1 Common neurotoxicity mechanism of OPs 
(A) Release of neurotransmitter acetylcholine from pre-synaptic neuron and subsequent 
binding to receptors on the post-synaptic neuron or muscle cells. (B) Termination of ACh 
function by AChE at cholinergic synapses. (C) Organophosphates bind to AChE and inhibit 
enzyme action, causing accumulation of free ACh at the synapse. 
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The primary biological targets of OPs are serine esterases. Once the OPs have bound to the 
active site of AChE, this leads to enzyme organophosphorylation and the accumulation of 
ACh at the nerve cholingenic synapse, resulting in the hyper-stimulation of muscarinic and 
nicotinic receptors (Hasan et al., 1979, Costa, 2006). The hydrolysis of OPs can either be via 
A-esterases e.g. PON1 or B-esterases e.g. AChE, butyrylcholinesterase (BuChE), and 
neuropathy target esterase  (NTE). Catalytic hydrolysis by A-esterases is known to break 
down OP compounds to their major metabolites (detoxification) without affecting esterase 
activity (Costa et al., 2003). Conversely, non-catalytic hydrolysis of OPs by B-esterases causes 
significant inhibition of esterase activity and leads to the adverse effect of toxicity (Costa, 
2006).  Poisoning with OPs may occur through inhalation, ingestion or exposure of the skin 
(Karki et al., 2004).  The severity of the symptoms depends on the extent of the OP-AChE 
binding. The inhibition of acetylcholinesterase by OPs through a stoichiometric reaction may 
last from a few hours to several days and may be reversible or irreversible, depending on the 
chemical nature of the OP (Chambers, 2004). Irreversible reaction is that the OP-AChE 
complex can undergo non-enzymatic dealkylation. This is known as an aging reaction, 
resulting in deactivation of phosphorylated esterase via the loss of one or two R groups 
(Costa, 2006) as shown in Figure 1.2.  
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Figure 1. 2 A simplified representation of interaction mechanism between OPs and 
esterases.   
Reaction (1) leads to reversibly organophosphorylated AChE. Reaction (2) leads to the spontaneous 
reactivation of AChE and hydrolysed OP. Reaction (3) leads to the stable inactive (aged) negatively 
charged organophosphorylated AChE. 
 
1.3 Clinical Presentation and Possible Treatments  
Clinical signs may include skeletal muscle fasciculation, respiratory failure, muscle weakness 
and ultimately death (Kose et al., 2009). Organophosphate poisoning has therefore become 
a major research area and a complete understanding of toxicity mechanism(s) is essential to 
identify novel OP protein targets. Exposure to OPs can be evaluated by measuring the 
activity of AChE in the blood or by the detection of OP metabolites in the urine (Atala & 
Lanza, 2001; Eskenazi et al., 2004). However, given the varying nature of AChE inhibition, this 
is dependent upon the specific OP involved (Atala & Lanza, 2001; Quistad, 2005). Protection 
from OP intoxication is suggested for military personnel (Chambers, 2004). This can be 
achieved through the neutralization of OPs by providing exogenous (non-target) esterases, 
such as oximes. This allows the phosphorylation of these non-target esterases prior to the 
phosphorylation of the target esterases. This retains the availability of active AChE and 
prevents undesirable toxic effects (Chambers, 2004). Also, in case of OPs poisoning, atropine 
can be provided for patients to reactivate unaged acetylcholinesterase (Worek & Eyer, 
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2006). However, their use were controversial and treatment depends on the type of OPs and 
the severity of poisoning (Cherian et al., 2005). 
1.4 Chemical Structure of Organophosphorous Compounds  
Organophosphates are esters derived from phosphoric acid (Figure 1.3), which inhibit AChE 
(Eddleston et al., 2008). Organophosphate molecules contain two lipophilic groups R1 and 
R2, and an X group which is the “leaving group” more liable to be displaced when an OP 
binds to the active site serine on AChE, through an organophosphorylation reaction forming 
a stable bond (Costa, 2006).  Figure 1.4 illustrates the structures of several common OP 
compounds.  Some OPs, such as,  chlorpyrifos, diazinon and PSP, which will be focused on in 
this study.  
 
 
 
 
 
 
 
 
Figure 1.3 General chemical formula of organophosphorous esters. 
Oxygen or sulphur are attached to the phosphorus. The leaving group detaches when OPs interact 
covalently at the active site of AChE.  R1 and R2 are commonly alkoxy, amino, thio alkyl and phenyl 
groups, which can be the same or vary. X can be a halogen or alkyl, alkoxy group. 
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Figure 1.4 The chemical structures of several common OP compounds. 
 
1.5 OPs of Relevance to this Study 
This study investigated the effects of PSP, two organophosphorothioate insecticides 
(diazinon and chlorpyrifos) and their acutely toxic metabolites (diazoxon and chlorpyrifos- 
oxon) on mitotic and differentiated H9c2 cardiomyoblasts, the chemical structures of which 
are shown in Figure 1.4. These OPs exhibit differential binding affinity either to AChE or to 
NTE from human tissue to exert their toxicity as shown in Table 1.1. Their bioactivation and 
mechanism to induce toxicity will be briefly discussed in the following sections.  
Table 1. 1 Sensitivity of different inhibitors of OPs toward human AChE and NTE. 
OPs AChE I50  (µM) NTE  I50 (µM) 
Chlorpyrifos oxon 0.01 0.2 (Lotti, 2000) 
Diazoxon 0.0068 (Colovid, 2010) no data presented 
Phenyl saligenin phosphate 0.12 0.003 (Lotti, 2000) 
I50: half maximal inhibitory concentration. 
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1.5.1  Chlorpyrifos  
Chlorpyrifos (O, O-diethyl O-3,5,6-trichloropyridin-2-yl phosphorothioate, chlorpyrifos-ethyl) 
was the first OP to be  released onto the market.  It has been used globally as an active 
pesticide in the agricultural sector (Fenske et al.,2002) and is also used widely in the non-
agricultural sector. For example, in professional golf lawn care, retail lawn care and in 
termite liquid barriers (Eaton et al., 2008; Rush et al., 2010).  However, exposure to trace 
amounts of more than 0.001–0.01 µg/kg/day of these toxic pesticides poses a health risk for 
farm workers (Eaton et al., 2008). 
Chlorpyrifos is well absorbed by the intestines and lungs and rapidly metabolized. The 
toxicity of chlorpyrifos is dependent on its biotransformation via oxidation reactions to form 
the active metabolites TCPy (3,5,6- trichloro-2-pyridinol), diethylthiophosphate (DETP) and 
diethylphosphate (DEP), or via desulphuration to form chlorpyrifos oxon (Chambers, 1992) 
as shown in Figure 1.5. These metabolites are mainly formed in the liver and brain 
(Chambers & Chambers, 1989).  
 
Figure 1.5 Metabolic pathway of chlorpyrifos.  
Desulphuration reaction lead to bioactivation of chlorpyrifos to a more potent cholinesterase 
inhibitor chlorpyrifos oxon, or dearylation reaction lead to the degradation of chlorpyrifos to  TCPy , 
DETP and DEP. Taken from (Eaton et al., 2008). 
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Bioactivation of chlorpyrifos is mainly induced by various cytochrome P450 (CYP) isoforms to 
produce chlorpyrifos oxon.  Cytochrome P450 enzymes are present in the liver and the 
activity of specific isoforms varies between individuals (Demorais et al., 1994) CYP isoforms 
such as CYP2B6, CYP1A1, CYP3A4 and are responsible for OP biotransformation and CYP2C19 
and paraoxonase is important for OP detoxification processes (Sams et al., 2004; Rose & 
Hodgson, 2005). However, the balance between the formation of oxon and its detoxification 
is dependent upon the expression/activity of the various CYP isoforms (Rose & Hodgson, 
2005). For example, CYP2B6 is mostly responsible for the formation of chlorpyrifos oxon, 
whilst CYP2C19 seems to have the highest deactivation activity. Furthermore, the expression 
levels of these isoforms varies between individuals (Sams et al., 2000). Thus, individuals with 
high CYP2B6 and low CYP2C19 are highly susceptible to chlorpyrifos toxicity (Sams et al., 
2004; Mutch & Williams, 2006). Therefore, the profile of CYP isoforms may be an important 
contributor to differences between individuals in their susceptibility to the adverse effects of 
chlorpyrifos (Stevens et al., 2003). 
Several studies have assessed the direct effects of exposure to chlorpyrifos oxon, which is 
known to be more potent inhibitor to AChE than its parent compound chlorpyrifos (Das & 
Barone, 1999; Zhao et al., 2006; Eaton et al., 2008). The influence of chlorpyrifos oxon were 
reported to cause cholingenic hyper-stimulation, which evokes neurobehavioral changes and 
induces alterations in gene expression (Slotkin et al., 2007). Chlorpyrifos toxicity has also 
been reported. For example, chlorpyrifos (60 µM) reduced pro-apoptotic gene expression 
(e.g. Bcl-2 (B-cell lymphoma 2), CDKN2A (cyclin-dependent kinase inhibitor 2A) and MTA2 
(metastasis associated 1 family member 2) in JAR cells (Saulsbury et al., 2008). It has also 
been reported that chlorpyrifos not only causes the inhibition of AChE activity but may also 
affect other organs. For example, Haas et al. (1983) reported gastrointestinal effects in 
piglets when exposed to chlorpyrifos and necropsy examination showed an increased level 
of intestinal fluid associated with severe diarrhoea and ending in mortality resulted from 
chlorpyrifos poisoning. Finally, chlorpyrifos can be detected in blood immediately after 
exposure.  Its clearance from blood can occur rapidly, whereas its clearance from the whole 
body appears to be slow, and higher concentrations of chlorpyrifos are found in lipid adipose 
tissue in its steady state (Eaton et al., 2008). 
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1.5.2  Diazinon 
Diazinon (O,O-diethyl-O-(2-isopropyl-4-methyl-6-pyrimidinyl phosphorothionate) is one of 
the most common and widely used pesticides. However, it has a potential toxic effect on 
water and food resources and therefore its use is highly restricted. Diazinon evaporates 
easily and its half-life varies depending on sunlight, pH, microorganisms present and the 
temperature of the environment (Zhang et al., 2011). Diazinon undergoes degradation 
through direct oxidation degradation hydrolysis, producing the metabolites 2-isopropyl-6-
methyl-pyrimidin-4-ol and diazoxon (Kouloumbos et al., 2003). Diazinon undergoes a 
sulphoxidation reaction to form the toxic metabolite diazoxon (Vittozzi et al., 2001). The 
structures of these metabolites are shown in Figure 1.6.  
 
 
 
Figure 1.6 Metabolic pathway of diazinon.  
The metabolite from the hydrolysis reaction is 2-isopropyl-6-methyl-pyrimidin-4-ol, while metabolite 
from the desulphuration pathway is diazoxon, which exhibits more potency in inhibiting AChE. Taken 
from (Kappers et al., 2001). 
Diazoxon is produced by oxidative desulphuration (P=S), which involves the substitution of 
sulphur with oxygen (P=O; Zhang et al., 2011). Moreover, diazoxon shows a high reactivity, 
which gives it a greater potency to inhibit AChE. It also exhibits more polarity than the 
parent compound and possesses a greater stability in aquatic environments (Kouloumbos et 
al., 2003). In vivo, diazinon metabolism is mediated by several cytochrome P450 isoforms 
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that include CYP2C19, CYP1A2, CYP3A4 and CYP2C19 (Kappers et al., 2001). Several enzymes 
e.g. CYP450, PON1 (paraoxonase 1), and B-esterase present in the intestines and liver are 
responsible for diazinon detoxification. Therefore, resistance to toxicity relies on the balance 
between bioactivation and detoxification following exposure to diazinon (Poet et al., 2003). 
Acute exposure to diazinon has been associated with long-term health problems (Barrett & 
Jaward, 2012). For example, it has been reported that diazinon can cause mutagenicity 
resulting in chromosome abnormalities and sister chromatid exchange (Cox, 2000). Other 
studies have reported renal toxicity following exposure to diazinon (Jha et al., 2013). For 
example, diazinon decreases the activity of metabolizing enzymes such as glutathione-S-
transferase and quinine reductase, leading to increased levels of blood urea nitrogen and 
serum creatinine (Shah & Iqbal, 2010). 
1.5.3 Phenyl saligenin phosphate  
PSP is an analogue of saligenin cyclic-o-tolyl phosphate (SCOTP), the active metabolite of tri-
ortho cresyl phosphate (TOCP), produced in hepatic cells (Fowler et al., 2008). Since TOCP is 
mainly used in aircraft engines. This may lead to an occupational exposure from toxic 
aerosols, potentially resulting in memory loss and cognitive dysfunction (Winder & Balouet, 
2001, Michaelis, 2011).  Extensive studies revealed that some OPs, including PSP and TOCP, 
neither of which is a pesticide, exert their toxicity by organophosphorylation and inhibition 
of NTE which results in organophosphate-induced delayed neuropathy (OPIDN) in vivo  
(Nomeir & Abou-Donia, 1986; Zhao et al., 2006). Both PSP and TOCP act similarly to produce 
neurodegenerative poisoning (Hargreaves, 2012). However, to date, human exposure to 
TOCP is poorly documented; this therefore represents a wide area for research which needs 
to be undertaken (Baker et al., 2013).  
1.6 Molecular Targets of PSP 
PSP has been found to interfere with other cellular targets such as cytoskeletal proteins, 
neurotrophin receptors and transglutaminase enzyme activity (Carlson & Ehrich, 2001; Harris 
et al., 2009; Pomeroy-Black & Ehrich, 2012). Therefore, it is worthwhile to discuss other 
targets involved after PSP exposure, in order to understand the potential molecular basis of 
PSP toxicity more fully. 
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1.6.1 Effect of PSP on neuropathy target esterase 
PSP has been shown to be a classical inhibitor of the NTE enzyme (Baker et al., 2013). NTEs 
are anchored in the endoplasmic reticulum and are essential for lipid metabolism (Forshaw 
et al., 2001; Van Teinhoven et al., 2002). Moreover, NTEs display high catalytic activity in 
neuronal cells, although NTE activity has been demonstrated in non-neuronal tissue and cells 
such as testicles, kidney, and lymphocytes. Increased expression of NTE occurs in the early 
stages of embryo development and is thought to play an important role in signal 
transduction and nervous system development (Lotti & Moretto, 1993; Moser et al., 2000; 
Road, 2010). Thus any alteration in neuronal NTE activity may cause disruption of the 
endoplasmic reticulum, followed by vacuolation in cell bodies leading to defects in cellular 
function (Van Teinhoven et al., 2002; Akassoglou et al., 2004).  
Organophosphorylation of NTE by OPs is necessary for the development of OPIDN (Costa, 
2006). OPIDN occurs when OPs interact with NTE and the latter undergoes an “aging” 
reaction, forming a terminal group with a negative charge linked to the active site of  
esterase, preventing enzyme to reactivate, as shown previously in Figure 1.2 (Williams, 
1983). Complete organophosphorylation of NTE prevents the outgrowth of axon-like 
processes in differentiating N2a cells, following exposure to PSP (Flaskos et al., 1994). 
Moreover, the inhibition of NTE may lead to neuronal degeneration and to modification of 
axonal morphology, both of which are early events of OPIDN in response to OP exposure 
(Ehrich & Jortner, 2001).  
1.6.2 Effect of PSP on mitogen-activated protein kinase  
To further characterize PSP-induced toxicity, the effects of PSP on mitogen-activated protein 
kinase (MAPK) and phosphoinositide-3-kinase/protein kinase B (PI-3K/PKB) signalling 
pathways has been investigated (Hargreaves et al., 2006; Pomeroy-Black & Ehrich, 2012). For 
a detailed description of MAPK and PI-3K/PKB signalling pathways, see section 1.9. These 
signalling pathways play a vital role in the neuronal response to OP exposure, as they are 
responsible for regulating neurite outgrowth and cell survival (Kaplan, 1995). An increase in 
both phosphorylated PKB and MEK1/2 protein kinases was observed in human SH-SY5Y 
neuroblastoma cells after PSP exposure (Pomeroy-Black & Ehrich, 2012). Interestingly this 
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study explored OP-induced activation of neurotrophin receptors by very low concentrations 
of PSP (e.g. 0.01-1.0 μM).  Thereby any disruption in these cascades may promote 
morphological changes and/or neuronal cell death (Nostrandt et al., 1992, Carlson et al., 
2000). The effect of other neuropathic OP compounds on MAPK pathway-signalling proteins 
has been demonstrated in differentiating mouse N2a neuroblastoma cells (Hargreaves et al., 
2006). For example, PSP (2.5 µM; 4 h) triggered transient activation of extracellular-signal-
regulated kinases 1/2 (ERK1/2) which is associated with inhibition of NTE activity in mouse 
N2a neuroblastoma cells (Hargreaves et al., 2006).  
1.6.3 Effect of PSP on cytoskeleton proteins  
Further studies have assessed the disruption of cytoskeleton proteins during the induction of 
OPDIN by PSP. For example, in white Leghorn hens, PSP (2.5 mg/kg) promoted an increase of 
serum autoantibodies toward cytoskeleton protein neurofilament (NF) subunits (El-Fawal & 
McCain, 2008). NF subunits are proteins that play a vital role in the regulation of axonal 
diameter and regulation of the dynamics of cytoskeletal proteins such as microtubules and 
actin filaments (Perrone Capano et al., 2001). If this regulation fails, cells will produce 
unstable microtubules with consequent disruption of axonal transport. Massicotte et al. 
(2003) also showed that PSP (1 µM) induces microtubule and neurofilament degradation 
associated with marked masses of cytoplasmic debris and neurite swelling in chick embryo 
dorsal root ganglia cultures. Hargreaves et al. (2006) also observed an increase in the 
phosphorylation of NF heavy chain in differentiating mouse N2a neuroblastoma cells when 
exposed to a sub-lethal neurite outgrowth inhibitory concentration of PSP (2.5 µM). 
Therefore, changes in these proteins can be considered as biomarkers for the progression of 
neuronal injury and neurotoxicity and a key event of the development of OPDIN following 
extensive PSP exposure (McConnell et al., 1999; Yang et al., 1999; Lalonde & Strazielle, 
2003). 
Previous studies have also shown that neuronal protein myelin-basic protein (MBP) is also 
phosphorylated by PSP (El-Fawal & McCain, 2008). This protein is a key component of myelin 
and is involved in its formation and maintenance (Boggs, 2006). It is also required for 
neuronal cell migration, survival and neurite outgrowth (Maness & Schachner, 2007). It is 
possible that phosphorylation of NF heavy chain and MBP might indicate myelin 
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degeneration and axonal damage, which was also seen in brain and spinal cord of chickens 
exposed to TOCP (Abou-Donia & Lapadula, 1990). Supporting evidence has come from an in 
vivo study by Ehrich & Jortner (2001), which reported that a toxic dose of PSP (10 mg/kg) 
resulting in the appearance of abnormal neurite growth and axonal damage in large 
myelinated fibres. All together, these studies support the claim that chronic exposure to PSP 
induces cytoskeletal disruption as well as NTE inhibition, which are all characteristic of an 
early event of OPIDN. 
1.7 Effect of Organophosphorous Compounds on The Cardiovascular System  
A number of studies have drawn attention to the cardiac effects associated with 
occupational exposure to OPs (Zoltani et al., 2006). Evidence suggests that cardiac 
complications may occur after exposure to OPs (Roth et al., 1993; Karalliedde, 1999); 
however, the pathophysiology of cardiotoxicity following exposure to OPs is still not known.  
Multiple studies have, however, reported that sudden death may take place after exposure 
to OPs, with patients showing myocardial necrosis and toxic myocarditis (Anand et al., 2009). 
This is due to the accumulation of ACh at ganglionic and cardiac centres leading to hypoxia 
and disruption of ion transportation (Karki et al., 2004). 
Growing evidence also suggests that OPs (e.g. methamidophos) may trigger cardiac 
hypertrophy (Calore et al., 2007). These authors suggest that the main cause of hypertrophy 
is a persistent systemic arterial hypertension following exposure to the toxin (Saadeh et al., 
1997).  Hypertrophy is caused by the modulation of several complex biochemical pathways, 
such as calcineurin signalling. Calcineurin is a serine/threonine phosphatase, whose 
activation leads to the dephosphorylation and activation of transcription factors such as the 
nuclear factor of activated T cells (NFAT). The NFAT transcription factor family is involved in 
the regulation and development of the cardiac system (Shiojima, 2005). These studies have 
increased the interest in the study of cardiac abnormalities associated with OP toxicity and 
how they may modulate cardiac specific signalling pathways. 
The various alterations seen in cardiac cells reveal a clinical picture of severe poisoning, with 
observed symptoms such as ventricular tachycardia, prolonged QT interval (the heart 
rhythm condition; measurement between Q wave and T wave in the heart's electrical cycle) 
and atrioventricular block (Kiss & Fazekas, 1979). Some authors believe that significant 
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cholinesterase inhibition in the plasma may produce changes in the electrocardiogram (ECG) 
leading to prolonged QT and ultimately cell death (Lotti, 2000). Pimentel & Carrington da 
Costa (1992) also reported that cholinergic overstimulation of cardiomyocytes is associated 
with lysis of myofibrils, micro-necrosis and an abnormal Z band. However, at present there 
are no current data concerning the cardiac biochemical markers associated with cardiac 
damage due to OP exposure. For this reason it is important to understand the molecular 
mechanisms associated with OP-induced cardiotoxicity. This project will investigate the 
effects of OPs on rat H9c2 cells and human stem cell derived cardiomyocytes. 
1.8 Alternative Molecular Targets of Organophosphates  
Emerging evidence suggests that not all of their toxicological actions involve the inhibition of 
the AChE, since other proteins and enzyme targets of OPs are involved (Casida & Quistad, 
2005; Lopachin & Decaprio, 2005). Investigations of other markers beyond AChE were 
essential to detect post-OP exposure. Interestingly, the hypothesis that OPs may affect 
targets other than AChE is supported by numerous studies and will be discussed in the 
following sections. 
1.8.1 Cytoskeleton proteins 
A number of studies have observed significant effects of OPs on motor proteins such as 
kinesin, which can result in the disruption in axonal transport (Massicotte et al., 2003). Thus 
kinesin mediates the transport of vesicles and organelles and other cellular proteins along 
the microtubules through the axon and it is essential for a number of cellular functions 
(Pernigo et al., 2013). Gearhart et al. (2007) have clearly shown that administration of 0.59 
nM diisopropylfluorophosphate and 10 μM chlorpyrifos affected kinesin function leading to 
impairment of axonal transport and axonal swelling of bovine brain cortex cells. This is 
further supported by Inui et al. (1993) who correlated axonal swelling with the development 
of organophosphate induced delayed neurotoxicity in male Wistar rats exposed to TOCP. 
According to Abou-Donia (1993) axonal swelling is mediated through the hyper-
phosphorylation of cytoskeletal proteins following TOCP exposure, leading to a decrease in 
transportation and an aggregation of proteins along the axon (Abou-Donia, 1993). 
Organophosphorus compounds were found to target cytoskeleton proteins such as tubulin, 
and thus they interfere with their assembly leading to impairment in microtubule function 
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(Prendergast et al., 2007). For example, low concentrations (0.005 and 0.01 mM) of 
chlorpyrifos oxon were found to bind to tubulin and prevent its polymerization (Grigoryan & 
Lockridge, 2009). Tubulin polymerization is implicated in the formation of microtubules 
which are essential components of the cytoskeletal system, which is disrupted in 
neurodegenerative diseases (Gendron & Petrucelli, 2009). It has also been shown that 
dichlorvos exposure results in increased phosphorylation of tubulin affecting its assembly, 
resulting in axon dissociation and synaptic dysfunction (Choudhary et al., 2006). Moreover, 
the effect of individual OPs on actin cytoskeleton filaments in human neuroblastoma cells 
varies and relies on their distinct potency and structural activity (Carlson & Ehrich, 2001). 
Future studies should focus on the identification of possible non-cholinergic targets of OP 
compounds, which will help to increase understanding of the molecular mechanisms of OP-
induced toxicity. 
1.8.2   Albumin adducts 
In 2005, Peeples et al. investigated novel protein targets for OPs used as pesticides. Initially, 
their research started by incubating mice with OP-labelled with FB-biotin (10-
(fluoroethoxyphosphinyl)-N-(biotinamidopentyl) decanamide). Labeled FP-biotin can be used 
to identify proteins that bind to OPs (Schopfer et al., 2005). Organophosphates including 
chlorpyrifos oxon, dichlorvos, diisopropylfluorophosphate and sarin were incubated with 
human serum albumin, after which albumin peptide sequences were compared with and 
without OP treatment by mass spectrometry (MS; Peeples et al., 2005). These compounds 
were found to bind covalently to Tyr411 and residue in albumin (Li et al., 2007). Thus, this 
OP-albumin binding shows more stability than OPs binding to the serine active site of 
cholinesterase (Read et al., 2010).  These findings support the claim that albumin is one of 
the biological markers that could act as a detoxifying protein in cases of OPs endogenous 
intoxication, however this also depend on the type of OPs (Xu et al., 2007; Lockridge & 
Schopfer, 2010).  
1.8.3   Acyl peptide hydrolase 
APH is a serine acyl peptide hydrolase primarily present in red blood cells which is 
responsible for cleaving N-acetylated peptides for detoxification (Shimizu et al., 2004). The 
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detection of such enzyme activity may show more sensitivity than other OP targets due to its 
life-span, which is approximately 120 days, thus lasting long after OP in vivo exposures 
(Umlas et al., 1991; Quistad et al., 2005). In vivo study with mice have demonstrated that OP 
exposure can inhibit the activity of APH in brain (Cardona et al., 2013).  Three types of 
insecticides (dichlorvos, naled, and trichlorfon) showed sensitivity to the APH enzyme 
(Quistad et al ,2005). Other study documented how other serine proteases (dipeptidyl 
peptidase IV and t-PA (tissue plasminogen activator) that belong to the APH subfamily may 
react with distinct types of OPs (Rosenblum & Kozarich, 2003). In comparison to AChE, 
different oxons (toxic metabolites of parent OP) showed ability to inhibit APH at lower 
concentrations than those required for AChE inhibition during in vivo exposure (Richards et 
al., 2000). APH has been shown to be a potentially sensitive biomarker for identifying OP-
delayed neurotoxicity with respect to AChE (Olmos et al., 2009).Based on these facts, 
inhibition of APH activity may be used as a biomarker for monitoring OP toxicity. 
Numerous non-cholinesterase targets of OPs were discussed in the previous section.  
However, it needs to be emphasized that other non-cholinesterase targets may be 
implicated in OP toxicity. An experimental design needs to be developed to study the 
association of all types of OPs with their specific targets. As the current study has focused on 
the effects of OPs on mechanisms of cell death and signaling pathways a detailed discussion 
of such events would be worthwhile. 
1.9 Cell Signalling 
Organophosphate exposure may modulate cell signalling pathways which are critically 
important in the development of differentiated cells and numerous other cellular processes 
including cell survival and cell death (Slotkin, 2005). Cell signalling is a response that occurs 
within the cytoplasm when a cell receives an external signal leading to the activation of a 
cascade to transfer internal signals to the desired place in order to achieve the appropriate 
intracellular action. Moreover, this control mechanism involves regulatory proteins 
communicating with each other through signal transduction pathways to evoke a myriad of 
cellular functions (Weinberg, 2007). 
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1.9.1 MAPK signalling pathway 
Mitogen-activated protein kinases (MAPKs) are a family of protein kinases that respond to 
stimuli and catalyse the phosphorylation of specific proteins inside the cell. They are 
involved in the regulation of numerous cellular functions that include cell proliferation, cell 
differentiation, cell survival and apoptosis (Kim & Choi, 2010). Their activation is induced by 
several external factors such as cytokines, growth factors and hormones (Stathopoulou et 
al., 2008). The mammalian MAPK family consists of three major groups, which are the 
extracellular signal-regulated kinases (ERK1/2), the c-Jun N-terminal kinases (JNK1/2/3) and 
the p38 MAPKs (p38 MAPK-α/β/γ/δ). Activated MAPKs phosphorylate a multitude of protein 
substrates that include transcription factors, in order to bring about a specific cellular 
response (Zhang et al., 2003). Each individual MAPK pathway involves the sequential 
activation of several different proteins kinases that are summarised in the following 
sections.  
1.9.2 Extracellular-signal-regulated kinases 1/2 
The ERK1/2 signalling pathway plays a key role cell proliferation and differentiation (Johnson 
& Lapadat, 2002). Activation of the ERK1/2 signalling pathway is initiated when a ligand such 
as epidermal growth factor (EGF), insulin, or platelet-derived growth factor (PDGF) binds to 
its respective tyrosine kinase receptor e.g. insulin receptor, EGFR, and PDGFR. This promotes 
receptor dimerization and auto-phosphorylation of tyrosine residues. After that the adaptor 
protein, growth factor receptor bound protein 2 (Grb2), binds to the phosphorylated 
receptor via its SH2 domain. Grb2 functions to link proteins to one another and contains one 
central SH2 and two SH3 domains which interact directly with Son of sevenless (Sos) and 
place Sos near the membrane. Sos functions as a ubiquitous guanine nucleotide exchanger 
for Ras and possesses a Ras binding site. Once Sos is recruited to the plasma membrane, it 
catalyses the exchange of GDP for GTP on the monomeric G-protein Ras (Pierre et al., 2011) 
as shown in Figure 1.7.  
 
Chapter 1 
19 
 
 
Figure 1.7 Activation of MAPK signalling transduction by RAS.  
Binding of a growth factor (GF) to a tyrosine kinase linked-receptor leading to receptor dimerization. 
The receptor then undergoes auto-phosphorylation and binds to Grb2 (adaptor protein) via its SH2 
domain.  Grb2 then interacts with Sos via SH3 domains which leads to the recruitment of Sos to the 
plasma membrane, which stimulates the exchange of inactive Ras-GDP  to its active Ras-GTP form. 
 
Activated Ras (Ras-GTP) then promotes the activation of several members of the MAPKKK 
family, which in this case are Raf protein kinases (A-Raf, B-Raf, C-Raf). Activated Raf triggers 
the downstream phosphorylation and activation of MEK1 and MEK2 (Weinberg, 2007). After 
that, MEK1 and MEK2 phosphorylate and activate ERK1/2 as shown in Figure 1.8; once 
activated, ERK1/2 phosphorylates a number of downstream targets including transcription 
factors (e.g. CREB; cAMP response element-binding protein), phospholipase A2 and 
ribosomal S6 protein kinase  (Bornfeldt, 1996; Chen et al., 1998; Davies et al.,2000).  These 
targets play essential roles in proliferative responses, cellular machinery and cytoskeletal 
reorganization (Reszka et al., 1995; Roskoski, 2012). The ERK1/2 pathway plays a major role 
in myocardial growth in the embryonic mouse (Stathopoulou et al., 2008). Similarly, 
reduction in phosphorylated ERK1/2 causes an alteration in the ventricular compact layer 
outgrowth and affects coronary vessel development (Lin et al., 2010). These observations 
support the fact that ERK1/2  is an essential  regulator of myocardial growth (Kang & Sucov, 
2005). 
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1.9.3 Jun N-terminal kinases 
JNK or Jun N-terminal kinases comprise three distinct members, namely JNK1, JNK2 and 
JNK3 (Derijard et al., 1994; Kallunki, 1994;  Gupta et al., 1996).  Generally these kinases are 
activated in response to stress stimuli such as heat shock, UV-radiation and osmotic shock 
(Bogoyevitch et al., 1996). Initially, their activation starts with the activation of small 
GTPases of the Rho family (Rac, Rho, Cdc42), which promote the activation of several 
members of the MAPKKK family e.g. MEKK1/2/4. Activated MAPKKKs then phosphorylate 
and activate MAPKK family e.g. MKK4/7  which in turn phosphorylate and activate JNK1-3 
(see Figure 1.8). Once JNK has been activated, it translocates to the nucleus and 
phosphorylates several transcription factors to induce programmed cell death or apoptosis 
(Weston & Davis, 2002; Dhanasekaran & Reddy, 2008). 
Several studies have shown that phosphorylated JNK evokes activation of the transcription 
factor AP-1 (activator protein 1; Kolomeichuk et al., 2008). The JNK/AP-1 pathway promotes 
apoptotic action via the increased transcription of pro-apoptotic genes such as TNF- (tumor 
necrosis factors-), Fas-L (Fas ligand) and Bak (Bcl2 antagonist/killer 1; Dhanasekaran & 
Johnson, 2007; Raman et al., 2007). In addition, JNK phosphorylates a number of pro-
apoptotic substrates, which play a vital role in the intrinsic and extrinsic pathways involved 
in apoptosis (see section 1.10). For example, JNK phosphorylates pro apoptotic BAD in 
primary granule cells which leading to the inhibition of pro-survival proteins such as Bcl-2 
(Gross et al., 1999). Moreover, JNK signals also induce the release of cytochrome C from 
mitochondria, leading to the activation of caspase-9 and ultimately apoptosis (Aoki et al., 
2002).  
There is substantial evidence derived from studies of the effect of JNK inhibition in different 
cell types (Chen & Tan et al., 1998; Maroney et al. 1999). For example, the inactivation of 
JNK prevents apoptosis in liver cells (Uehara et al., 2005). Similarly, Ferrandi et al. (2004) 
observed that JNK inhibitors attenuated apoptosis of rat cardiomyocytes. In addition, the 
knockout of JNK1 and JNK2 in mice causes a defects in T-cells and apoptosis, while JNK3 was 
found to be responsible for excitotoxicity of the murine hippocampus (Yang et al., 1997). 
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Figure 1.8 Mitogen-activated protein kinase (MAPK) signaling pathways.  
ERK and JNK pathways are presented schematically. Each pathway is initiated by Ras activation, 
which phosphorylates serine/threonine residues of MAPKKK, which subsequently phosphorylates 
tyrosine/threonine residues of a MAPKK. This leads to the activation of MAPK, which in turn activates 
other protein kinases involved in cellular responses. 
 
1.9.4 The  Protein kinase B/Akt signalling pathway 
There are three PKB/Akt isoforms in mammalian cells, namely, PKBα/Akt1, PKBβ/Akt2 and 
PKBγ/Akt3 (Cheng et al., 1992).  PKB/Akt is employed in the centre of downstream signalling 
pathways that are activated in response to a wide variety of extracellular stimuli including 
GPCR (G-protein-coupled receptors) agonists and growth factors.  PKB is involved in the 
regulation of cellular growth, metabolism and cell survival via the phosphorylation of 
downstream targets (Brazil & Hemmings, 2001; Song et al., 2005; Dillon et al., 2007). PKB 
activation is associated with the downstream effector PI-3K. As shown in Figure 1.9, the 
pathway starts with the up-stream activation of PI-3K via the monomeric G-protein Ras 
(Wymann et al., 2003). Activated PI-3K phosphorylates PIP2 (phosphatidylinositol 4,5-
bisphosphate) resulting formation of the second messenger PIP3 (phosphatidylinositol 
(3,4,5)-trisphosphate). Increases in PIP3 lead to the recruitment PDK1 (pyruvate 
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dehydrogenase kinase 1) to the plasma membrane and subsequent phosphorylation of PKB 
at Thr308. PKB is then phosphorylated at Ser473 by mTORC2 (mammalian target of rapamycin 
Complex 2) leading to full activation of the enzyme (Weinberg, 2007). However, the activity 
of PKB can be de-regulated by PTEN (Phosphatase and tensin homolog). PTEN is a 
phosphatase responsible for dephosphorylating PIP3 to PIP2, thereby causing the inactivation 
of the PKB signalling pathway (Simpson & Parsons, 2001).  
 
 
Figure 1.9 Schematic representation of PKB/Akt activation.  
Activation of PKB/Akt signalling pathway is initiated by RAS activation, which in turn activates PI3K. 
PI3-Kinase is activated and generates the second messenger PIP3, that activates the downstream 
PKB/Akt. PKB/Akt is an important mediator of organismal growth.  
 
The role of the PKB/Akt cascade in the heart is characterized as a central effector in cardiac-
signalling mechanisms (Lee et al., 2009).  The functional description of PKB/Akt is a growth-
promoting protein that stimulates myocyte growth, allowing the recruitment of angiogenic 
growth factors such as VEGF (Vascular endothelial growth factor) and inducing coronary 
angiogenesis (Shiojima & Walsh, 2006).  In normal heart cells, PKB-dependent signalling 
pathways maintain the balance between the two mechanisms, myocyte growth and 
coronary angiogenesis. Activation of the PKB-mTOR pathway induces both myocyte growth 
and coronary angiogenesis recruitment (Takahashi et al., 2002). However, prolonged 
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activation of PKB results in a blockage in VEGF secretion and attenuation of coronary 
angiogenesis, which leads to the development of cardiac pathological stimuli (Shiojima & 
Walsh, 2006). Thus, the PKB/Akt signalling pathway is implicated in the regulation of cardiac 
growth (DeBosch et al., 2006). 
1.10 Apoptosis and necrosis 
Apoptosis is a form of programmed cell death which is energy-dependent. It plays an 
essential role in both physiological and pathological processes (Norbury & Hickson, 2001). It 
is regulated by specific receptors that activate downstream caspases, which leads to the 
degradation of proteins and subsequent apoptosis (Metzstein et al., 1998). An alternative 
form of cell death is necrosis, which is considered to be an uncontrollable passive process 
and is known to be an energy-independent death (McLaughlin et al., 2001). Necrosis is 
characterized as the degenerative processes that can  exclusively occur  after cell death; it is 
known to be an irreversible and un-regulated process (Elmore, 2007).  
Structural changes and the biochemical network of cell death have been investigated, using 
a number of approaches, to determine the difference between apoptosis and necrosis with 
regard to various extracellular stimuli.  Studies found that apoptotic cells appear to be DNA-
fragmented: the cells shrink and exhibit membrane blebbing, but they do not release their 
cellular organelles into the extracellular space; thus they are rapidly phagocytosed, 
preventing inflammation (Savill & Fadok, 2000; Kurosaka et al., 2003). In contrast, necrosis 
shows a swelling of the cell and a loss of membrane integrity, followed by the release of 
cellular constituents to the surrounding tissue, forming an inflammatory response (Kerr et 
al., 1972; Majno & Joris, 1995; Trump et al., 1997). However, despite the fact that each type 
of cell death can have different mechanisms, it can be difficult to distinguish necrosis from 
apoptosis using morphological analysis. In fact both forms of cell death may occur 
simultaneously relying on intracellular ATP (Adenosine triphosphate) and caspase activation 
(Zeiss, 2003). Major differences between apoptosis and necrosis are summarized in Table 1.2 
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Table 1.2 Apoptosis versus necrosis. Taken from (King , 2000). 
 Apoptosis Necrosis 
Stimuli Genomic damage 
Imbalance in signalling pathways 
Programmed tissue remodeling 
Hypoxia 
Changes in pH 
Hypoxia 
Anoxia 
Absence of nutrients 
 
Morphological 
changes 
 
Individual cell affected 
Decreased cell volume 
Condensed chromatin 
Unaffected lysosome 
No inflammatory response 
Apoptotic bodies are phagocytes  
Groups of cells affected 
Increased cell volume 
Fragmented chromatin 
Abnormal lysosome 
Marked inflammatory response 
Cell lysis 
 
Molecular 
changes 
Gene activity required for 
programmed cell death 
Increase in intracellular calcium 
Ion pumps continue to function 
Don’t require gene activity 
Unaffected intracellular calcium 
Impaired ion pumps 
 
1.10.1 Two distinct signalling pathways of apoptosis 
The molecular machinery of apoptosis involves two main pathways, the extrinsic and the 
intrinsic pathway, both of which converge on the cleavage of caspase-3 and result in a 
biochemical modification of the cell (Igney & Krammer, 2002).  Caspase-3 is a proteolytic 
enzyme belonging to the cysteine protease family, playing a major role in both apoptotic 
pathways (Gown & Willingham, 2002). Its sequential activation occurs in the early stages of 
apoptosis, similar to other caspase family members, as shown in Figure 1.10 (Krysko el al., 
2008). The extrinsic pathway is initiated by extracellular ligand binding to death receptors at 
the plasma membrane; such ligands are members of the TNF (tumour necrosis factor) family. 
Some examples of include FasL, TNF-α and TRAIL (TNF-related apoptosis-inducing ligand. 
(Chicheportiche et al., 1997). Members of their receptors possess a cytoplasmic “death 
domain” (Ashkenazi & Dixit, 1998). Once these receptors are activated by ligand binding, the 
adaptor protein FADD (Fas associated death domain) is  recruited and binds to the death 
domains of the receptor (Wajant, 2002). The resultant DISC (death-inducing signalling 
complex), cleaves pro-enzyme caspase-8 into active caspase 8 (Kischkel et al., 1995). 
Caspase-8 then activates the “executioner” caspase-3, thereby converging with the intrinsic 
pathway (Weinberg, 2007). Following activation, caspase-3 cleaves various death substrates 
such as ICAD (inhibitor of caspase activated DNase) and lamin, which in turn induces the 
apoptotic cell phenotype (Weinberg, 2007). The extrinsic pathway can be controlled by c-
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FLIP (cellular FLICE-like inhibitory protein). This protein binds to the FADD and caspase-8, 
thus inhibiting apoptotic signals (Kataoka et al., 1998). 
An alternative extrinsic apoptotic pathway is triggered by cytotoxic T-cell. These cells are 
able to kill target cells such as tumour cells and virus-infected cells by attaching to their 
surface and secreting the serine protease granzyme B (Trapani & Smyth, 2002). Following 
secretion, granzyme B attaches and becomes internalized in the cytosol of target cells, 
resulting in the cleavage of pro-caspases 10 and 3.  In this way, they converge with other 
apoptotic pathways, leading to morphological biochemical changes which characterize 
apoptotic cell death.  
Another spectrum of apoptotic cell death is the non-receptor intrinsic pathway, since it is 
initiated by internal signals that originate within the cell such as excessive calcium, radiation, 
free radicals and hypoxia (Elmore, 2007).  These signals cause the mitochondria to release 
cytochrome c and Smac (second mitochondria-derived activator of caspases) into the 
cytoplasm. Cytochrome c interacts with Apaf-1 (apoptotic protease activating factor-1) 
forming an apoptosome complex resulting in the activation of caspase-9, while 
Smac/DIABLO proteins (second mitochondria-derived activator of caspases /direct IAP 
binding proteins) function to inactivate anti-apoptotic proteins (Weinberg, 2007). The 
resultant active caspase-9 is involved in processing pro-caspase-3 into active effector 
caspase-3, thereby converging with the extrinsic pathway as shown in Figure 1.10 (Hill et al., 
2004). 
The release of cytochrome c from mitochondrial channels is regulated by members of the 
Bcl-2 family of proteins (Cory & Adams, 2002). For example, anti-apoptotic proteins including 
Bcl-2 (B-cell lymphoma 2) and Bcl-XL (B-cell lymphoma-extra-large) are involved in keeping 
the outer mitochondrial channel closed, thus preventing the release of cytochrome c. On the 
other hand, Bax (Bcl-2-associated X protein), Bad (Bcl-2-associated death promoter), Bak 
(BcL-2 antagonist/killer 1) and Bid (BH3-interacting domain death agonist) are pro-apoptotic 
proteins that function to open mitochondrial channel and induce the release of cytochrome 
c to stimulate the initiation of apoptosis (Weinberg, 2007). Therefore, Bcl-2 family proteins 
play a major role in determining whether a cell commits to apoptosis or cell survival (Elmore, 
2007). 
Chapter 1 
26 
 
 
Figure 1.10 A simplified schematic representation of extrinsic and intrinsic apoptotic 
pathways.   
Each pathway requires specific stimuli to induce molecular machinery events that promote activation 
of their own caspase (8,10,9). The resultant active caspase-3 induces apoptotic cell death. 
 
1.10.2 OP-induced apoptosis 
Several studies have shown that OP exposure results in the induction/modulation of 
apoptosis. For example, exposure to chlorpyrifos resulted in DNA double-strand breaks 
associated with cell apoptosis in human HeLa and HEK293 cells (Li et al., 2015). A large 
amount of evidence has shown that OP-induced cell death involves several apoptotic 
markers such as cytochrome c release, caspase activation, and nuclear fragmentation (Saleh 
et al., 2003). For example, treatment of NK-92C1 cells with the OP dichlorvos triggered 
apoptosis via JNK activation and subsequent caspase-3 stimulation (Li et al., 2007). Another 
study using primary cortical neuron cells reported that chlorpyrifos induced neurotoxicity, 
triggered apoptosis and reduced mitochondrial function via the activation of ERK1/2, JNK, 
and p38 MAP signalling pathways (Caughlan et al., 2004). This is consistent with a recent 
study that found that chlorpyrifos targeted 40% of apoptotic genes in undifferentiated and 
differentiating PC12 cells (Slotkin & Seidler, 2012). Taken together, these findings suggest 
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that OPs induce cell death by apoptotic-dependent pathways both in vivo and in vitro. 
Studies demonstrating OP-induced apoptosis are summarized in Tables 1.3 and 1.4. 
 Table 1. 3 OP-induced cell death by apoptotic-dependent pathways In vivo studies 
 
 
 
Table 1. 4 OP-induced cell death by apoptotic-dependent pathways in vitro studies 
 
 
 
 
Organophosphate 
 
Animal model Dose Incubation Time 
Dichlorvos Rat brain 6 mg/kg bw    12 weeks 
(Kaur et al., 2007) 
Chlorpyrifos Mouse retina 63 mg/kg  Single treatment- 24 h  
 (Yu et al., 2008) 
Diazinon New born rats 1 or 2 mg/kg    
on postnatal 
days 1-4  
4 days  
(Slotkin & Seidler, 2007) 
Phosphamidon Wistar strain male 
albino rats 
35 ppm in 
drinking 
water 
30 days  
(Akbarsha & Sivasamy, 
1997) 
Organophosphate Cell line Concentration Incubation time 
Chlorpyrifos PC12 cell line 30 μM 24 and 72 h 
(Slotkin & Seidler, 2012) 
Chlorpyrifos and 
dichlorvos 
Human monocyte 
cell line U937 and   
NK-92MI , NK-
92CI cell lines 
25, 50, 100 ppm  4h  (Li et al., 2009) 
Carbofuran Rat neuronal 
cortical cells   
500 µM 3 days (Kim et al., 2003) 
Endosulfan and 
zineb 
SH-SY5Y human 
neuroblastoma 
cells 
100 µM 20 h (Jia & Misra, 2007) 
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1.11 H9c2 cells 
Of particular interest to the current study was the availability of a cardiomyocyte like rodent 
cell line. H9c2 cells are derived from embryonic rat heart tissue (Kimes & Brandt, 1976) and 
have been used widely as an in vitro model, since they display similar morphological, 
electrophysiological and biochemical properties to primary cardiac myocytes (Hescheler et 
al. 1991). A number of studies have used mitotic H9c2 cells which possess a more skeletal 
muscle-like phenotype and express nicotinic acetylcholine receptors (Kimes & Brandt, 1976; 
Zara et al., 2010).  However, H9c2 cells in their mitotic form lack some of the properties of 
cardiomyocytes, such as gap junction communication and T tubules, and also show an 
absence of multi-nucleated cells due to cardiomyocyte de-differentiation (Hescheler et al., 
1991). With regard to H9c2 mitotic cells, this may actually limit the utilization of H9c2 cells 
and for this reason differentiated H9c2 cells represent a more physiological relevant cell 
model. 
1.11.1 Differentiation of H9c2 cells  
A number of studies have used this cell line as an in vitro model for cytotoxicity studies 
(Hosseinzadeh et al., 2011). Under the right conditions, H9c2 cells are able to be 
differentiate into a more cardiomyocyte-like phenotype. This property enhances the use of 
H9c2 cells as a model cell line in which to study OP-induced toxicity.  When cultured with 
reduced levels of foetal bovine serum (FBS) and 10 nM retinoic acid, H9c2 cells undergo 
morphological and physiological changes (Menard et al., 1999). These changes include the 
appearance of elongated multinucleated myotubes with recognizable actin filaments and 
branched fibres of differentiated cardiomyocytes (Kadivar et al., 2006; Zara et al., 2010). 
Differentiation of H9c2 cells into a more cardiomyocyte-like phenotype is associated with 
the increased expression of cardiac specific proteins. For example, it has been shown that 
differentiated H9c2 cells express specific cardiac markers such as cardiac specific Ca2+ 
channels and cardiac troponin (Menard et al., 1999). Cardiac troponin is a specific cardiac 
cytoskeleton protein that is involved in muscle contraction (O’Brien et al., 2008). 
Furthermore, its expression has been shown in differentiated human embryonic stem cell-
derived cardiomyocytes but not in undifferentiated human embryonic stem cells (Xu et al., 
2002).   
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At the molecular level, differentiation of H9c2 cells is regulated via a complex signal 
transduction pathway involving lipid and protein kinases. Several kinase cascades are 
associated with and up-regulated during cellular differentiation; the activation of such 
cascades may help to explain the differentiation process in cell behavior (Qiao et al., 2012). 
For example, the PI-3K/PKB pathway promotes the differentiation of H9c2 cardiomyoblasts  
(Kim, 1999; Naito et al., 2003). In addition, PKC (protein kinase C) has been reported to be 
involved in the differentiation of H9c2 cells (Zara et al., 2010). The interaction of PKC with 
serine/arginine-rich splicing factor 2 (SC35) contributes to the morphological changes that 
are related to the cardiomyoblast phenotype (Zara et al., 2010). More importantly, the 
physiological and cellular changes associated with retinoic acid-induced differentiation is 
complex and involves the expression of distinct proteins (Duester, 2013).  It is therefore 
important to identify how retinoic acid induces differentiation.  
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1.11.2 Cardiac excitation-contraction coupling  
Excitation-contraction coupling (ECC) is the process where heart cells contact via an action 
potential process. Actin potential is an electrical stimulation achieved by an ion flux through 
a specialised channels in the cardiomyocyte membrane (sarcolemma) leading to heart 
contraction. Calcium ions is an important mediator for cardiac excitation-contraction process 
by entering in and out the heart cells during each action potential (Katz, 1992) . When 
calcium ions enter the cell through L-type calcium channels located on the sarcolemma. This 
calcium activates a calcium release from the sarcoplasmic reticulum (SR) through a 
specialised calcium receptors  called ryanodine receptors and further induce a large release 
of calcium in the cell (Flucher & Franzini-Armstrong, 1996) as shown in Figure 1.11. 
 
Figure 1.11 Cardiac contraction mechanism 
Calcium ions inter the cardiac cell via L-type calcium channels. Calcium then activates 
ryanodine receptors on the sarcoplasmic reticulum. ryanodine receptors induce calcium 
release from the sarcoplasmic reticulum leading to increase cytosolic calcium. As the 
contractile cycle ends, cytosolic calcium returns to the sarcoplasmic reticulum via the 
sarcoplasmic reticulum calcium channel. 
Chapter 1 
31 
 
Cardiac contraction is regulated by binding of free calcium ions to troponin-C protein which 
is a part of the regulatory contract complex attached to the thin filaments (Mckillop & 
Geeves, 1993). Binding of calcium ions to troponin-C results in the conformational change of 
troponin/tropomyosin complex and exposing the actin binding site. Cross-bridge formation 
of myosin to actin occurs with ATP hydrolysis to ADP+Pi. A power stroke moves actin 
filament toward the center of the sarcomere and ADP+Pi are released from myosin heads as 
ATP energy is used to contract cardiac muscle (Mckillop & Geeves, 1993). At low cytosolic 
calcium concentration induces a conformational change in troponin complex leading 
troponin/tropomyosin complex binding to actin and a new ATP binds to the myosin head. 
Binding of ATP to myosin lowers the binding affinity of myosin to actin and allows myosin 
release from actin. (Balaban et al., 2003). Myosin then cock back to its position and ready to 
make cross bridge for a further contracting cycle (Balaban et al., 2003). 
The H9c2 cell line has been established from embryonic rat cardiac ventricle and it has 
properties similar to neonatal and adult cardiomyocytes (Menard et al., 1999). After 
undergoing differentiation, these cells can functionally express L-type calcium channels ATP-
sensitive potassium channels (Menard et al., 1999). Examination of the action potential and 
contractility of H9c2 cells cardiac cells has been well-established previously by using cell 
contraction assay. H9c2 cells was successfully proven to contract by measuring changes in 
the planar surface areas at different time point (Ku et al., 2011). Previous study also 
characterized the calcium dependent activation and ion selectivity in H9c2 cells. In H9c2 
myotubes, cells were found to express L-type calcium that activates potassium channels 
directly or indirectly via calcium induced calcium release from sarcoplasmic reticulum. Thus, 
H9c2 cell line has served as a useful alternate of cardiac and skeletal muscles (Wang et al., 
1999).  
1.11.3 The role of retinoic acid in the differentiation of H9c2 cells 
Retinoic acid (RA) is an active form of vitamin A (retinol). It is involved in cardiac 
development as well as in cellular proliferation and differentiation in the mammalian 
embryo (N’soukpoé-Kossi et al., 2014). RA enters the cell and binds to cellular retinoic acid-
binding protein (CRABP), which facilitates its transport into the nucleus. In the nucleus, RA 
binds to the nuclear receptor RAR/RXR (retinoic acid receptor/ retinoid X receptor) 
heterodimer which recognizes a specific DNA sequence within the target gene known as the 
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RA response element (RARE; Chambon, 1996). In response, this recruits co-activator 
proteins, which themselves induce transcriptional activity and trigger cardiac differentiation 
as shown in Figure 1.12 (Kumar & Duester, 2011). 
 
 
 
Figure 1.12 Retinoic acid signaling pathway in H9c2 cells. 
Retinol enters the cell and binds to cellular retinoic acid-binding proteins (CRABPs) and is 
metabolized to retinaldehyde followed by metabolism of retinaldehyde to retinoic acid (RA). RA 
binds to CRABPs, enters the nucleus and binds to RARs and RXRs, termed heterodimer receptor 
(RAR/RXR). These heterodimers bind to RAREs in target genes and regulates gene expression. 
 
Commitment to cardiac lineage is controlled by the up-regulation of specific cardiac genes 
such as Nkx2.5, which promotes differentiation of progenitor cells into cardiomyocytes 
(Martinez-Fernandez et al., 2014). Homeobox protein Nkx2.5 is expressed in the secondary 
heart field where it acts upstream of the BMP (bone morphogenic protein) and the FGF 
(fibroblast growth factor) pathways, both of which promote myocardial differentiation (Prall 
et al., 2007; Dyer et al., 2010). Nkx2.5 is also known to interact with another transcriptional 
factor, namely, Pitx2c, where this interaction is normally required for heart looping (Simard 
et al., 2009).   
Chapter 1 
33 
 
More recent studies have suggested that RA acts in parallel to EPO (erythropoietin) 
pathways and in this way both EPO and RA induce the release of cardiac mitogens, such as 
neuregulin (Chen et al., 2002; Kang & Sucov, 2005). RA also induces cardiomyocyte 
proliferation through biochemical pathways that involve the activation of PI-3K and ERK1/2 
(Niederreither & Dolle, 2010). Furthermore, it has been observed in heart tissue that has a 
deficiency in RXR (a specific RA receptor) produces a reduction in the phosphorylation of PKB 
and ERK1/2, two important signalling pathways associated with cellular proliferation and 
differentiation (Kang & Sucov, 2005). 
Another function of RA is the regulation of growth factor signalling such as FGF (fibroblast 
growth factor), as confirmed in a study of the developing hearts of chickens and mice (Mima 
et al., 1995). Moreover, it was also found that FGF was responsible for controlling cardiac 
proliferation at early stages of development (Lavine et al., 2005). Potentially, the activation 
of FGF expression is important with regard to heart expansion, as demonstrated in Zebrafish 
where excess exposure to RA leading to an increased expression of fibroblast growth factor 
9 in the epicardial layer (Marques et al., 2008).  
As previously mentioned, RA-mediated pathways play a critical role in cell lineage control 
(Huang et al., 2011). More importantly, RA induces the differentiation of cardiac myoblasts 
and a key to understanding this is the characterization of embryonic stem cell models that 
have been differentiated towards cardiac lineage. For instance, Wobus et al. (1997) 
observed that RA controls the differentiation of precursor germ cells in a concentration-
dependent manner (Wobus et al., 1997).  Similarly, Honda et al. (2005) noticed that RXR 
directs the undifferentiating embryonic stem cell into a beating cardiomyocyte. Indeed, 
blocking the RA receptor prevents progenitor cells from differentiating into cardiomyocytes 
(Zhou et al., 1995; Wang et al., 2002). Moreover, it was also found that RA inhibited the 
expression of myogenin in embryonic muscle cells, leading to the inhibition of myogenic 
differentiation and enhancing cardiac differentiation (Xiao et al., 1995). Myogenin is a 
transcription factor involved in the coordination of skeletal muscle development that is 
regarded as a specific marker for skeletal muscle (Menard et al., 1999). 
It is also important to note that electrophysiological studies have confirmed that RA induces 
differentiation of cardiomyocytes (Menard et al., 1999). For example, RA induces the 
Chapter 1 
34 
 
expression of cardiac specific ion channels e.g. L-type Ca2+ channels (Gassanov et al., 2008) 
which are crucial for cardiac contractile function (Trautwein & Hescheler, 1990). 
Furthermore, RA is associated with an increased expression level of the pore-forming 1C 
subunit of cardiac L-type Ca2+ channels, which is essential for maintaining the cardiac 
phenotype  (Kimes & Brandt, 1976; Kolossov et al.,1998).  
On the basis of the above it can be seen that RA is involved in the differentiation of 
cardiomyoblasts into cardiomyocyte-like cells. To date, very few studies have investigated 
the effects of organophosphates on cardiac cells. The present study will therefore 
investigate the effect of OPs using H9c2 cardiomyoblasts cells that have been derived from 
embryonic cardiac tissue and have similar features to cardiomyocytes. This will provide 
further valuable understanding of the cellular mechanisms involved in OP-induced 
cardiotoxicity. 
1.12 Stem cells 
Stem cells are defined by 3 fundamental properties and they the ability to self-renew and 
replace themselves, the ability to differentiate into 1 or more lineages or specialized cell 
types, and enormous proliferative potential to renew and maintain the tissues they populate 
(Thomson, 1998). Potency specifies the differential potential of the stem cells. Totipotent 
stem cell is the fertilised egg that gives rise to the first divisions of the cell. These cells can 
differentiate into embryonic and extraembryonic cell types; only the morula cells are 
totipotent which are able to become all tissue type including a placenta. Pluripotent stem 
cells (PSCs) are cells that originates from the inner mass cell of the blastocyst and have the 
ability to generate several different tissue types, excluding the placenta. Multipotent stem 
cells can produce only cells of a closely related family of cells e.g. cells in the brain that give 
rise to different neural cells and glia, but they can not produce blood cells or haematopoietic 
cells, which can give rise to different blood cell types, but they can't produce brain cells. 
Unipotent stem cells are able to develop into only one kind of cell. They normally develop 
into the same type of cell as those in the tissue from which they derive (Figure 1.13; Odorico 
et al.,2001). Finally, stem cells can be divided into different types, namely embryonic stem 
cells (ESCs), adult stem cells (ASCs) and induced PSCs (iPSCs).  
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Figure 1.13 Simple diagram of stem cell potency. 
Differential potential of the stem cells are totipotent embryonic stem cell that can produce any type 
of cells. Pluripotent stem cell that can also differentiated in to any specialized cell type, this include 
endoderm, mesoderm and ectoderm cell line and excluding embryonic tissue. Multipotent stem cell 
that can give a raise to unipotent stem cell, which can be differentiated into one specific cell type. 
 
1.12.1 Embryonic stem cells  
ESCs are PSCs that have the ability to differentiate into the three embryonic germ layers, 
which are the ectoderm, mesoderm, and endoderm (Shamblott et al., 1999). These cells can 
be isolated and maintained as undifferentiated cell lines or stimulated to differentiate into 
specific cell lineage in the body (Thompson, 1998). ESCs can be distinguished from 
multipotent cells present in adults according to their pluripotency, as multipotent cells are 
only capable to differentiate into specific tissue cells (Thompson, 1998). ESCs specific 
properties have attracted major research interest, particularly in cell therapy (Mitsui et al., 
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2003). However, a number of ethical controversy have been raised in relation to the 
utilisation of human embryos as a cell source (McLaren, 2001). 
1.12.2 Adult stem cells  
ASCs are undifferentiated cells found throughout the body that divide to replace dying cells 
and regenerate damaged tissue. They are also known as somatic stem cells which can be 
found in children as well as adults (Takahashi et al., 2006). These cells can appear to exist in 
bone marrow and other tissues. However, in vitro, their differentiation process is challenging 
and poses some difficulties, as they have less possibility to differentiate in culture than ESCs. 
Ethically, these somatic stem cells are well accepted and they are not mired in controversy 
because no embryos are harmed when obtaining them (Wang et al., 2009). However, most 
ASCs are considered unipotent, as they are destined to grow into the same cell type from 
which tissue they originate (Avasthi et al., 2008).  
Certain ASC types are multipotent such as, mesenchymal stem cells (MSCs). They are highly 
heterogenous cells population consist of multiple cell types with different potential for 
proliferation and differentiations. They can be also be isolated from placenta and umbilical 
cord. Umbilical cord blood (UCB) makes allogeneic cell treatment possible due to the low 
possibility of immune rejection (Erices et al., 2000; Weiss & Troyer, 2006). Moreover, these 
cells have been shown to be useful in cellular therapy, as their healing effects have been 
proven in many pre-clinical and clinical studies. MSCs have been clinically tested and are 
associated limited ethical concerns (Hida et al., 2008). The possibility of healing 
improvement of impaired cardiac function via an MSC lineage derived from UCB has shown a 
practical recovery ability (Nishiyama et al., 2007). However, there is a remarkably low 
amount of MSCs in UCB (Kogler et al., 2004; Terai et al., 2005). Therefore, additional 
experiments need to be undertaken to establish an efficient source for MSCs. 
1.12.3 Induced pluripotent stem cells  
Previous researchers have proposed that cardiomyocytes can be derived from various 
human tissues as a source of stem cells (e.g., foetal tissues, adult cardiac progenitor tissue, 
BM and adipose tissue). However, cardiomyocytes derived from foetal or adult tissue are 
controversial due to their limited plasticity, which prevents their complete differentiation 
into functional cardiomyocytes (Dimmeler et al., 2008). Cardiomyocytes derived from adult 
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cardiac progenitor cells were shown to possess the strong opportunity to differentiate into 
beating cells (Blin et al., 2010). Furthermore, the ability of PSCs to efficiently differentiate 
into contracting cardiomyocyte-like cells has been demonstrated in vitro (Kehat et al., 2001; 
Mummery, 2003). However, due to the difficulties to obtain cardiomyocyte from adult 
cardiac progenitor, there have been breakthroughs of human induced pluripotent stem cell 
(iPSc). New techniques have been established  to provide a new source of differentiated 
functional cardiomyocytes in vitro that share similar properties of cardiomyocyte derived 
from hESC (Zhang et al., 2009). Therefore the current study utilised cardiomyocyte iPSCs due 
to the difficulty of obtaining them from human PSCs. 
iPSCs can be described as genetically reprogrammed somatic cells to express specific genes 
to transform the cells into an ESC–like state with defining properties. iPSCs possess the 
advantage of being similar to ESCs, as they can form different cell type (Takahashi & 
Yamanaka, 2006). The reprogramming of adult somatic cells (human fibroblasts) to iPSCs has 
been established by the transduction of transcription factors, such as Oct4 (octamer-
binding transcription factor 4), Sox2 (Sex determining region Y-box 2) and  Klf4 (Kruppel-like 
factor 4; Takahashi et al., 2007; Shi et al., 2008; Huangfu et al., 2008). These iPSCs are 
capable of indefinitely renewing themselves and differentiating into numerous cell types, 
including pancreatic β-cells, hepatocytes, haematopoietic cells and cardiomyocytes (Sanders, 
2012). More recently, certain reprogramming factors and chemical compounds, such as 5'-
azacytidine (a DNA demethylating agent) and valproic acid (a histone deacetylase inhibitor), 
have been demonstrated to improve the efficiency of iPSCs without causing genetic 
alterations (Mikkelsen et al., 2008). To emphasise cardiac differentiation, iPSCs can be 
treated with signalling molecules, such as activin A and BMP4 (bone morphogenic protein 4; 
Laflamme et al., 2007, Yang et al., 2008). Remarkably, some studies have reported minimal 
and insignificant differences in transcriptional profiles between cardiomyocytes derived 
from ESCs and cardiomyocytes derived from iPSCs. Moreover, Gupta et al. (2010) reported 
that the two types of PSC-derived cardiomyocytes’ transcriptional profiles were identical. It 
has also been demonstrated that ESC and iPSC-derived cardiomyocyte types show similar 
sarcomere organisation and the ability to differentiate into cardiomyocyte subtypes (eg, 
ventricular, atrial, and nodal); furthermore, they are both able to differentiate into 
cardiomyocyte subtypes like ventricular, atrial and nodal cardiomyocytes (Zhang et al., 
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2009). This appears to indicate that it is possible for iPSCs to replace ESCs successfully for 
cardiac tissue engineering and cell-based treatment sources as shown in Figure 1.13 (Batalov 
& Feinberg, 2015).  
 
 
 
 
 
Figure 1.11 Schematic representation of iPSC generation  
Patient-derived somatic cells can be reprogrammed or genetically engineered and expanded in vitro 
to produce iPSC. These cells then can differentiate into the interested specialized cell type and 
candidate for several use including disease modelling and drug screening. Taken from (Batalov & 
Feinberg, 2015).  
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1.15 Aims and Hypothesis 
Literature review indicated that OPs can and cause human poisoning. Exposure to OPs lead 
to neurotoxic effects depending on the dose, frequency of exposure, and the type of OP. 
Toxicity of OP may also induce toxic myocarditis and a late occurrence of sudden death. At 
present, the majority of studies have focused on the effects of OPs on the central nervous 
system. There is very little information on the effect of OPs on muscle function, particularly 
toxic effects on cardiac muscle. There for it was important to investigate direct  toxic effect 
of OPs on cardiomyocytes. The present study hypothesis that OPs would cause apoptotic cell 
death in H9c2 cardiomyocyte-like cells, and modulate cell signalling involved in cell death 
and cell survival.  In addition OPs may target specific proteins involved in cardiac contraction 
leading to a serious cardiac complication. There for this study aimed :  
• To study the morphological characteristics of differentiated H9c2 
cardiomyocytes. 
• To determine the effects of OPs on the viability of undifferentiated (mitotic) and    
differentiated rat H9c2 cells. 
• To identify cell signalling pathways implicated in OP-induced effects.     
• To detect and identify using dansylated PSP possible protein targets of PSP in 
differentiated H9c2 cells. 
• To assess the effect of sub-lethal concentrations of OPs on the differentiation of 
H9c2 cells. 
• To validate the cytotoxic effects of OPs in a human induced pluripotent stem cell 
derived cardiomyocytes 
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2.1 Material 
2.1.1 Cell culture reagents 
Dulbecco’s modified Eagle’s Medium (DMEM), foetal bovine serum (FBS), trypsin (10 ×), L-
glutamine (200 mM), penicillin (10,000 U/ml)/streptomycin (10,000 µg/ml) were purchased 
from BioWhittaker Lonza Group Ltd., UK. Phosphate buffered saline (PBS) were obtained 
from Life Technologies (Invitrogen, UK). All-trans-retinoic acid was obtained from Sigma-
Aldrich Co. Ltd (Gillingham, Dorset, UK). All other chemicals were purchased from Sigma-
Aldrich and of analytical grade.  
2.1.2 Human induced plouripotent stem cells (hiPSC-CC)  cell culture 
Vial of frozen hiPSC-CC, cardiomyocyte plating medium-basal, Cardiomyocyte Growth 
supplement were purchased from (Sciencell research laboratories, Carlsbad, USA).  
2.1.3 Chemical compounds 
Chlorpyrifos, chlorpyrifos oxon, diazinon, and diazoxon were purchased from Greyhound 
Chromatography and Allied Chemicals (Birkenhead, Merseyside, UK). Phenyl saligenin 
phosphate (PSP) and dansylated PSP were synthesized in house at Nottingham Trent 
University. Stock concentrations of 100 mM OPs were diluted in DMSO (dimethyl 
sulphoxide), which was present in all treatments including the control at a final 
concentration of 0.5 % (v/v). 
2.1.4 Kinase inhibitors 
LY 294002 (30 mM), PD 98059 (50 mM), SB 203580 (30 mM), SP 600 125 (20 mM) and 
wortmannin (10 mM) were obtained from Tocris Bioscience (Bristol, UK) were diluted in 
DMSO which was present in all treatments including the control at a final concentration of 
0.5 % (v/v). 
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2.1.5 Antibodies 
Table 2. 1 List if Primary antibodies for Western blotting and immunocytochemistry 
techniques and their working dilutions. 
 
 
Antibody 
 
Working 
dilution 
(Western 
blotting) 
 
Working 
dilution 
(immuno- 
Cytochem.) 
 
 
Company 
 
Monoclonal phospho-specific JNK 
(Thr183/Tyr185) 
 
1:1000 
NA New England Biolab, 
UK, 9251 
Polyclonal total unphosphorylated JNK  
 
1:1000 
NA New England Biolab, 
UK, 9252 
Polyclonal phospho-specific PKB (Ser473)  
1:1000 
NA Sigma-Aldrich, UK, 
9271 
Polyclonal total unphosphorylated PKB   
1:1000 
NA New England Biolab, 
UK, 9272 
Monoclonal phospho-specific ERK1/2 
(Thr202/Tyr204) 
 
1:1000 
NA Sigma-Aldrich, UK, 
M8159 
Monoclonal phospho-specific p38 MAPK 
(Thr180/Tyr182) 
 
1:1000 
NA New England Biolab, 
UK, 9216 
Polyclonal total unphosphorylated p38 
MAPK  
 
1:1000 
NA New England Biolab, 
UK, 9212 
Monoclonal total unphosphorylated 
ERK1/2 (9107) 
 
1:1000 
NA New England Biolab, 
UK, 9107 
Monoclonal cleaved caspase-3  
1:500 
 
1:500 
New England Biolab, 
UK, 9661 
 
Polyclonal Troponin 1 
 
 
1:1000 
 
1:1000 
 
Abcam, UK, 47003 
   
 
Polyclonal Tropomyosin 
 
 
1:100 
 
1:500 
 
Abcam, UK, ab77884 
 
  
Monoclonal  α-actin 
1:1000 1:100 Abcam, 
UK,  ab124964 
GAPDH 1:1000 NA Abcam, Uk, ab8245 
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Table 2. 2 List if secondary antibodies for western blotting and immunocytochemistry 
techniques and  their working dilutions.  
 
Antibody 
 
Working dilution 
(Western blotting) 
Working dilution 
(immuno- 
cytochemistry) 
 
Company 
Anti-mouse IgG-HRP 1:5000 NA Sigma-Aldrich,UK 
(A4416) 
Anti-rabbit IgG-HRP 1:5000 NA Sigma-Aldrich, UK 
(A0545) 
Anti-mouse-Alexa 568 NA 1:200 Molecular Probes, 
UK, A-11031 
Anti-rabbit-Alexa 568 NA 1:200 Molecular Probes 
Invitrogen, UK, 
A10042 
 
2.2 Methods  
2.2.1 Cell Culture 
Cells (H9c2) derived from rat embryonic cardiomyoblast were purchased from the European 
Collection of Animal Cell Cultures in (Porton Down, UK). Mitotic H9c2 cells were  cultured in  
T75 culture flasks in  Dulbecco’s Modified Eagle’s Medium (DMEM), supplemented with 2 
mM L-glutamine, 10% (v/v) Fetal Bovine Serum, 100 U/ml penicillin and streptomycin (100 
µg/ml). Cells were grown in a humidified incubator of 5% CO2, 95% air at 37 °C and left 
overnight.  Cells were grown until they reached 70-80% confluence and growth monitored  
using a light microscope. Cells were sub-cultured by removing the medium and washing the 
cells with 10 ml sterile phosphate buffered saline (PBS). Cells were then detached  by using 
trypsin (0.05 % w/v)/EDTA (0.02 % w/v) in PBS and left for 2-3 min in the humidified 
incubator. 10 ml of fully supplemented DMEM medium was added to the trypsinized cells 
and centrifuged for 5 min at 5000 xg. Supernatant was discarded and the cell pellet 
resuspended in 1 ml of the medium. Cells were then further sub-cultured  (1:5 split ratio). 
2.2.2 H9c2 cell differentiation 
Differentiation of H9c2 cells were induced by culturing the myoblasts cells for 7 days with  
growth medium (DMEM) supplemented with 1% (v/v) FBS and 10 nM all-trans retinoic acid. 
The medium was replaced every 2 days. To confirm the effect of differentiating treatment, 
cells were monitored under a light microscope every 2 days. Cells showed cardiomyocyte-
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like phenotype by forming multinucleated elongated myotubes. Further confirmation was 
performed by monitoring the expression of cardiac specific troponin 1 via 
immunocytochemistry and western blotting. 
2.2.3 Human induced stem cell (hiPSC-CC) cell culture 
Prior to HPSC-CC culture, three wells of 6-well plate were coated with 2 ml 1% (v/v)  
fibronectin in sterile Ca2+ and Mg2+ free Dulbecco’s phosphate buffered saline, (DPBS) per 
well and incubated overnight in a humidified incubator at 37oC. Next day Cardiomyocyte 
Plating Medium (CPM) was warmed at room temperature, and the coating fibronectin 
solution aspirated from the three wells and 1 mL of the warmed CPM was added to each 
well. Cryopreserved cells (hiPSC-CC), obtained from Sciencecell research laboratories, were 
thawed gently in a  water bath (37oC) for 90 seconds and transferred to a 15 mL conical tube, 
resuspended in 10 ml of CPM and centrifuged at 5000 xg for 5 min at room temperature. 
The supernatant was carefully aspirated avoiding any disturbance of the cell pellet and 6 mL 
of CPM add to the pellet with gentle mixing 2 - 3 times. After which 2 mL of cell suspension 
was added to each fibronectin coated well (3000,000 cell/well) and incubated 48 h in a 
humidified incubator 37oC to avoid any disturbance of cultured cells. On the third day the 
medium was replaced by cardiomyocyte growth medium (CGM) to remove unattached cells. 
Cells were then detached by trypsin (0.05 % w/v)/EDTA (0.02 % w/v) in sterile phosphate 
buffered saline (PBS). Maturation and contraction of HPSC-CC was induced by culturing the 
cells for 7 days in CGM. The CGM medium was replaced every 48 h. The cells were 
monitored under light microscope to maturation and contraction. Further confirmation was 
performed by monitoring the expression of cardiac specific troponin 1, trypomyosin and α-
actin via immunocytochemistry. 
2.2.4 Cells count 
The amount of viable cells was determined prior to any treatment. Trypan blue exclusion 
assay a method was used to estimate viable cell count. The H9c2 cell pellets were re-
suspended in 1.0 ml of medium that was prepared during sub-culturing (section 2.2.1). A 
volume of 10 μl of cell re-suspension was mixed with 10 μl trypan blue dye. This mixture was 
pipette onto an Improved Neubauer haemocytometer (Camlab, UK) (0.1 mm depth, 400 
mm-2) and the cells were counted in the four (0.1 mm3) corner squares via light microscope 
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at (100x) magnification (Olympus CK40-54-SLP, Japan). The cell density per ml was then 
calculated according to the following formula : 
 Cell density = cell number (mean from four fields) x 104 x dilution factor 
2.2.5 Experimental procedure  
 
Figure 2.1 A schematic representation of the experimental procedure 
A) Cultured mitotic H9c2 cells. B) Cells were induced to differentiate for 7 days. C) Differentiated 
H9c2 cells are incubated with the desired concentration of OPs at different time points. Different 
analyses were performed to study the effect of different concentrations of OPs on differentiating 
H9c2 cells. 
 
2.2.6 Immunocytochemistry 
Cells (H9c2) were seeded in 8-well chamber slides (BD Falcon Culture Slide) at a cell density 
of 15,000 cells/ chamber, for 24 hours with DMEM medium. The medium was removed and 
replaced with differentiation medium and incubated for a further 7 days with the 
differentiation medium changed every 2 days. After 7 days incubation H9c2 cells were 
completely differentiated. The medium was then aspirated gently from the chambers and 
the adherent cells were washed gently with pre-warmed PBS (37 C°) three time for 5 min. 
Cells were then fixed in 3.7% (w/v) paraformaldehyde (Sigma-Aldrich, UK) in PBS for 15 min 
at room temperature without agitation. Cells were then washed gently with pre-warmed 
PBS (37 °C) three times for 5 min and  permeabilized with 0.1% (v/v) Triton X-100 in PBS for 
15 min at room temperature without agitation. Cells were washed gently with pre-warmed 
PBS (37 °C) three times for 5 min. Fixed cells were then blocked by incubating the cells for 2 
h with 3% (w/v) bovine serum albumin (BSA) in PBS (BSA/PBS) at room temperature without 
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agitation to prevent non-specific binding of antibodies. After blocking, cells were then 
incubated with specific primary antibody (1:1000) in 3 % (w/v) BSA in PBS (see table 2.1) and 
left over night at 4 °C in a humidified chamber. Cells were then washed gently with PBS three 
times for 5 min to remove unbound primary antibody. Cells were then then incubated for 2 
h at 37 °C in a humidified chamber with the secondary antibody anti-mouse immunoglobulin 
G conjugated Fluorescein isothiocyanate (FITC; Abcam, UK),  diluted 1:1000 in 3 % (w/v) BSA 
in PBS (see table 2.2). The chamber slides were then washed gently three times with PBS for 
5 min. Cells were air dried and mounted with Vectashield® mounting medium (Vector 
laboratories Ltd, Peterborough, UK) containing DAPI (4',6-diamidino-2-phenylindole) nuclear 
counterstain for nuclear visualization. Slide were then cover-slipped and sealed from the 
edges of the cover slip by transparent nail varnish and left to dry for 5 min at room 
temperature. Finally, immunostained cardiomyocytes were visualized using an Olympus 
DP71 epifluorescence microscopic system equipped with an argon/krypton laser (FITC: 
EX493/EM528; DAPI: EX360/EM460).  
2.3 Cell Viability Assays 
2.3.1 MTT assay 
Cell viability was determined by measuring the activity of mitochondria respiratory chain via 
MTT (thiazolyl blue tetrazolium bromide, Sigma-Aldrich) reduction assay. The MTT is a dye 
that will is converted to water-insoluble purple formazan on the reductive cleavage of its 
tetrazolium ring by the respiratory enzyme succinate dehydrogenase in active mitochondria. 
Undifferentiated H9c2 cells were seeded in 24-well plat at a density of 15,000 cells/well for 
24 h (Sarstedt, Leicester, UK) in fully supplemented DMEM growth medium. Cells were then 
subsequently induced to differentiate for 7 days as described above in section (2.2.2). Cells 
were then treated with OPs at the indicated concentrations and incubation time. Following 
OPs exposure, cell viability was determined by incubating the cells with 0.5 mg/ml MTT 
solution in DMEM at 37 °C for 1 h. After that, the medium in each well was aspirated, and 
replaced with 500 µl of DMSO. The plate was then gently agitated to ensure sufficient 
dissolution of the water-insoluble purple formazan crystals. After that, 200 μl of the resulting 
solution was transferred into a 96-well plate (Sarstedt, Leicester, UK) and the absorbance of 
the solutions was read at 570 nm using a standard 96-well plate reader (Expert 96, Scientific 
laboratory, UK). The absorbance of the blank was subtracted from each sample absorbance 
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reading and the viability of the cells is directly proportional to the MTT reduction, which 
determined by the absorbance of the solubilized formazan product at 570 nm.  
2.3.2 LDH assay 
Cytotoxicity induced by OPs was assessed by lactate dehydrogenase (LDH) release into the 
culture medium. The LDH assay was performed according to the manufacturer’s instructions 
(CytoTox 96® non-radioactive cytotoxic assay kit, Promega, Southampton, UK). The assay is a 
colorimetric assay based on the measurement of LDH release from damaged tissue that 
catalyze the conversion of lactate to pyruvate via reduction of NAD+ to NADH. Then, the 
dehydrogenase enzyme diaphorase (present in the substrate mix in the kit)  coupled with 
NADH and the formation of red formazan product tetrazolium salt (INT). Thus, LDH release 
was proportional to the red formazan product. Cells (H9c2) where seeded into 96-well plates 
at a density of 5000 cells/well (Sarstedt, UK) and incubated overnight at 37 °C in fully 
supplemented DMEM growth medium to allow cell to adhere at the bottom of the plate.  
Cells were then differentiated for 7 days in differentiation medium as described in section 
(2.2.2). Following OP exposure, the plate was centrifuged (5 min, 300 g) to allow cellular 
debris to be compacted to the bottom of wells. A volume of 50 µl of the supernatant was 
then transferred to a new non-sterile 96 well plate and 50 µl of the reconstituted assay 
buffer (10 ml assay buffer added to one bottle of substrate mix, in kit) added to each sample 
well. The plate was then covered with foil and incubated at room temperature for 30 min 
using a mixer shaker. After that, a volume of 50 µl of assay stop solution (1 M acetic acid) 
was added to stop the reaction. The change in absorbance was monitored at 490 nm using a 
standard plate reader.  
2.3.3 Acetylcholinesterase (AChE) activity assay 
Cells (H9c2) were cultured in T75 culture tissue flasks and induced to differentiate for 7 days 
as described in section (2.2.2). Following experimentation, cells were detached using trypsin 
(0.05 % w/v)/EDTA (0.02 % w/v) and incubated for 2-3 min at 37 °C. Following detachment, 
10 ml of fully supplemented medium was added to the flask and centrifuged for 5 min at 
5000 Xg. The supernatant was then discarded and the pellet was resuspended in 1 ml ice 
cold PBS and transfered to an Eppendorf tube on. The cell suspension was centrifuged at 
47,000 xg for 3 min. Supernatant was discarded and 1 ml of ice cold 200 mM sodium 
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phosphate buffer (pH 7.4) containing 0.2% (v/v) Triton X-100 was added to the pellet and 
mixed gently up and down using a pipette. 100 µL of the sample suspension was added to 96 
well plate in four replicates,  followed by 50 µL of (0.03 % w/v) 1.25 mM acetyl thiocholine 
iodide in PBS and 50 µL of (0.047 % w/v) 1.25 mM of 5,5-dithiobis (2-nitro-benzoic acid) 
DNTB in PBS with gentle mixing. Using a standard plate reader change in absorbance was 
monitored at 405 nm and was linear over a 10 min period. Color intensity is proportional to 
the enzyme activity and data were expressed as mean specific activity (absorbance 
change/min/mg protein) from at least three independent experiments. 
2.4 Coomassie Blue Staining 
Cells were stained with Coomassie blue for morphological change detection and visualised 
under light microscopy. Cells were cultured and differentiated for 7 days as mentioned 
previously and exposed to OPs. The growth medium was aspirated and the cells were 
washed with PBS three times. The cells were then fixed at -20 °C with 90 % (v/v) methanol 
solution for 15 min. The methanol fixing solution was then removed and Coomassie blue 
staining solution (0.1% (w/v) Coomassie brilliant blue G, 50 % (v/v) methanol, 10 % acetic 
acid) was added the cells for 10 min to stain the cells. Staining solution was aspirated and 
stained cells were washed three times with deionised water and left to air dry at room 
temperature. 
2.5 Western Blot 
2.5.1 Cell lysis 
To examine the activation or the expression of cell signaling proteins, Western Blotting was 
employed. Cells (H9c2) were differentiated for 7 days in T25 tissue culture flasks. Following 
experimentation cells were rinsed twice with 2 ml of warmed PBS. A volume of 300 μL of hot 
(100 °C) sodium dodecyl sulfate buffer (0.5% w/v SDS in Tris buffered saline) was added and  
cells were removed by a scrapper from the flask surface. The resulting cell lysates were 
transferred to 1.5 ml Eppendorf™ tubes in order to guarantee the total lysate.  Cell lysates 
were then boiled for 10 min and samples stored at  -20°C until required.  
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2.5.2 Protein estimation 
Protein concentration in cell lysates was measured by  Bicinchoninic acid (BCA) protein 
method (Bio- Rad laboratories, Hertfordshire, UK) . In brief,  5 μl of the sample cell lysate  
was added in duplicate to a 96 well plate. After which 200 µl of assay reagent B and 25 µl of 
assay reagent A (1 ml of reagent A, 20 µl of reagent S, and set according to the instructions 
of the manufacturer) were added. The samples were then covered with foil and placed in 
the shaker for 30 min at room temperature. Bovine serum albumin (BSA) protein standards 
were prepared in a range of 0–10 mg/ml.  A standard plate reader was used to read the 
absorbance at 620 nm and the concentration of  the protein samples  were compared with 
standard curve produced of BSA.  
2.5.3 SDS-PAGE 
A volume of 75 μl of the sample lysate was mixed with 25 μl 4x Laemmli (8 % w/v SDS, 40 % 
(v/v) glycerol, 10 % (v/v) β-mercaptoethanol, 0.01 % (w/v) bromophenol blue, 250 mM Tris-
HCl pH 6.8) in deionised water and boiled for 10 min. A 0.75 mm thickness 15 % (w/v) 
acrylamide gel was prepared, which contained the resolving gel (23 % (v/v) deionised water, 
50 % (v/v) ProtoGel® acrylamide mix (30 % acrylamide solution 37.5:1 ratio, Geneflow Ltd, 
Staffordshire, UK), 25 % (v/v) 1.5 M Tris-HCl pH 8.8, 1 % (v/v) SDS solution, 10 % (w/v) 
Ammonium persulfate (APS) solution and 0.04 % (v/v) N,N,N’,N’-
tetramethylethylenediamine (TEMED) and were poured in to the gel cast  (Bio-Rad Mini-
Protean III system)  and a space was left at the top of the gel cast for the stacking gel 
(Stacking gel; 68 % (v/v) deionised water, 17 % (v/v) ProtoGel® acrylamide mix, 12.5 % (v/v) 
1.0 M Tris-HCl pH 6.8, 1 % (v/v) SDS solution (10 % (w/v) Sodium dodecyl sulphate in 
deionised water) 1 % (v/v) APS solution (10 % (w/v) Ammonium persulfate in deionised 
water), 0.1 % (v/v) TEMED) and the comp was added immediately. Once the gel was 
polymerized, 5 μl of protein ladder (Precision Plus Protein™ dual standards, Bio-Rad 
laboratories, Hertfordshire, UK)  and the buffered lysate samples which contained 15 µg of 
protein were loaded into the gel wells. After that the gel was placed in electrophoresis 
container that contained  1x electrophoresis buffer (0.01 % (w/v) SDS, 2.5 mM Tris, 192 mM 
glycine, pH 8.3,). Gels were run at 200 V for 45 min. After protein separation,  gels were 
placed  in Western blot transfer buffer (25 mM Tris, 192 mM glycine and 20% (v/v) MeOH) at 
4°C for 5 min. 
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2.5.4 Western blot 
Proteins were transferred to nitrocellulose membranes using a Bio-Rad Trans-Blot system. A 
set up of a wet transfer was performed as follows; pre-wet sponge - filter paper - gel- 
nitrocellulose membrane - filter paper – pre-wet sponge. The layers were then placed into a 
western blotting cassette and closed gently to avoid air bubble and placed in the transfer 
tank that contained chilled transfer buffer. Proteins were transferred at 100 V for 1 h. After 
electrotransfer of the proteins, the nitrocellulose membrane was stained by Ponceau red 
stain (Sigma-Aldrich, UK) to confirm protein transfer from the gel. The membranes were 
then washed with PBS for 5 min with agitation to remove Ponceau staining. Un-occupied 
protein binding sites on the membrane were blocked using blocking buffer (5 % (w/v) 
skimmed milk powder and 0.1% v/v Tween-20 in TBS) for 1 h at room temperature with mild 
agitation. This will prevent nonspecific binding of the antibodies. Following blocking, the 
proteins of interest were detected by using primary antibodies diluted in a fresh blocking 
buffer  (1:1000; see table 2.1) and incubated overnight at 4°C with mild agitation. After that, 
the antibody is removed and the membrane was washed with TBS/tween three times for 15 
min. The membrane was then incubated for 2 hours at room temperature with mild 
agitation with secondary antibody conjugated with horseradish peroxidase diluted in a 
blocking buffer (1:1000; see table 2.2). The membrane was then washed at room 
temperature in TBS/Tween three times for 15 min. Blots were developed by Ultra 
Chemiluminescence Detection System (Cheshire Sciences Ltd, Chester, UK) and proteins 
were quantified by (Advanced Image Data Analysis). Software (Fuji; version 3.52). Target 
protein were normalized to GAPDH or to its total protein target to measure the value of 
target protein. 
2.6 Two-Dimensional Electrophoresis (2-DE)  
2D gel electrophoresis could separate proteins in a mixture according to  their charge (pI) in 
the first dimension and their molecular weight in the second dimension. This reproducible 
technique enable protein identification when combined with mass spectrometry. and 
assessment of protein expression levels.  
Differentiated H9c2 cells (7 days) were cultured in T25 culture flasks. Following 
experimentation, cells were washed twice with warm PBS (37 °C) and lysed in 300 μL of urea 
lysis buffer (8 M urea, 50 mM DTT, 4% w/v CHAPS, and 0.2% v/v Bio-Lyte 3/10 ampholyte; 
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Bio-Rad, UK) in deionised water. Cell lysates were then precipitated in a proportion of 10% 
(v/v) cell lysate to 90 % (v/v) acetone and kept overnight in -20 °C. After that, the 
precipitated cell lysates were then centrifuged at 10,000 RCF at 4°C for 10 min and the 
supernatant removed. The pellets were partially covered to prevent any contamination and 
left to dry for 1 h in the fume cupboard. To determine protein concentration, 5 µl of the 
sample was used for DC Lowry protein assay. An amount 300 μg of protein sample was 
added to 120 µL rehydration buffer (Biolite®ampholytes (pH 3-10), 8 M urea, 50 mM DTT, 
0.0002% (w/v) bromophenol blue, 4% (w/v) CHAPS, 0.2% (v/v) Biolite®ampholytes (pH 3-10) 
in deionised water. In the first-dimension (isoelectric focusing), 120 µl of the sample was 
applied on to an IEF focusing tray making sure that the spreading of the protein sample was 
even and makes contact with the cathode and anode of the wires. Then a 7 cm 3-10 pH 
ReadyStrip™ IPG strips (pH 3−10; Bio-Rad, UK) was applied in the IEF tray in contact with the 
protein sample without any air bubbles and sample protein was absorbed into the IPG gel to 
allow a passive rehydration for 1 h at room temperature. After that, mineral oil (Bio-Rad 
laboratories, Hertfordshire, UK) was added  on top of the IPG strip to avoid buffer 
evaporation. The protein sample then went through active rehydration at 50 V for 16 hours. 
Once the rehydration was completed, IEF system electrode wicks (Bio-Rad laboratories, 
Hertfordshire, UK) were added in-between the top of the electrodes in the focusing tray and 
the IPG strip to ensure an effective focusing and to get rid of excess salt. A linear voltage 
slope up to 250 V was then applied for 20 min. A second linear voltage slope increasing to 
4000 V was applied for 2 h. A rapid voltage slope to 4000 V for 10,000 Volt-hours was then 
applied. Finally, a rapid voltage slope down to 500V was applied to the gel for 25 h. After 
that, IPG strips were equilibrated by placing the IPG strips in 2500 µl of equilibration buffer 1 
(1.5 M Tris/HCl pH 8.8, 6 M urea, 50 % (v/v) glycerol, 2 % (w/v) DTT, 2 % (w/v) SDS, in 
deionised water) for 10 min at room temperature with gentle agitation. Equilibration buffer 
1 was then removed and 2500 µl of equilibration buffer 2 added  (2 % (w/v) SDS, 50 % (v/v) 
glycerol, 6 M urea, 2.5 % (w/v) iodoacetamide, 1.5 M Tris/HCl pH 8.8, in deionised water) for 
10 min at room temperature with gentle agitation. After equilibration, proteins were 
resolved in IPG strips and applied for the second dimension gel, were proteins are separated 
according to their molecular size. IPG strips were placed on the top of 15 % (w/v) SDS 
acrylamide gel (including a stacking gel) as described in section 2.6.3.  Then a 0.5 cm strip of 
filter paper was immersed in a mixture of 10 % (v/v) protein ladder (Precision Plus Protein™ 
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dual standards, Bio-Rad laboratories, UK, Hertfordshire) and 90 % (v/v) 4x Laemmli buffer 
(40 % (v/v) glycerol, 8 % w/v SDS, 0.01 % (w/v) bromophenol blue, 250 mM TRIS-HCl pH 6.8, 
10 % (v/v) β-mercaptoethanol, in deionised water) and placed at the IPG strips side for 
comparison of molecular weight. Gel molten ReadyPrep™ (Bio-Rad laboratories, UK, 
Hertfordshire) were then added over the IPG strip. A 1x electrophoresis buffer was added in 
to electrophoresis container (Bio-Rad laboratories, UK, Hertfordshire) and 200 V was applied 
for 45 min to allow protein separation. After electrophoresis, the gels were washed for 5 min 
in deionised water for three times. The gels were then stained by ProtoBlue™safe colloidal 
coomassie G-250 stain (Bio-Rad laboratories, IK, Hertfordshire), and the gel left for staining 
overnight at room temperature. After staining, the gel was then washed for 1 h in deionised 
water to remove any additional background staining. Stained gels were imaged by Syngene 
G-box with Genesnap software. The gels were then placed between two layers of acetate 
plastic that contain 0.001 % w/v sodium azide solution in deionised water at 4 °C to maintain 
the gel and avoid its breaking.  
2.6.1 SameSpot analysis 
The imaged gel was then analyzed by the software known as Progenesis SameSpot (V 
3.1.3030.23662, Non- linear Dyramics, UK). The images of the gels were aligned to a gel 
picked to be a control, either untreated mitotic or untreated differentiated H9c2 cells. 
Densitometric analysis was then carried out to identify gel spots proteins which have 
decreased or increased in expression when compared to the control spot in the control gel. 
The significance of the change in density of the gel spots is then reported with p < 0.05 
reported as a significant change and spots were circled with a defined number. 
2.6.2 De-staining 
Proteins whose expression was significantly altered were selected and excised from the gels 
using a pipette tip cut the exact size spot. Excised proteins were placed in a 1 ml Eppendorf™ 
tube containing a mixture of equal volumes of deionised water, 50 mM ammonium 
bicarbonate, and acetonitrile and incubated for 5 min at 37 °C with gentle agitation. The 
supernatant was poured carefully making sure that the gel spot is still inside the Eppendorf™ 
tube. A mixture containing equal volumes of 50 mM ammonium bicarbonate, deionised 
water and acetonitrile was added and incubated at room temperature for 15 min with gentle 
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agitation. After that, an equal volume of 100 % acetonitrile was added for spot dehydration 
and incubated for 5 min at room temperature with gentle agitation. The supernatant was 
removed  and 50 mM ammonium bicarbonate solution was added and incubated for 5 min 
at room temperature with gentle agitation. The supernatant was again removed  and 100 % 
acetonitrile was added for 1 min at room temperature poured. A volume of 100 µl of 
deionised water was added for 5 min to make sure that the proteins  were completely 
rehydrated. The supernatant was removed and trypsin digestion mixture was added (16.6 µl 
100 mM ammonium bicarbonate, 1 µl Mass spectrometry grade Promega gold trypsin, and 
7.6 µl deionised water) and incubated at 37 °C for 16 h. 1 µl 1 % (v/v) Trifluoroacetic acid 
(TFA) was added to terminate the digestion reaction. 
2.6.3  ZipTip reverse phase chromatography 
After tryptic digestion of the proteins, samples  were prepared for MALDI-TOF MS (matrix-
assisted laser desorption/ionization mass spectrometry) using C18 ZipTips (200 Å pore size; 
Millipore, Hertfordshire, UK) to concentrate and sanitize the peptide sample. A Milllipore 
C18 ZipTip was set by cleaning in 80 % v/v acetonitrile with 10 µl pipette tip for three times 
cycling, followed by 10 µl pipette tip in 0.1 % v/v TFA for three times cycling. The peptide 
digest was then bound to the C18 ZipTip chromatography medium by 10 µl of the peptide 
digest sample for 25 times cycling. The C18 ZipTip was then washed in 0.1 % TFA 10 µl three 
times cycling. The bound peptides were then eluted from the chromatography medium by 
the up-take of 5 µl of 80 % acetonitrile and cycled 25 times into a sterile 0.5 ml Eppendorf™ 
tube. 1.5 µl of the peptide digested sample was then added onto the MTP 384 ground steel 
Mass Spectrometry target plate (Bruker, UK) and 1.5 µl of CHCA matrix mixture (5mg/ml α-
Cyano-4- hydroxycinnamic acid (Bruker, UK), 50 % v/v acetonitrile, 0.1 % v/v TFA) was added 
to the peptide digest spot with a gentle mix by the pipette tip and covered to prevent 
contamination and left to dry at room temperature for 15 min. For calibration, a volume of 1 
µl of peptide calibrate mixture (Bruker peptide calibration standard) was added next to the 
protein samples onto the MTP 384 ground steel Mass Spectrometry target plate along with 1 
µl CHCA matrix mixture was spotted onto the target plate.  
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2.6.4 MALDI-TOF MS/MS 
Target plate containing the digested peptides was analysed by Bruker Ultraflextreme MALDI-
TOFTOF mass spectrometer (reflectron positive mode, ion suppression m/z 650, and mass 
range m/z 0−4000). Calibrate mixture spot was used to calibrate the mass spectrometer with 
a Laser power and shots (≈ 1000-3000 shots) to produce the best SNR (signal-to-noise ratio). 
Proteins were identified using Bruker-Daltonics Biotools (v 3.2, build 2.3) software, searched 
against the SwissProt database, rat species, using Mascot (version 2.3 server, Matrix Science, 
UK), PMF 100 ppm tolerance, and reported according to percentage sequence coverage 
(SC%). MS/MS search parameters: MS tolerance, 100 ppm; MS/MS tolerance, 0.8 Da; and 
three missed cleavages. All identified proteins exhibited Mascot scores that were considered 
statistically significant (p < 0.05). 
2.7 Binding of Dansylated PSP to Purified Tropomyosin.  
To validate the identification of one of the proteins labeled by dansylated PSP, 10 µl of 
purified human heart tropomyosin (10 μg; Lee Biosolutions, USA) was incubated with 10µl of 
25 μM dansylated PSP or unlabeled PSP for 1 h at room temperature  The sample was then 
mixed with 6 µl of 4x Laemmli and incubated for 5 min at 100 °C.  The sample was then 
subjected to SDS/PAGE on a 0.75 mm thickness 10 % acrylamide gels, which contain 
resolving gel (40 % (v/v) deionised water, 33 % (v/v) ProtoGel® acrylamide mix (30 % 
acrylamide solution 37.5:1 ratio, Geneflow Ltd, Staffordshire, UK), 25 % (v/v) 1.5 M Tris-HCl 
pH 8.8, 1 % (v/v) SDS solution, 1 % (v/v) APS solution and 0.04 % (v/v) TEMED) and were 
poured in to the gel cast  (Bio-Rad Mini-Protean III system)  and a space was left at the top of 
the gel cast for the stacking gel (Stacking gel; 68 % (v/v) deionised water, 17 % (v/v) 
ProtoGel® acrylamide mix, 12.5 % (v/v) 1.0 M Tris-HCl pH 6.8, 1 % (v/v) SDS solution (10 % 
(w/v) Sodium dodecyl sulphate in deionised water) 1 % (v/v) APS solution (10 % (w/v) 
Ammonium persulphate in deionised water), 0.1 % (v/v) TEMED) and the comp was added 
immediately. Once the gel was polymerized, 5 μl of protein ladder (Precision Plus Protein™ 
dual standards, Bio-Rad laboratories, Hertfordshire, UK)  and the sample was then loaded 
into the gel wells. After that the gel was  placed in electrophoresis container that contain in a 
1x electrophoresis buffer (0.01 % (w/v) SDS, 2.5 mM Tris, and pH 8.3, 19.2 mM glycine). 
Then, 200 Voltage was applied for 45 min. The gels were removed from the electrophoresis 
tank and from the glass casting frames and placed in 10% methanol for 15 minute to allow 
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fixation. The fluorescence visualized under UV light. Gels were imaged by Syngene G-box 
with Genesnap software. The same gel was then stained by ProtoBlue™safe colloidal 
coomassie G-250 stain (Bio-Rad laboratories, IK, Hertfordshire), and the gel left for staining 
overnight at room temperature. After staining, the gel was then washed for 1 h in deionised 
water to remove any additional background staining. Stained gels were imaged by Syngene 
G-box with Genesnap software. 
2.8 Statistical analysis 
Statistical analysis was performed using Prism software (GraphPad 6 version 6, 
California, USA). Statistical significance was determined by one-way ANOVA 
(analysis of variance of means) which  compares three or more sets of data, with 
Student’s t test being used to compare two sets of data. Tukey’s multiple 
comparison post hoc analysis was used to further demonstrate significant 
differences between multiple data sets. (p < 0.05 was considered statistically 
significant and highlighted with an asterix (*). Organophosphate IC50 values 
(concentrations of drug producing 50% of the maximal inhibition) derived from 
MTT assays and EC50 values (concentrations of drug producing 50% of the maximal 
stimulation) derived from LDH assays were obtained by computer assisted curve 
fitting using Prism software. All data is presented as the mean ± SEM The n in the 
text refers to the number of separate experiments. The number of replicates within 
each experiment is indicated, where appropriate, in the figure ligends.
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3.1 Introduction 
H9c2 cells are cardiomyoblasts derived from embryonic rat heart cells that display skeletal 
muscle properties and cardiac-specific characteristics (Sardao et al., 2007). In addition, these 
cells possess similar electrical signalling pathways to those present in adult cardiomyocytes. 
Therefore, they are widely used as an in vitro model to study molecular mechanisms 
associated with toxicology, hypertrophy and apoptosis (Pereira et al., 2011; Watkins et al., 
2011). Importantly, H9c2 cells have the ability to differentiate and develop into a more 
cardiomyocyte-like phenotype when treated with all-trans retinoic acid (RA) and in the 
presence of low-serum medium (Menard et al., 1999). However, to date, the vast majority of 
toxicity studies use mitotic H9c2 cells as a model cell line, while differentiated H9c2 cells 
display the formation of myocytes/myotubes from H9c2 myoblasts (Pagano et al., 2004). 
Furthermore, it has been shown that differentiated H9c2 cells display increased expression 
of cardiac-specific markers, such as troponin (Menard et al., 1999), and cytoskeleton 
proteins, such as myogenin and actin (Pagano et al., 2004). More interestingly, when 
comparing mitotic and differentiated H9c2 cells in toxicological studies. It has been found 
that differentiated H9c2 cells show more sensitivity to toxic agents such as doxorubicin 
(Branco et al., 2012). This might relate to the observation that differentiated H9c2 cells 
showed increased levels of mitochondrial superoxide compared to their undifferentiated 
state (Branco et al., 2012). In addition, another study also showed that differentiated H9c2 
cells were found to be more susceptible to toxicity than their mitotic form when exposed to 
the β-receptor agonist isoproterenol (Branco et al., 2011). However, no studies have 
investigated the effect of OPs using differentiated H9c2 cells. The use of differentiated H9c2 
cells provides a better model to study the cytotoxic effect of OPs and facilitates a better 
understanding of the cellular mechanism(s) involved in OP-induced cardiac toxicity.  
As reported previously, culturing mitotic H9c2 cells in low-serum medium and RA will induce 
differentiation of H9c2 cardiomyoblasts (Menard et al., 1999). The present study has 
assessed the effective differentiation of H9c2 cells by morphological characterisation of 
cardiomyoblasts as they differentiate into cardiomyocytes. Moreover, it has monitored the 
expression of cardiac-specific markers, such as cardiac troponin 1. After assessment of the 
cardiomyocyte-like phenotype, further studies were conducted to identify novel proteins 
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expressed in differentiated cells; these novel proteins may be implicated in OP-induced 
toxicity. 
3.2 Aims 
The aim of the work in this chapter was to investigate the differentiation of mitotic H9c2 
cells into a more cardiomyocyte-like phenotype. Initial experiments examined the 
morphological characteristics of differentiated cardiomyocyte-like H9c2 cells and confirmed 
the expression of known specific cardiac markers, such as troponin, during cardiogenic 
differentiation. Subsequently, mass spectrometry was used to identify novel proteins that 
were significantly expressed in differentiated H9c2 cells. 
3.3 Methods 
As described in chapter 2 section 2.2.5, 2.4, 2.5 and 2.6. 
3.4 Results 
3.4.1 Morphological characterisation of cardiomyocyte-like cells 
Rat cardiomyoblast H9c2 cells were cultured in differentiation medium (containing 1% v/v 
foetal bovine serum [FBS] and 10 nM RA) for 7 days to induce differentiation into a more 
cardiomyocyte-like phenotype. Following 7 days differentiation, cells were stained with 
Coomassie Blue and cell morphology was assessed microscopically. As shown in Figure 3.1, 
after 24 h culture under normal culture conditions, mitotic cells exhibit a rounded cell mono-
nucleated cell (control). H9c2 cells following 7 days in differentiation medium appeared 
larger, elongated and multinucleated.  
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Figure 3.1 Light microscopy examination of H9c2 cells.  
Mitotic H9c2 cells (control) cultured under normal culture conditions (medium alone) appear to be 
mono-nucleated rounded myoblasts (black arrow); differentiated cells undergo a morphological 
change when treated with 1% FBS and 10 nM RA in DMEM medium for 7 days. Cells appear 
elongated and some are multinucleated (red arrow). Images were visualised on days 2, 4 and 7 using 
a 20× objective lens. Scale bar = 100 μm.  
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3.4.2 Measurement of cardiac-specific troponin  
To confirm mitotic H9c2 cell differentiation to a more cardiomyocyte-like phenotype, the 
expression of the cardiac-specific marker troponin 1 in cells cultured in differentiation 
medium was monitored over a period of 9 days using western blot analysis and compared 
with that of control mitotic cells. In agreement with previous studies, cardiac troponin 1 
expression increased following H9c2 cardiomyocyte-like differentiation (Branco et al., 2011). 
Quantitative values (in percentages) showed that troponin 1 expression peaked after 7days 
treatment (see Figure 3.2). Data was confirmed by immunocytochemistry, results showing 
significant increase in troponin 1 staining at 4, 7 and 9 days when compared to the control 
mitotic cells. In agreement with the western blot data, troponin 1 expression peaked after 7-
day treatment. Structural examination of 7 and 9 day differentiated cells demonstrated 
large, long, multi-nucleated myotubes displaying clear myofilaments. This provided 
additional evidence that the cells had gained a cardiac-like phenotype (see Figure 3.3). 
 
 
Figure 3.2 Cardiac-specific troponin 1 expression in differentiating H9c2 cells. 
Mitotic H9c2 cells (control) were differentiated with RA (10 nM) in a 1% FBS medium. (A) Cell lysates 
(15 µg) were analysed for cardiac troponin 1 expression on days 1, 2, 4, 7 and 9 via western blotting 
using anti-cardiac troponin 1 antibody. Lysates were also analysed on separate blots for GAPDH 
expression to confirm equal protein loading. Quantified values are expressed as a percentage of 
troponin 1 expression in control mitotic cells (100 %) and represent the mean ± SEM of three 
independent experiments. *p<0.05 and ****p < 0.0001 versus control (mitotic) cells. 
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Figure 3.3 Cardiac-specific troponin expression of H9c2 cells upon differentiation. 
 Mitotic H9c2 cells (control) were cultured in differentiation medium and cardiac troponin 1 was 
assessed on days 1–9 via indirect immunofluorescence staining using a cardiac-specific troponin 1 
antibody (green) and DAPI counterstain for nuclear visualisation (blue) of H9c2 cells. Scale bar = 100 
μm. Images presented are from one experiment and are representative of four experiments. 
Quantified data are expressed as a percentage of control (mitotic) cell values and represent the 
mean ± SEM of four independent experiments. ***p < 0.001 and ****p < 0.0001 versus control 
(mitotic) cells. 
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3.4.3 Identification of proteins associated with H9c2 cell differentiation 
The results presented thus far indicate that 1% FBS and 10 nM all-trans RA in DMEM 
medium induced differentiation of H9c2 cells to a cardiomyocyte-like phenotype. To identify 
other proteins and monitor changes in protein expression associated with H9c2 cell 
differentiation, 2D gel electrophoresis was performed as described in Chapter 2. Several 
protein spots, which were significantly increased in expression in differentiated H9c2 cells 
when compared to undifferentiated cells. Four protein spots (Spot ID: 1, 2, 3, 5) were 
significantly up regulated in differentiated H9c2 cells as determined by using Progenesis 
SameSpot software (see Table 3.1). Protein spots were visually distinct for spot picking 
(Figure 3.4). Protein spots were picked from the stained gel and digested with trypsin 
followed by MALDI-TOF mass spectrometry analysis of the peptides produced. Mass 
spectrometry analysis identified tropomyosin ß-chain, tropomyosin α4-chain, cytoplasmic α-
actin and vimentin as novel proteins that exhibited a significant increase in levels in 
differentiated H9c2 cells when compared to mitotic H9c2 cells. The identified proteins are 
listed in Table 3.2. These proteins were also confirmed by comparison of their gel position 
with their theoretical molecular weights and isoelectric point (pI).  
Table 3.1 Progenesis SameSpot analysis represent a significant increase in density of 
protein spot in differentiated H9c2 cells.  
 
Data table represent a significant increase in protein spots densities using ANOVA analysis of protein 
spot densities. Data values of 3 accumulated 2D gel electrophoresis, *p < 0.05 was viewed as 
significant.  
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Figure 3.4 Representative 2D gel images of protein expression in H9c2 cells. 
 A) Mitotic cells and B) cells differentiated with 1% FBS and 10 nM all-trans RA in DMEM medium for 
7 days. Cell lysates (300 µg) were analysed by 2D gel electrophoresis using pH 3–10 gradient strips. 
Gels were stained with ProtoBlue Safe colloidal Coomassie G-250 stain and Gel images analysed using 
Progenesis SameSpots software. Data values of 3 accumulated 2D gel electrophoresis and circled 
spots represent proteins that showed significantly stronger staining when compared to mitotic cells. 
Spot 1, vimentin; spot 3, cytoplasmic α-actin; spot 5, tropomyosin ß-chain; spot 2, tropomyosin α4-
chain. 
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Table 3.2 Identification of novel proteins significantly expressed in differentiated H9c2 
cells. 
 
Proteins significantly expressed in differentiated H9c2 cells were identified using MALDI-TOF 
MS (PMF) as described in the Material and Methods. Sequencing data were analysed using 
Mascot software and reported according to percentage sequence coverage (SC%) or Mascot 
score (ion scores for PMF > 51 indicate extensive homology). All identified proteins exhibited 
Mascot scores that were considered statistically significant (*p < 0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
Spot 
number 
 
Protein 
 
Accession 
no. 
 
PMF 
sequence 
coverage (%) 
 
Mascot 
score 
 
kDa 
 
pI 
1 vimentin P20152 56 79.7 54 6.3 
3 α-actin P62737 53 76.2 42 4.72 
5 tropomyosin  
ß-chain 
P58774 9 73 33 4.2 
2 tropomyosin  
α4-chain 
P09495  
45 
92 28.5 4.4 
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To further validate the MALDI-TOF MS/MS data, α-actin and tropomyosin were selected to 
confirm their up-regulation in differentiated H9c2 cells via western blot. As shown in Figure 
3.5 there was a significant increase in reactivity of cell lysates with anti-α-actin and anti-
tropomyosin antibodies in the differentiated cells when compared to the undifferentiated 
control cells.  
 
 
 
Figure 3.5 Cardiac cytoskeleton α-actin and tropomyosin expression in differentiating H9c2 
cells.   
Mitotic H9c2 cells (control) were differentiated with RA (10 nM) in a 1% FBS medium. Cell lysates (15 
µg) were analysed for cardiac tropomyosin on day 7 via western blotting using anti-α-actin and anti-
tropomyosin antibody. Lysates were also analysed on separate blot for GAPDH expression to confirm 
equal protein loading. Quantified densitometry values are expressed as the percentage of α-actin 
and tropomyosin expression in control mitotic cells (100 %) and represent the mean ± SEM of three 
independent experiments. **p < 0.01 versus control cells. 
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3.5 Discussion 
3.5.1 Assessment of the differentiated H9c2 cardiomyocyte-like phenotype 
In the present study, H9c2 myoblast cells were induced to differentiate to produce a well-
established H9c2 cardiomyocyte-like phenotype in vitro. Establishment of a differentiated 
H9c2 cell model will enable further examination of OP toxicity in a cardiomyocyte-like cell 
line. The current results confirmed the differentiation of mitotic H9c2 cells to 
cardiomyocyte-like characteristics; cells expressed cardiomyocyte-specific markers, such as 
troponin 1. Troponin 1 expression increased during the time course of cell differentiation 
when cultured in low-serum medium and all-trans RA. In contrast, expression of troponin 1 
was not detected in mitotic H9c2 cells. The data presented support the hypothesis that all-
trans RA and low-serum medium enhance the differentiation of H9c2 myoblasts to 
myocytes/myotubes, as reported in previous studies (Menard et al., 1999; Pagano et al., 
2004; Comelli et al., 2011).  
Mitotic H9c2 cells have been used previously as an in vitro model in several toxicological 
studies (Spallarossa et al., 2005; Ellis et al., 2010; Hosseinzadeh et al., 2011), since they 
display morphological, electrophysiological and biochemical properties that are similar to 
those of primary cardiac myocytes (Hescheler et al., 1991). With regard to H9c2 mitotic cells, 
these may lack some cardiomyocyte properties, such as gap junction communication and T 
tubules, which will limit their use (Hescheler et al., 1991). However, H9c2 cardiomyoblasts 
have the ability to differentiate into cardiac muscle cells under certain growth conditions. In 
their differentiated state, cells express specific cardiac proteins, such as L-type voltage-
dependent Ca2+ channels and undergo morphological and physiological changes (Menard et 
al., 1999). These changes include the appearance of elongated multinucleated myotubes 
consistent with noticeable branched fibres and actin filaments (Kadivar et al., 2006; Zara et 
al., 2010). These characteristics show that the H9c2 cell line is an appropriate model for 
studying the effects of OPs on the cardiomyocyte phenotype. More interestingly, H9c2 
cardiac-like differentiation was shown to be more susceptible to toxicity when exposed to 
toxic compounds, such as isoproterenol, in comparison with their mitotic form (Branco et al., 
2011). Hence, the use of differentiated H9c2 cells to study OP-induced cytotoxicity 
represents a more physiologically relevant cellular model than mitotic H9c2 cells. 
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In the present study, the process of cellular differentiation proceeded by culturing mitotic 
H9c2 cells in low FBS and 10 nM RA medium for 7 days in a similar manner to that used in 
previously published studies investigating cardiomyocyte-like differentiation (Menard et al., 
1999; Kageyama et al., 2002; Comelli et al., 2011). Treatment of the cells confirmed 
successful cardiac differentiation into more cardiac-like phenotype characteristics. In terms 
of their morphological features, differentiated cells appeared to be thin and multinucleated 
cells, as shown by Coomassie staining and compared with the mitotic cell line (Figure 3.1). 
This is consistent with previous research that investigated cardiomyocyte-like differentiation 
(Menard et al., 1999; Kageyama et al., 2002). Moreover, as shown in Figure 3.2, western blot 
analysis demonstrated that differentiated cells expressed higher amounts of cardiac 
troponin 1, a specific marker of cardiac differentiation (Decker et al., 2009; Kuzmenkin et al., 
2009). This globular protein present in myocardial tissue plays an important role in actin–
myosin interactions, which are necessary for muscle contraction (O’Brien, 2008). Troponin is 
released in serum as a result of myocardial injury; it is considered to be more specific than 
other cardiac biomarkers (Apple et al., 1999; Brogan et al., 1999). More interestingly, the OP 
fenthion induces cardiotoxicity and increased the levels of troponin 1 in blood rats (Yavuz et 
al., 2008). Therefore, troponin 1 expression and/or release can be monitored as a sensitive 
marker indicating the presence of OP poisoning. 
Immunofluorescence staining confirmed the increase in troponin 1 expression in the 
cardiomyocyte-like phenotype induced by RA treatment of H9c2 cells. Cells appeared to 
change from rounded shaped to elongated multinucleated cells characterised by the parallel 
arrangement of the branched fibres. This was previously shown to be accompanied by the 
formation of myofibrils, intercalated disks and T tubules (Perissel et al., 1980; Isenberg & 
Klockner, 1982). The developed ultra-structural features were in accordance with those 
observed in the differentiation of primary cultures of cardiomyocytes (Borisov et al., 2008). 
Striated cardiac myofilaments are involved in the development of sarcomere assembly 
structure with appearance of dense Z-lines in the cardiac cytoskeleton (Niederreither et al., 
2001). In differentiated H9c2 cells, cells were characterised by the organised, linear 
arrangement of filamentous architecture in the cytoskeleton, indicating the formation of 
ultra-structural assemblies required for cardiac myogenesis. In contrast, undifferentiated 
H9c2 cells appear to be devoid of myofilaments. 
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3.5.2 Expression of proteins associated with differentiated H9c2 
cardiomyocyte-like cells  
It was apparent that differentiated H9c2 cells exhibited increased expression of cardiac-
specific troponin 1. However, it would be of interest to investigate further proteins 
expressed in differentiated cells as these novel proteins may be implicated in OP-induced 
toxicity in differentiated H9c2 cells. The present study identified several other proteins that 
were expressed more highly in differentiated H9c2 cells; these proteins are listed in Table 
3.2. They include α-actin, tropomyosin ß-chain, tropomyosin α4-chain and vimentin. Proteins 
were selected based on visual observation of spots from 2D gels electrophoresis and 
confirmed by their significant score in Progenesis SameSpot analysis and MALDI-TOF MS/MS.  
All proteins identified are cytoskeletal proteins, thereby confirming the cytoskeletal changes 
of mitotic cells adopting structural cardiomyocyte-like features. The increased expression of 
these cytoskeletal proteins may contribute to the process of myogenesis-like differentiation 
(Comelli et al., 2011). Identifying significant protein expression changes in differentiated 
H9c2 cells gives the opportunity to study biochemical remodeling and specific pathways 
involved in the process of differentiation (Branco et al., 2015). Although 2D gel 
electrophoresis is a powerful tool in proteomic identification and cardiac troponin is a 
specific cardiac marker. This method occasionally under estimated the presence of proteins. 
However, failure to detect specific proteins such as troponin 1 does not confirm its absence 
from the sample and this may be due to several reasons. One reason may be that the 
troponin is less abundant in the samples prepared for 2D gel electrophoresis. 
Tropomyosin isoforms represent important regulators of microfilament stability in both 
muscle and non-muscle cells (Robinson & Shoichiro, 2006). It regulates the interaction of 
some actin-binding proteins, such as, ADF-cofilin, Arp2/3, formin, and tropomodulin (Lehrer 
& Morris, 1984; Clayton et al., 2010). Tropomyosin is a component of contractile filaments 
known also as a sarcomeric contractile protein. In cardiac muscle, regulation of myosin 
binding to actin is achieved by tropomyosin and troponin complex. In the presence of 
troponin and the absence of elevated level of Ca2+, tropomyosin blocks the interaction of 
myosin heads (thick filaments) with actin (thin filament) allowing filament sliding and 
subsequent muscle contraction (McKillop & Geeves; 1993). Generally, tropomyosin is a 
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muscle-specific marker protein and it has been previously used to evaluate differentiated 
cardiomyocytes derived from human embryonic stem cells (Hollweck et al., 2011).  
The α-actin is a cytoskeletal actin-binding protein and a member of the spectrin superfamily. 
It forms an anti-parallel rod-shaped dimer with one actin-binding domain at each end of the 
rod and join the actin filaments in multiple cell-type and cytoskeleton frameworks (Pollard & 
Cooper, 2009). In cardiac and muscle cells, it is localized at the Z-disk and stabilizes the 
muscle contractile mechanism and associates with a number of cytoskeletal and 
signaling molecules to form an important structural and regulatory roles in cytoskeleton 
organization (Sjoblom et al., 2008). The up-regulation of α-actin expression observed as a 
consequence of RA treatment, reflects the increased expression of functional skeletal muscle 
actin that was observed in trans-differentiation of embryonic rat stem cells to adult 
cardiomyocytes (Swynghedauw, 1986). Furthermore, Yamada et al. (2007) also observed 
increased expression of cardiomyocyte specific genes such as, cardiac α-actin in 
cardiomyocytes derived from mesenchymal stem cells. More interestingly, disruption of α-
actin levels may be a potential biomarker for OP exposure in differentiated H9c2 cells, as 
previous results have demonstrated that the OP pesticide malathion induced a decrease in 
α-actin expression and caused the re-distribution of cellular microfilaments in the human 
mammary carcinoma cell line MCF-7 (Cabello et al., 2003). 
MALDI-TOF MS/MS analysis of 2D gels also identified increased levels of vimentin in 
differentiated H9c2 cells. Vimentin is a cytoskeletal protein that is normally expressed in 
mesenchymal cells; an increase in its expression can indicate the transition of epithelial cells 
to mesenchymal cells (Hendrix et al., 1997). Mesenchymal cells are precursor cells that are 
important in the formation of heart valves during embryonic development (Casper, 2004). 
Therefore, the increased expression of vimentin in the present study may further verified 
the transformation of mitotic cells into a more cardiomyocyte-like phenotype. A potential 
link between the effects of the OP sarin and vimentin has been previously investigated in the 
central nervous system of rats. Thus, the toxic effect of sarin leads to a change in level of 
vimentin that causes astrocyte dysfunction associated with astroglial dedifferentiation 
(Tirupapuliyar et al., 2002). Since these cytoskeletal structural proteins, such as tropomyosin 
isoforms, α-actin and vimentin, are significantly expressed when compared to the 
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cardiomyoblast form of H9c2 cells, it will be worthwhile to study the effect of OPs on them 
during the differentiation of H9c2 cells. 
3.6 Conclusion 
H9c2 rat cardiomyoblasts treated with all-trans-RA and low-serum medium were 
investigated for cardiomyogenic differentiation. The results demonstrated morphological 
changes developing over a period of 7 days of differentiation. The cardiomyocyte-like 
phenotype was confirmed by the expression of the cardiac-specific marker troponin 1, which 
indicates the formation of cytoskeletal branched fibres and the development of myogenesis. 
Finally, differentiation of H9c2 cells was associated with the increased expression of several 
cytoskeletal proteins of which tropomyosin and α-actin were identified. These proteins are 
strongly linked with the development of the myofilament assembly, which contains tubular 
and Z-structure proteins.  
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4.1 Introduction 
Diazinon and chlorpyrifos are highly toxic, commonly used pesticides that induce 
neurotoxicity by primary inhibition of acetylcholinesterase (AChE) activity in neuromuscular 
junctions and the central nervous system (Chambers, 1992; Hargreaves, 2012). Thus, 
adverse effects of OPs can be fatal to non-target species including humans. PSP is a 
structural analogue of saligenin cyclic-o-tolyl phosphate (SCOTP) an active metabolite of tri-
ortho-cresyl phosphate (TOCP) which is commonly used in jet engine oils and jet hydraulic 
fluid due to its anti-wear properties under certain conditions of temperature and humidity 
(Liyasova et al., 2011). However, they were found to be toxic to both passengers and 
aircrew, resulting in muscle weakness, dizziness, nausea, disorientation and memory loss 
(Schopfer et al., 2010; Carletti et al., 2011; Liyasova et al., 2011). The appearance of 
neurological symptoms of OP-induced delayed neuropathy (OPIDN) is caused by 
bioactivation of TOCP to active the toxic metabolite SCOTP (Carletti et al., 2011). The 
majority of studies have focused on the effects of OP toxicity on the central nervous system.  
However, there is very little information on the effect of OPs on muscle function, particularly 
toxic effects on cardiac muscle. Cardiotoxic effects are also of particular concern because it 
has not yet been established whether the latter effects are induced due to excessive 
accumulation of ACh, or due to the inhibition of the enzyme itself (Baskin & Whitmer, 1991).   
A considerable number of studies have shown that OPs interfere with the signalling 
pathways associated with members of the MAPK family (Kaplan, 1995; Hargreaves et al., 
2006, Pomeroy-Black & Ehrich, 2012). For example, chlorpyrifos was found to induce 
apoptosis of rat cortical neurons via the activation of ERK1/2, p38 MAPK and JNK signalling 
(Caughlan et al., 2004). On the other hand, PSP was found to cause a significant activation of 
PI-3K signalling, a pathway which plays an important role in neurite outgrowth (Pomeroy-
Black & Ehrich, 2012). More importantly, other studies have reported that OPs may affect 
several biochemical pathways independently from inhibition of AChE activity (Akbarsha & 
Sivasamy, 1997). Therefore, it was important to further explore the cytotoxic effect of OPs at 
the molecular level. The present study will investigate the effects of OPs on protein kinase 
signalling cascades that play an important role in cell survival (PKB, ERK1/2) and cell death 
(JNK and p38 MAPK). Inhibitory studies will be directed to ascertain which MAPK pathway 
mediated the toxic effects of OPs. H9c2 cells will be exposed to OPs in the presence of 
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specific inhibitors of PKB, ERK1/2, JNK and p38 MAPK. Inhibitors are used are SP 600125 (10 
µM; JNK1/2 inhibitor), LY294002 (30 µM, PI3K inhibitor), PD 98059 (50 µM, MEK1/2 
inhibitor), SB 203580 (30 µM; p38 MAPK inhibitor) and Wortmannin (100 nM, PI-3K).  
Organophosphates have also been found to induce apoptosis in vivo in mice, rats and 
Drosophila melanogaster and also in vitro in different cell types such as neuronal cells, 
fibroblasts and placental cells (Li, 2010). In particular, PSP induces apoptosis in a 
concentration dependent manner in human SH-SY5Y neuroblastoma cells, as determined by 
the measurement of activation of caspase-3, suggesting that apoptosis is a consequence of 
OP poisoning (Ehrich et al., 1997). Therefore, in the present study, the effect of OPs on 
caspase-3 will be investigated to establish the role of apoptosis.  
Previous studies have reported possible covalent binding of OPs (e.g. chlorpyrifos oxon, 
diazoxon and dichlorvos) to target proteins other than AChE, such as albumin and transferrin 
(Peeples et al., 2005; Li et al., 2009). However, the identity of protein targets for OPs in 
cardiac cells has not been investigated. This study utilized fluorescently labeled OPs 
(dansylated OP) to identify critical proteins is required in order to fully understand the 
mechanisms of OP-induced cytotoxicity. This type of approach is an accurate, specific and 
sensitive means of detecting novel protein targets of toxic compounds (Greenbaum et al., 
2002).  
4.2. Methods 
 As described in chapter 2 section 2.3, 2.5, 2.2.5, 2.6 and 2.7. 
4.3 Aims 
This study is designed to examine the effect of the OPs chlorpyrifos and diazinon, their 
corresponding metabolites (chlorpyrifos oxon and diazoxon), and PSP on the viability of 
mitotic and differentiated rat embryonic cardiomyoblast-derived H9c2 cells and to identify 
novel non-acetylcholinesterase protein targets  of OPs to fully understand the mechanisms 
to determine the molecular mechanisms underlying their cytotoxicity. 
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4.3 Results 
4.3.1 Effects of organophosphates on the viability of mitotic H9c2 cells 
Initial experiments in this study investigated the cytotoxic effects of OPs and their 
metabolite on the viability of mitotic H9c2 cells, which display properties of skeletal muscle. 
The effects of OP treatment on cell viability were assessed by monitoring MTT reduction (a 
measure of cellular dehydrogenase activity) and measurement of LDH activity released into 
the culture medium. Chlorpyrifos at concentration of 200 μM and 100 μM inhibited MTT 
reduction following 24 and 48 h exposure (Figure 4.1a and c) but had no effect on LDH 
release at these time points (Figure 4.1b and d). In contrast, chlorpyrifos oxon at 
concentrations up to 200 μM had no significant effect (p> 0.05) on MTT reduction or LDH 
release after 48 h of exposure (Figure 4.2). Also, at concentrations up to 200 µM both 
diazinon and its acutely toxic metabolites diazoxon had no significant effect (p> 0.05) on 
MTT reduction or LDH release following 48 h of exposure (see Figures 4.3 to Figure 4.4).   
Phenyl saligenin phosphate significantly (p˂0.05) induced cell death in a concentration and 
time-dependent manner, as determined by MTT reduction and LDH release following 24 h 
and 48 h exposure (Figure 4.5). Therefore, subsequent experiments assessed the effects of 
PSP on LDH release and MTT reduction at earlier time points e.g. 1, 2, 4, and 8 h (see Figures 
4.6 to Figure 4.7).  The data from these experiments revealed that PSP induced inhibition of 
MTT reduction was first evident at 4 h (IC50 = 8.5 ± 5.5 µM), with comparable results 
obtained at 8 h exposure (IC50 = 7.1 ± 4.7 µM). Similarly, significant (p˂0.05) LDH release was 
first evident at 4 h (EC50 = 13 ± 1.1 µM) and at 8 h (EC50 = 13 ± 1.5 µM), with levels of LDH 
release comparable to those observed following 24 h of treatment. Overall, these data 
indicate that PSP displays marked cytotoxicity towards mitotic H9c2. 
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Figure 4.1 Effect of chlorpyrifos on the viability of mitotic H9c2 cells monitored by MTT 
reduction and LDH release.  
Mitotic H9c2 cells were exposed to the indicated concentrations of chlorpyrifos for 24 h (panels A 
and B) and 48 h (panels C and D). Following chlorpyrifos exposure, cell viability was assessed by 
measuring the metabolic reduction of MTT by cellular dehydrogenases (A and C) and release of LDH 
(B and D). Data are expressed as a percentage of control cell values (=100%) and represent the mean 
± SEM of four independent experiments each performed in quadruplicate (MTT) or sextuplicate 
(LDH). **p ˂ 0.01 ****p ˂ 0.0001 versus the control response.  
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Figure 4.2 Effect of chlorpyrifos oxon on the viability of mitotic H9c2 cells monitored by 
MTT reduction and LDH release.  
Mitotic H9c2 cells were exposed to the indicated concentrations of chlorpyrifos oxon for 24 h (panels 
A and B) and 48 h (panels C and D). Following chlorpyrifos oxon exposure, cell viability was assessed 
by measuring the metabolic reduction of MTT by cellular dehydrogenases (A and C) and release of 
LDH (B and D). Data are expressed as a percentage of control cell values (=100%) and represent the 
mean ± SEM of four independent experiments each performed in quadruplicate (MTT) or 
sextuplicate (LDH).  
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Figure 4.3 Effect of diazinon on the viability of mitotic H9c2 cells monitored by MTT 
reduction and LDH release.  
Mitotic H9c2 cells were exposed to the indicated concentrations of diazinon for 24 h (panels A and B) 
and 48 h (panels C and D). Following diazinon exposure, cell viability was assessed by measuring the 
metabolic reduction of MTT by cellular dehydrogenases (A and C) and release of LDH (B and D). Data 
are expressed as a percentage of control cell values (=100%) and represent the mean ± SEM of four 
independent experiments each performed in quadruplicate (MTT) or sextuplicate (LDH).  
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Figure 4.4 Effect of diazoxon on the viability of mitotic H9c2 cells monitored by MTT 
reduction and LDH release.  
Mitotic H9c2 cells were exposed to the indicated concentrations of diazoxon for 24 h (panels A and 
B) and 48 h (panels C and D). Following diazoxon exposure, cell viability was assessed by measuring 
the metabolic reduction of MTT by cellular dehydrogenases (A and C) and release of LDH (B and D). 
Data are expressed as a the percentage of control cell values (=100%) and represent the mean ± SEM 
of four independent experiments each performed in quadruplicate (MTT) or sextuplicate (LDH).  
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Figure 4.5 Effect of PSP on the viability of mitotic H9c2 cells monitored by MTT reduction 
and LDH release.  
Mitotic H9c2 cells were exposed to the indicated concentrations of PSP for 24 h (panels A and B) and 
48 h (panels C and D). Following PSP exposure, cell viability was assessed by measuring the metabolic 
reduction of MTT by cellular dehydrogenases (A and C) and release of LDH (B and D). Data are 
expressed as a percentage of control cell values (=100%) and represent the mean ± SEM of four 
independent experiments each performed in quadruplicate (MTT) or sextuplicate (LDH). *p ˂ 0.05, 
**p ˂ 0.01, ***p ˂ 0.001, ****p ˂ 0.0001 versus the control response.  
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Figure 4.6 Effect of PSP on the viability of mitotic H9c2 cells monitored by MTT reduction 
and LDH release.  
Mitotic H9c2 cells were exposed to the indicated concentrations of PSP for 1 h (panels A and B) and 2 
h (panels C and D). Following PSP exposure, cell viability was assessed by measuring the metabolic 
reduction of MTT by cellular dehydrogenases (A and C) and release of LDH (B and D). Data are 
expressed as a percentage of control cell values (=100%) and represent the mean ± SEM of four 
independent experiments each performed in quadruplicate (MTT) or sextuplicate (LDH).  
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Figure 4.7 Effect of PSP on the viability of mitotic H9c2 cells monitored by MTT reduction 
and LDH release. 
Mitotic H9c2 cells were exposed to the indicated concentrations of PSP for 4 h (panels A and B) and 8 
h (panels C and D). Following PSP exposure, cell viability was assessed by measuring the metabolic 
reduction of MTT by cellular dehydrogenases (A and C) and release of LDH (B and D). Data are 
expressed as a percentage of control cell values (=100%) and represent the mean ± SEM of four 
independent experiments each performed in quadruplicate (MTT) or sextuplicate (LDH). *p ˂ 0.05, 
**p ˂ 0.01, ***p ˂ 0.001, ****p ˂ 0.0001 versus the control response.  
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4.3.2 Effects of organophosphates on the viability of differentiated H9c2 cells 
Mitotic H9c2 cells can be differentiated into a more cardiomyocyte-like phenotype as shown 
in Chapter 3. Therefore, the effect of OP treatment on the viability of differentiated H9c2 
cells was investigated. Chlorpyrifos at 200 µM and 100 µM inhibited MTT reduction 
following 24 and 48 h exposure (Figure 4.8a and c) and at 200 µM triggered a small but 
significant (p˂0.05) release in LDH at these time points (Figure 4.8b and d). In contrast, 
chlorpyrifos-oxon at concentrations up to 200 µM had no significant effect on MTT reduction 
or LDH release after 48 h exposure (Figure 4.9). At concentrations up to 200 µM, both 
diazinon and diazoxon had no significant effect (p>0.05) on MTT reduction or LDH release 
following 48 h exposure (see Figures 4.10, Figure 4.11).  
In differentiated cells, PSP significantly inhibited (p˂0.05) the reduction of MTT and triggered 
the release of LDH following 24 h and 48 h of exposure (Figures 4.12). Subsequent 
experiments assessed the effects of PSP on MTT reduction and LDH release at earlier time 
points e.g. 1, 2, 4, and 8 h (see Figures 4.13, Figure 4.14). The data from these experiments 
revealed that PSP-induced MTT reduction and was first evident at 2 h (IC50 = 6.5 ± 1.2 µM), 
with further inhibition observed following 4 h (IC50 = 12.8 ± 4.9 µM) and 8h (IC50 = 25 ± 9.3 
µM) exposure. In contrast, PSP-induced LDH release was first evident at 4 h (EC50 = 15.8 ± 6.1 
µM) and increased at 8 h (EC50 = 15.1 ± 4.3 µM), when levels of LDH release were 
comparable to those observed following 24 h treatment. Overall, these data (summarised in 
Table 4.1) indicate that PSP displays greater toxicity towards differentiated H9c2 cells 
compared to the other OPs tested. 
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Figure 4.8 Effect of chlorpyrifos on the viability of differentiated H9c2 cells monitored by 
MTT reduction and LDH release.  
Mitotic H9c2 cells were exposed to the indicated concentrations of chlorpyrifos for 24 h (panels A 
and B) and 48 h (panels C and D). Following chlorpyrifos exposure, cell viability was assessed by 
measuring the metabolic reduction of MTT by cellular dehydrogenases (A and C) and release of LDH 
(B and D). Data are expressed as a percentage of control cell values (=100%) and represent the mean 
± SEM of four independent experiments each performed in quadruplicate (MTT) or sextuplicate 
(LDH). *p ˂ 0.05, **p ˂ 0.01, ****p ˂ 0.0001 versus the control response.  
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Figure 4.9 Effect of chlorpyrifos oxon on the viability of differentiated H9c2 cells monitored 
by MTT reduction and LDH release.  
Differentiated H9c2 cells were exposed to the indicated concentrations of chlorpyrifos oxon for 24 h 
(panels A and B) and 48 h (panels C and D). Following chlorpyrifos oxon exposure, cell viability was 
assessed by measuring the metabolic reduction of MTT by cellular dehydrogenases (A and C) and 
release of LDH (B and D). Data are expressed as a percentage of control cell values (=100%) and 
represent the mean ± SEM of four independent experiments each performed in quadruplicate (MTT) 
or sextuplicate (LDH).  
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Figure 4.10 Effect of diazinon on the viability of differentiated H9c2 cells monitored by 
MTT reduction and LDH release.  
Differentiated H9c2 cells were exposed to the indicated concentrations of diazinon for 24 h (panels A 
and B) and 48 h (panels C and D). Following diazinon exposure, cell viability was assessed by 
measuring the metabolic reduction of MTT by cellular dehydrogenases (A and C) and release of LDH 
(B and D). Data are expressed as a percentage of control cell values (=100%) and represent the mean 
± SEM of four independent experiments each performed in quadruplicate (MTT) or sextuplicate 
(LDH).   
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Figure 4.11 Effect of diazoxon on the viability of differentiated H9c2 cells monitored by 
MTT reduction and LDH release.  
Differentiated H9c2 cells were exposed to the indicated concentrations of diazoxon for 24 h (panels A 
and B) and 48 h (panels C and D). Following diazoxon exposure, cell viability was assessed by 
measuring the metabolic reduction of MTT by cellular dehydrogenases (A and C) and release of LDH 
(B and D). Data are expressed as a percentage of control cell values (=100%) and represent the mean 
± SEM of four independent experiments each performed in quadruplicate (MTT) or sextuplicate 
(LDH).  
 
 
 
  
Chapter 4 
87 
 
 
 
 
Figure 4.12 Effect of PSP on the viability of differentiated H9c2 cells monitored by MTT 
reduction and LDH release.  
Differentiated H9c2 cells were exposed to the indicated concentrations of PSP for 24 h (panels A and 
B) and 48 h (panels C and D). Following PSP exposure, cell viability was assessed by measuring the 
metabolic reduction of MTT by cellular dehydrogenases (A and C) and release of LDH (B and D). Data 
are expressed as a percentage of control cell values (=100%) and represent the mean ± SEM of four 
independent experiments each performed in quadruplicate (MTT) or sextuplicate (LDH). *p ˂ 0.05, 
**p ˂ 0.01, ***p ˂ 0.001 ****p ˂ 0.0001 versus the control response.  
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Figure 4.13 Effect of PSP on the viability of differentiated H9c2 cells monitored by MTT 
reduction and LDH release.  
Differentiated H9c2 cells were exposed to the indicated concentrations of PSP for 1 h (panels A and 
B) and 2 h (panels C and D). Following PSP exposure, cell viability was assessed by measuring the 
metabolic reduction of MTT by cellular dehydrogenases (A and C) and release of LDH (B and D). Data 
are expressed as a percentage of control cell values (=100%) and represent the mean ± SEM of four 
independent experiments each performed in quadruplicate (MTT) or sextuplicate (LDH). *p ˂ 0.05, 
**p ˂ 0.01 versus the control response.  
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Figure 4.14 Effect of PSP on the viability of differentiated H9c2 cells monitored by MTT 
reduction and LDH release.  
Differentiated H9c2 cells were exposed to the indicated concentrations of PSP for 4 h (panels A and 
B) and 8 h (panels C and D). Following PSP exposure, cell viability was assessed by measuring the 
metabolic reduction of MTT by cellular dehydrogenases (A and C) and release of LDH (B and D). Data 
are expressed as a percentage of control cell values (=100%) and represent the mean ± SEM of four 
independent experiments each performed in quadruplicate (MTT) or sextuplicate (LDH). *p ˂ 0.05, 
**p ˂ 0.01, ***p ˂ 0.001, , ****p ˂ 0.0001  versus the control response. 
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Table 4.1 Summary of effects of organophosphorous compounds on the viability of H9c2 
cells. (+) represent significant  effect (p˂0.05) and (−) represent no significant effect 
(p>0.05) of four independent experiments. 
 
 
ORGANOPHOSPHOR0US 
COMPOUND 
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4.4 Phenyl Saligenin Phosphate Induced Apoptosis in H9c2 Cells 
From the previous results in this study it was found that PSP significantly induced H9c2 cell 
death in a concentration and time dependent manner in both mitotic and differentiated 
cells. Whilst MTT reduction and LDH release are widely used markers of cell viability, they do 
not discriminate between apoptotic and necrotic forms of cell death. To assess whether PSP-
induced cell death involved apoptosis via caspase-3 activation following PSP exposure, 
caspase-3 activation was initially monitored by Western blotting at different time periods, 
(e.g., 1, 2, 4 and 8 h) using an antibody that recognises the large fragments (17/19 kDa) of 
activated caspase-3. As evident in Figure 4.15, treatment of differentiated H9c2 cells with 25 
µM PSP for 4 h triggered a significant increase (p˂0.05) in caspase-3 activation. Similar 
results were obtained when PSP-induced caspase-3 activation was monitored via 
immunocytochemistry as shown in Figure 4.16. 
 
Figure 4.15 PSP-induced caspase-3 activation in differentiated H9c2 cells.  
Differentiated H9c2 cells (7 days) were incubated without (-) or with (+) 25 µM PSP for the indicated 
time periods. Following PSP, exposure cell lysates (15 µg protein) were analysed for caspase-3 
activation (17 kDa) by Western blot analysis using specific caspase-3 antibody. The same samples 
were consequently analysed to confirm equal loading of protein in each well using anti-GAPDH 
antibody. Quantified data are expressed as percentage of control cell values (100%) and represent 
the mean ± SEM of three independent experiments.*p < 0.05 versus untreated control cells. 
 
A 
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Figure 4.16 PSP-induced caspase-3 activation in differentiated H9c2 cells. 
Differentiated H9c2 cells (7days) were exposed to 25 µM PSP for 4 h and assessed for caspase-3 
activation via immunocytochemical staining. A) Untreated differentiated H9c2 control cells; only 
nuclei shown by DAPI staining (blue). B) Caspase-3 activity detected using FITC-labelled anti-activated 
caspase-3 (green) after 4 h incubation with 25 µM PSP. Scale bar = 100 µm. Images presented are 
from one experiment and are representative of three. 
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4.5 Effects of Phenyl Saligenin Phosphate on Protein Kinase Activation  
PSP-induced cell death in mitotic and differentiated H9c2 cells may involve the modulation 
of pro-survival and/or pro-apoptotic signalling pathways. It is generally accepted that ERK1/2 
and protein kinase B (PKB; also known as Akt) promote cell survival by activating anti-
apoptotic signalling pathways, whereas the activation of JNK and p38 MAPK are associated 
with apoptotic cell death (Armstrong, 2004; Hausenloy & Yellon, 2007). PSP-induced 
modulation of protein kinase activity was assessed by Western blotting using phospho-
specific antibodies that recognise phosphorylated motifs within activated ERK1/2 (pTEpY), 
p38 MAPK (pTGpY), JNK (pTPpY) and PKB (S473). Exposure of differentiated H9c2 cells to PSP 
(25 µM) for 1 h, 2 h, 4 h and 8 h had no significant effect on the levels of phosphorylated 
PKB, ERK1/2, (Figure 4.17 and Figure 4.18) or p38 MAPK (no appearance of any bands). In 
marked contrast, PSP (25 µM) induced a time dependant increase in JNK1/2 activation  in 
differentiated H9c2 cells with significant activation observed at 4 h (Figure 4.19). 
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Figure 4.17 Effect of PSP on PKB activation in differentiated H9c2 cells.  
Differentiated H9c2 cells (7 days) were exposed to 25 µM PSP for the indicated time periods after 
which cell lysates (15 µg protein) were analysed for PKB activation (56 kDa) by Western blot analysis 
using anti-phospho-specific PKB antibody. The same samples were consequently analysed to confirm 
equal loading of protein in each well using anti-total PKB antibody. Quantified data are expressed as 
the ratio of phosphorylated PKB to total PKB and represent the mean ± SEM of three independent 
experiments.   
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Figure 4.18 Effect of PSP on ERK1/2 activation in differentiated H9c2 cells.  
Differentiated H9c2 cells (7 days) were exposed to 25 µM PSP for the indicated time periods after 
which cell lysates (15 µg protein) were analysed for ERK1/2 activation (42/44 kDa) by Western blot 
analysis using anti-phospho-specific ERK1/2 antibody. The same samples were consequently analysed 
to confirm equal loading of protein in each well using anti-total ERK1/2 antibody. Quantified data are 
expressed as the ratio of phosphorylated PKB to total PKB and represent the mean ± SEM of three 
independent experiments.   
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Figure 4.19 PSP induced JNK1/2 activation in differentiated H9c2 cells.  
Differentiated H9c2 cells (7 days) were exposed to 25µM PSP for the indicated time periods after 
which cell lysates (15 µg protein) were analysed for JNK1/2 activation (46/54 kDa) by Western blot 
analysis using anti-phospho-specific JNK1/2 antibody. The same samples were consequently analysed 
on separate blots to confirm equal loading of protein in each well using anti-total JNK1/2 antibody. 
Quantified data are expressed as ratio of phosphorylated JNK1/2 to total JNK 1/2 and represent the 
mean ± SEM four independent experiments. ****p ˂ 0.0001 versus untreated control cells.  
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4.6 The Effect of the JNK1/2 Inhibitor SP600125 on PSP-Induced Cell Death 
and JNK 1/2 Activation 
To investigate further the role of JNK1/2 in PSP-induced cell death, differentiated H9c2 cells 
were pre-treated for 30 min with the JNK1/2 inhibitor SP 600125 (10 µM; Bennett et al. 
2001) prior to OP exposure. As shown in Figure 4.20, SP 600125 had no significant effect on 
25 µM PSP-induced inhibition of MTT reduction or LDH release following 4 h or 8 h OP 
exposure. Western blot analysis was subsequently used to establish whether SP 600125 (10 
µM) had attenuated PSP-induced JNK1/2 activation in H9c2 cells. As depicted in Figure 4.21, 
SP 600125 pre-treatment significantly inhibited PSP (25 µM)-induced JNK1/2 activation 
following 1h and 2 h OP exposure. However, it did not block PSP-induced JNK1/2 activation 
after 4 h of exposure, which presumably accounts for the lack of effect observed with SP 
600125 when monitoring PSP-induced inhibition of MTT reduction and release of LDH at 4 h 
and 8 h. Since PSP-induced caspase-3 activation was evident at 1 h and 2 h OP exposure, 
present study determined the effect of SP 600125 on PSP-induced caspase-3 activation at 
these earlier time points via immunocytochemistry. As shown in Figure 4.22, SP 600125 (10 
µM) attenuated PSP-induced caspase-3 activation, confirming the involvement of JNK1/2 in 
PSP-mediated cell death in H9c2 cells. For comparison, the kinase inhibitors LY 294002 (30 
µM; PI-3K inhibitor), PD 98059 (50 µM; MEK1/2 inhibitor), SB 203580 (30 µM; p38 MAPK 
inhibitor) and wortmannin (100 nM; PI-3K inhibitor) had no significant effect on PSP-induced 
caspase-3 activation (Figure 4.23). 
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Figure 4.20 Effect of the JNK1/2 inhibitor SP 600125 on PSP-induced inhibition of MTT 
reduction and release of LDH. 
 Differentiated H9c2 cells (7 days) were pre-treated for 30 min with the JNK1/2 inhibitor SP 600 125 
(10 μM) prior to exposure to 25 μM PSP for 4 h (panels A and B) and 8 h (panels C and D) in the 
presence and absence of SP 600125 as indicated. Following PSP exposure, cell viability was assessed 
by measuring the metabolic reduction of MTT by mitochondrial dehydrogenases (A and C) and 
release of LDH (B and D). Data are expressed as the percentage of control cell values (= 100%) and 
represent the mean ± SEM of at least three independent experiments each performed in 
quadruplicate (MTT) or sextuplicate (LDH). *p < 0.05, **p < 0.01 ***p < 0.001 and ****p < 0.0001 
versus the untreated control response. 
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Figure 4.21 Effect of the JNK1/2 inhibitor SP 600125 on PSP-induced JNK1/2 activation. 
Differentiated H9c2 cells (7 days) were pre-treated with SP 600125 (10 µM, JNK1/2 inhibitor) 30 min 
prior to stimulation with 25 µM PSP for A) 1h, B) 2h and C) 4h. Cell lysates (15 µg protein) were 
analysed for JNK1/2 activation (46/54 kDa) by Western blot using anti-phospho-specific JNK1/2 
antibody. The same samples were consequently analysed to confirm equal loading of protein in each 
well using anti-total JNK antibody. Quantified data are expressed as the percentage of control cell 
values (100%) and represent the mean ± SEM of three independent experiments. *p < 0.05 versus 
the untreated control response. 
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Figure 4.22 Effect of the JNK1/2 inhibitor SP 600125  on PSP-induced caspase 3 activation. 
Differentiated H9c2 cells (7 day) were exposed to 25 µM PSP for A) 1 h, B) 2h, and C) 4 h in the 
presence and absence of SP 600125 (10 µM; 30 min pre-incubation). Following PSP exposure, 
caspase 3 activation was assessed via immunocytochemistry using anti-active caspase 3 antibody 
(green) and DAPI counterstain for nuclei visualisation (blue). Scale bar = 100 µm. Images presented 
are from one experiment and representative of four. Quantified data are expressed as a percentage 
of control cell values and represent the mean ± SEM of four independent experiments. **p<0.01, 
***p<0.001, ****p<0.0001, (a) versus control and (b) versus PSP alone treated cells. 
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Figure 4.23 Effects of PI-3K, MEK1/2 and p38 MAPK inhibition on PSP-induced caspase 3 
activation.  
Differentiated H9c2 cells (7 day) were exposed to 25 µM PSP for 4 h in the presence and absence of  
LY 294002 (30 µM; PI-3K inhibitor), PD 98059 (50 µM; MEK1/2 inhibitor), SB 203580 (30 µM; p38 
MAPK inhibitor;) and wortmannin (100 nM; PI-3K inhibitor) 30 min pre-incubation. Following PSP 
exposure, caspase 3 activation was assessed via immunocytochemistry using anti-active caspase 3 
antibody (green) and DAPI counterstain for nuclei visualisation (blue). Scale bar = 100 µm. Images 
presented are from one experiment and representative of four.  Quantified data are expressed as a 
percentage of control cell values and represent the mean ± SEM of four independent experiments. 
****p<0.0001, (a) versus control and (b) versus PSP alone treated cells. 
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4.7 Effects of phenyl saligenin phosphate on AChE activity in differentiated 
H9c2 cells 
In order to establish the relationship between the cytotoxic effects of OPs in differentiated 
H9c2 cells and the level of AChE activity, cholinesterase assays were performed in the 
presence and absence of 25 µM chlorpyrifos, diazinon and their metabolites (chlorpyrifos 
oxon, diazoxon) and PSP. Figure 4.24 shows that there was much stronger inhibition of AChE 
by the oxon forms chlorpyrifos oxon and diazoxon, followed by the parent compounds 
chlorpyrifos and diazinon. By contrast, PSP proved to be a very weak inhibitor of AChE 
activity in H9c2 cells, causing only approximately 30% inhibition compared to control levels 
of activity.   
 
Figure 4.24 Effects of OP compounds on acetylcholinesterase activity. 
Cells were induced to differentiate for 7 days and then exposed to A) chlorpyrifos B) chlorpyrifos 
oxon C) diazinon D) diazoxon E) PSP for (8 h,25 μM). Shown are the mean specific activities ± SEM 
from three independent experiments. **p<0.01, ***p<0.001, ****p<0.0001 versus non-OP-treated 
control cells (Student’s t test).  
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4.8 Dansylated PSP 
This study utilized fluorescently labeled PSP (dansylated PSP), which was a gift from Dr. 
Garner (Nottingham Tent University) as shown in Figure 4.25 This type of approach is an 
accurate, specific and sensitive means of detecting novel protein targets of toxic compounds 
(Greenbaum et al., 2002). 
 
 
 
Figure 4.25 Chemical structures of A) PSP and B) dansylated PSP. 
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As illustrated in the current study that a concentration of 25 µM of PSP was incubated with 
differentiated H9c2 cells and produced optimal cardiotoxicity associated with the activation 
(phosphorylation) of JNK signalling pathways and the induction of apoptosis by caspase-3 
activation. Proteins that bind to OPs can be separated by denaturing gel electrophoresis and 
visualized under UV transillumination as simplified in Figure 4.26. This was followed by 2D 
gel electrophoresis and MALDI-TOF mass spectrometry to identify tryptic peptides.  
 
 
 
 
Figure 4.26 Strategy of using dansylated PSP for protein targeting.  
The H9c2 cells enriched proteins are incubated with dansylated PSP, cell lysates are then separated 
by  SDS PAGE and target proteins visualized under UV transillumination. 
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4.8.1 Dansylated-PSP induced cytotoxicity in H9c2 cells 
Prior to investigation of novel protein targets of PSP, initially more thorough analyses were 
undertaken in order to compare the cytotoxic effects of dansylated PSP with those of PSP 
shown in section 4.3.2. Differentiated H9c2 cells were treated with different concentrations 
of dansylated PSP up to (200 µM) for 8 h. From the assay results obtained, it can be seen 
that dansylated PSP was shown to reduce significantly MTT reduction and increase the 
release of LDH in a concentration dependent manner, as indicated in Figure 4.27.  
 
 
 
 
Figure 4.27 Effect of dansylated PSP on the viability of differentiated H9c2 cells monitored 
by MTT reduction and LDH release.  
Differentiated H9c2 cells (7 days) were exposed to the indicated concentrations of dansylated PSP for 
8 h. Following PSP exposure, cell viability was assessed by measuring the metabolic reduction of MTT 
by mitochondrial dehydrogenases (A) and the release of LDH (B). Data are expressed as a percentage 
of control cell values (=100%) and represent the mean ± SEM of three (MTT) or four (LDH) 
independent experiments, each performed in quadruplicate (MTT) or sextuplicate (LDH). *<p0.05, 
**p<0.01, ***p<0.001 and ****p<0.0001 versus control response. 
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4.8.2 SDS-PAGE analysis for dansylated-PSP binding to differentiated H9c2 
cells 
Differentiated H9c2 cells were incubated for 8 h with 25 µM dansylated-PSP. This 
concentration and time point were chosen based upon results obtained from the 
cytotoxicity experiments described in section 4.3.2. Following incubation, cell lysates were 
initially subjected to SDS-PAGE and dansylated PSP binding proteins visualised under UV 
light. In these experiments the presence of a detectable fluorescent band was defined as a 
positive test and hence the presence of protein targets, whereas undetectable fluorescence 
is defined as a negative result.  As shown in Figure 4.28, several bright fluorescent bands 
were identified via SDS PAGE of dansylated-PSP treated cell lysates, indicating the presence 
of OP labeled target proteins, while in non-PSP treated control cells there were no 
fluorescent bands. Later, the gels were stained with Coomassie blue to confirm the presence 
of proteins in differentiated H9c2 cells. However, further experiments were required in 
order to identify these target proteins. 
 
Figure 4.28 Visualisation of proteins labeled with dansylated-PSP. 
 Differentiated H9c2 cells were untreated or treated with dansylated PSP (8 h, 25 µM) and cell lysates 
(15 µg) were separated by SDS-PAGE. A) Gels were visualised under UV light. The arrows point to 
prominently dansylated-PSP labelled proteins. B) After visualisation of fluorescent bands, the same 
gels were stained with Coomassie blue to confirm the presence of protein bands. Images are 
presented from three independent experiments. 
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4.8.3 Identification of PSP labeled proteins by mass spectrometry  
Identification of dansylated PSP labelled proteins was achieved by 2D gel electrophoresis 
followed by MALDI-TOF analysis of the peptides produced by trypsin digestion. 
Differentiated H9c2 cells were untreated (control) or treated with 25 µM dansylated-PSP, 
and cell lysates prepared and subjected to 2D gel electrophoresis. Visualisation of 2D gels 
under UV light revealed control cells did not show any fluorescent spots (Figure 4.29a). In 
comparison, treated cells showed several fluorescent protein spots (Figure 4.29b). After 
visualisation under UV light, gels were stained with ProtoBlue™ safe colloidal Coomassie G-
250 stain and imaged as described in Chapter 2 (section 2.7). In order to identify dansylated-
PSP labeled protein targets, Progenesis SameSpots software was used and was able to 
identify three protein spots that showed significant binding of labeled PSP  (Figure 4.29d). To 
identify these spots, these proteins were excised from the stained gel and digested by 
trypsin, and analyzed by a MALDI-TOF/TOF mass spectrometry. Target protein spots showed 
significant similarities with searched databases; these identified proteins are listed in Table 
4.2. 
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Figure 4.29 Visualisation of proteins labelled with dansylated PSP.  
Differentiated H9c2 cells were untreated or treated with dansylated PSP (8 h, 25 µM) and cell lysates 
processed and analysed by 2D gel electrophoresis using pH 3-10 gradient strips. Gels were visualised 
under UV light (panels A and B) prior to staining with ProtoBlue™safe colloidal Coomassie G-250 stain 
(panels C and D). Gel images are presented from three independent experiments and were analysed 
using Progenesis SameSpots software and circled spots represent those labelled with dansylated PSP. 
Spot 1: nucleolar protein 58; Spot 2: tropomyosin α-4; Spot 3: heat shock protein β-1. A list of 
identified proteins labelled by dansylated PSP is provided in Table 6.1  
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Table 4.2 Identification of PSP-Binding proteins in differentiated H9c2 cells. 
Spot 
no. 
Protein Accession 
no. 
PMF 
sequence 
coverage 
(%)
a
 
Identified peptide 
sequence 
(MS/MS) 
Mascot 
score b 
kDa pI 
2 tropomyosin α-4 P09495 39 - 52 28.5 4.4 
3 Heat shock 
protein β-1 (HSP-
27) 
P42930 - LFDQAFGVPR 80 22.9 6.1 
1 nucleolar protein 
58 
Q9Q286 32 - 52 59.5 9.2 
 
H9c2 cells treated with dansylated PSP (8 h, 25 μM) were analyzed by 2D gel electrophoresis and 
PSP-labeled proteins identified using MALDI- TOF MS (PMF) or MS/MS as described in chapter 2 
(section 2.7.4). Sequence data were analyzed using Mascot software and reported according to 
percentage sequence coverage (SC%) or Mascot score (ion scores for MS/MS > 27 indicate identity or 
extensive homology; > 51 for PMF). All identified proteins exhibited Mascot scores that were 
considered statistically significant (*p < 0.05). aMALDI-TOF MS. bMS/MS. 
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4.9 Binding of dansylated PSP to purified tropomyosin 
To confirm the identification of one protein labelled by dansylated PSP, tropomyosin was 
chosen for validation by incubation of purified human heart tropomyosin (10 µg) with or 
without dansylated PSP or unlabelled PSP. The purified tropomyosin was then subjected to 
SDS-PAGE and visualised under UV light followed by staining with Coomassie blue. As shown 
in Figure 4.30, purified tropomyosin was labelled with dansylated PSP. 
 
 
 
 
Figure 4.30 Labeling of purified human heart tropomyosin with dansylated PSP.  
Human heart tropomyosin (10 µg) was incubated for 1 h in presence or absence of 
dansylated/unlabelled PSP (25 µM). Tropomyosin samples were then subjected to SDS-PAGE, 
visualised under UV light (B) and subsequently stained with Coomassie Blue (A). Lane 1: tropomyosin 
incubated with Tris-buffered saline; Lane 2: tropomyosin incubated with DMSO (the solvent for PSP); 
Lane 3: tropomyosin incubated with unlabeled PSP; Lane 4: tropomyosin incubated with dansylated 
PSP. Gel images are presented from three independent experiments. 
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4.10 Discussion  
4.10.1 Phenyl saligenin phosphate-induced cytotoxicity  
Organophosphate poisoning may affect heart function causing cardiac complications such as 
bradycardia due to enhanced cholinergic stimulation and conduction disturbance (Brill et al., 
1984; Wang et al., 1998). Thus far, a limited number of studies have investigated cardiac 
toxicity induced by OPs, but still the detailed mechanisms underlying the cellular toxicity are 
not known (Ludomirsky et al., 1982, Saadeh et al., 1997) and there is very little information 
on the direct effect of OPs on muscle cell function. 
Initial experiments in this study examined chlorpyrifos and diazinon and their in vivo 
metabolites chlorpyrifos oxon and diazoxon. It was found that chlorpyrifos showed toxic 
effects at the highest concentrations >100 µM in mitotic and differentiated H9c2 cells. 
Chlorpyrifos oxon, diazinon and diazoxon at concentrations up to 200 µM had no cytotoxic 
effects on mitotic and differentiated H9c2 cardiomyoblast cells. These results are in stark 
contrast to the cardiovascular consequences of acute OP poisoning, which reflects over-
activity of sympathetic and parasympathetic pathways due to enhanced levels of 
acetylcholine (Roth et al. 1993; Anand et al., 2009). 
The oxon forms of chlorpyrifos and diazinon did not show any cytotoxic effects in H9c2 cells. 
Taking into account the fact that oxon metabolites of chlorpyrifos and diazinon are potent 
inhibitors of AChE  (Eaton et al., 2008). This supports the view that the cytolethal effects of 
these compounds is not only associated with AChE inhibition (Masoud et al., 2003). This is in 
agreement with the results of Saulsbury et al. (2008) who investigated the differences 
between chlorpyrifos and chlorpyrifos oxon, and found that chlorpyrifos induced a reduction 
in cell viability more than its oxon metabolite. Thus, OP intoxication depends on the 
physiological response of cells towards specific OP compounds (Rush et al., 2010). In 
summary, OPs that mediate acute in vivo toxicity, primarily via AChE inhibition, display little 
cytotoxicity towards mitotic and differentiated H9c2 cardiomyoblasts. In marked contrast, 
PSP (a weak AChE inhibitor) displayed pronounced cytotoxicity towards both mitotic and 
differentiated H9c2 cells. PSP is an analogue of SCOTP, an active neuropathic metabolite of 
TOCP which is known to be a direct inhibitor of NTE (Chen et al., 2012) and a weak inhibitor 
of AChE (Jortner & Ehrich 1987). Hence, the cytotoxic effects of PSP observed in this study 
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are presumably mediated via non-cholinergic mechanisms. As shown in Figure 4.7a, findings 
pointed to PSP cytotoxic effects on mitotic H9c2 cells at the shorter incubation time 4 h with 
MTT reduction and LDH release, whereas in differentiated H9c2 cells PSP-induced toxicity 
was evident at 2 h when monitoring MTT reduction (Figure 4.13c). Here, results showed that 
MTT reduction was more sensitive than LDH release in detecting cytotoxic events in 
differentiated cells. The difference in sensitivity between MTT and LDH assays is in 
agreement with previous studies, which have reported the MTT assay as being more 
sensitive in detecting cytotoxic effects (Fotakis & Timbrell, 2006). These cytotoxic effects are 
consistent with earlier studies that have shown that PSP inhibits MTT reduction in mouse 
N2a neuroblastoma cells and human hepatic HepG2 cells (IC50 values of approximately 10-15 
µM; Harris et al., 2009). 
4.10.2 Phenyl saligenin phosphate-induced apoptosis  
It has been questioned whether the observed PSP-induced cytotoxicity is associated with 
apoptosis or necrosis. Therefore, caspase-3 was measured following PSP exposure. The 
present findings showed that treatment with PSP (25 µM) triggered the rapid activation of 
intracellular caspase-3 (Figure 4.15 and Figure 4.16), indicating that PSP induced apoptosis in 
cultured differentiating H9c2 cells. These results are consistent with a previous study 
showing that PSP (10 and 100 µM) induced apoptosis in human SH-SY5Y cells via activation 
of caspase-3 (Carlson et al., 2000). As PSP was found to be a weak inhibitor of AChE (Figure 
4.24e), and this also supports the fact that OP-induced apoptosis can occur independently 
from AChE inhibition (Li, 2010). A review by Ehrich et al. (1997), which compared various 
OPs, concluded that PSP-induced apoptosis was inversely associated with the extent of AChE 
inhibition.  
4.10.3 Phenyl saligenin phosphate-induced JNK1/2 signalling 
There is increasing evidence showing that apoptosis is modulated by different members of 
the MAPK family (Hetman & Xia, 2000). However, there is very little known about the effect 
of OPs on MAPK signaling pathways in differentiated H9c2 cells. To determine whether 
various MAP kinase signaling pathways were involved with PSP-induced apoptosis, the 
current study investigated the effect of PSP exposure on protein kinase cascades associated 
with cell survival (ERK1/2 and PKB) and cell death (p38 MAPK and JNK1/2). It was presumed 
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that PSP induced cytotoxic effect may induce activation of ERK1/2, PKB, p38 MAPK and 
JNK1/2 signalling pathway. In the current study it appears that PSP did not significantly 
modulate PKB phosphorylation or ERK1/2 MAPK or p38 MAPK activation status in 
differentiated H9c2 cells (Figure 4.17; Figure 4.18; with anti-p38 no bands appeared). In 
contrast, previous reports provided evidence that administration of sub-lethal 
concentrations of PSP was able to modulate these important protein kinase signal 
transduction pathways. For example, in differentiating mouse N2a neuroblastoma cells, PSP 
triggered the transient activation of ERK1/2 (2.5 µM; 4 h; Hargreaves et al. 2006). Also, 
Pomeroy-Black & Ehrich (2012) observed elevated levels of phosphorylated PKB in human 
SH-SY5Y neuroblastoma cells following exposure to PSP (0.1 µM). It is notable that the effect 
of PSP on PKB activation in SH-SY5Y cells was a consequence of OP-induced activation of the 
low affinity neurotrophin p75 receptor (Pomeroy-Black & Ehrich 2012). Thus, neurotrophins 
play an important role in neuronal survival and development (Ginty, 2002). 
Data from this study also showed that PSP administration to differentiated H9c2 cells was 
found to increase significantly the phosphorylation of JNK 1/2 (Figure 4.19) indicating that 
JNK1/2 activation plays a major role in PSP-induced apoptosis in differentiated H9c2 cells. As 
this is supported by previous study that reported that JNK1/2 pathway plays an important 
role in the induction of apoptosis (Dhanasekaran & Reddy, 2008). Thus, as JNK1/2 belongs to 
the MAPK family, any disturbance in MAPK pathways could lead to morphological changes 
which may induce loss of cell viability as observed in previous studies (Nostrandt et al., 1992; 
Carlson et al., 2000). These results are consistent with an earlier study showing that sarin 
and soman-like organophosphate nerve agents ([bis(isopropyl methyl)phosphonate, BIMP 
and bis(pinacolyl methyl)phosphonate, BPMP]) induce JNK activation in  rat brain cells 
(Niijima et al., 2000). Interestingly, the activation of JNK by these two OPs was dependent 
upon phospholipase C and protein kinase C activation (Nijima et al., 2000). 
Moreover, activation of the JNK pathway initiates harmful inflammation and, if unabated, 
can lead to apoptosis (Abraham & Clark, 2006). Interestingly, in cultured adult rat cardiac 
ventricular myocytes, JNK activation triggers the release of pro-apoptotic molecules such as 
cytochrome c and AIF (apoptosis-inducing factor; Aoki et al., 2002). This may suggest the 
potential mechanism of PSP-induced apoptosis in differentiated H9c2 cells. 
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To ascertain the role of the JNK1/2 pathway in PSP-induced cytotoxicity, H9c2 cells were 
exposed to PSP in the presence of the JNK1/2 inhibitor SP 600125. However, pre-treatment 
with SP 600125 (10 µM) did not reverse the toxic effect of PSP in terms of either MTT 
reduction or LDH release following 4 h or 8 h exposure (Figure 4.20).  In contrast, pre-
administration of SP 600125 attenuated PSP-induced JNK1/2 activation at 1 h and 2 h (Figure 
4.21a and b). However, SP 600125 ineffective to block JNK activation at 4 h (Figure 4.21c).  
The results showed that SP 600125 did not play a vital role in preventing cell death as shown 
in MTT and LDH assay. The reversible inhibition of PSP-induced JNK1/2 activation by SP 
600125 may reflect removal of the inhibitor from the cell (although the inhibitor was present 
throughout the experiment) and/or its metabolism to an inactive metabolite. Another 
possibility may be that alternative pathways are involved in the death machinery of 
differentiated H9c2 cells. 
However, SP 600125 did block caspase-3 activation at 1 h, confirming the involvement of 
JNK1/2 in PSP-induced apoptosis. It is interesting to note that although SP 600125 blocked 
caspase-3 activation at 4 h, it did not block PSP-induced JNK1/2 activation at 4 h (Figure 4 
22). This is could potentially be a consequence of caspase-3 activation being downstream of 
JNK1/2 and hence inhibition of JNK1/2 at early time points (˂2 h) prevents subsequent 
caspase-3 activation. Regarding the clinical relevance, a previous study has shown that 
similar levels of SCOTP (an analogue of PSP) can be achieved in the heart tissue after normal 
levels of accidental exposure (Somkuti & Abou-Donia, 1990). Since the present data showed 
that 25 µM PSP was able to induce caspase-3 activation at the first hour of exposure, it is 
most likely that such levels can be achieved transiently in vivo. More interestingly, previous 
study shown that 100 µM TOCP were observed in heart tissue in rats after a repeated oral 
doses (50 mg/kg) of TOCP, suggesting that high levels of metabolite are achievable and 
longer exposure of PSP at lower concentrations can induce caspase-3 activation (Somkuti & 
Abou-Donia, 1990). 
Furthermore, pre-treatment with other kinase inhibitors LY 294002, PD 98059, SB 203580 
and wortmannin did not block caspase-3 activation at 1,2 and 4 h, confirming that neither 
ERK 1/2 nor p38 MAPK and PKB are involved in PSP-induced cell death (Figure 4.23). 
Although this is the first report describing PSP-induced activation of JNK 1/2 in differentiated 
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H9c2 cells, further studies are required to reveal other molecular mechanisms implicated in 
PSP-induced cytotoxicity towards H9c2 cells.  
4.10.4 Effect of OPs on cellular AChE activity in differentiating H9c2 cells 
In the current study, the results from AChE activity assays showed that exposure to 
chlorpyrifos and diazinon and their acutely toxic metabolites (diazoxon and chlorpyrifos 
oxon) was associated with significant inhibition in AChE activity (Figure 4.24a, b, c and d).  
The extent of inhibition associated with each compound was in agreement with previous 
observations in nerve tissue treated with chlorpyrifos and diazinon showing significant 
inhibition of AChE activity (Murphy, 1986; Sultatos, 1994). In contrast, PSP confirmed to be a 
weak inhibitor of AChE under the same experimental conditions as used for LDH and MTT 
assays (Figure 4.24 e). These data pointed to the idea that cytotoxic effects of PSP on H9c2 
cells were unrelated to significant cholinesterase inhibition and it is more likely that other 
cellular targets contribute to its toxicity. At present the cellular effect(s) of neuropathic OPs, 
such as PSP, on cardiomyocytes are largely unknown. 
4.11 Identification of PSP Binding Proteins. 
Over the years, OPs are known to be a highly reactive compounds that have been shown to 
bind to the active site of AChE causing hyper-stimulation of cholinergic receptors resulting in 
OP intoxication (Abdollahi & Karami-Mohajeri, 2012). However, OPs are also known to 
interact with non-cholinergic targets. For example, mass spectrometry analysis has 
demonstrated that OPs may bind to human albumin (Ding et al., 2008; Li et al., 2007), alpha- 
and beta-tubulin (Grigoryan et al., 2008), human transferrin and mouse transferrin  (Li et al., 
2009). In a previous study, OPs were confirmed to form covalent adducts on tyrosine 
residues of these proteins (Grigoryan et al., 2009). Binding of OPs such as chlorpyrifos-oxon 
with tubulin was found to inhibit tubulin polymerization, affecting neuronal cytoskeleton 
function resulting in neuronal cytotoxicity in the hippocampus of rodent brain (Prendergast 
et al., 2007; Grigoryan et al., 2008). On the other hand, other OP-binding proteins such as 
albumin and transferrin were not linked to any toxic effects. Thus OP adducts with these 
proteins may serve as biomarkers for OP exposure (B. Li et al., 2009). Despite the variety of 
proteins identified as targets to different OPs, to date targets proteins of PSP in cardiac cells 
have not been investigated.  
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Exposure to PSP was found to induce OPIDN, in which NTE inhibition and found to be a 
primary target (Jortner & Ehrich, 1987). NTE is a member of the patatin-like phospholipase 
(PNPLA) family, whose functions include regulation of lipid metabolism and cell signalling 
(Chang et al., 2010; Richardson et al., 2013). Although NTE (PNPLA6) has been detected in 
non-neuronal tissues including human heart (Wilson et al., 2006), it is not known whether 
mitotic or differentiated H9c2 cells express NTE. Although beyond the scope of the present 
study, it would be of interest to investigate NTE expression and the effect of PSP on NTE 
activity in H9c2 cells.  Previous studies have only focused on the effect of PSP on proteolytic 
enzymes, as well as cytoskeleton proteins and signalling molecules in neuronal cells 
(Hargreaves 2012; Pomeroy- Black & Ehrich 2012). However, the mechanism of PSP toxicity 
in differentiated cardiac cells remains unclear. For this purpose in the present study, 
modified (dansylated) PSP was used to facilitate the search of new biomarkers and 
identification of protein targets of PSP in differentiated H9c2 cells. 
Several methods are available to tag proteins and molecules and the most commonly used 
tags on a chemical probe are biotin, fluorescent, and radioactive tags, which use simple 
labeling techniques to identify the protein of interest in gel electrophoresis with high protein 
selectivity (Patricelli et al., 2001). However, both fluorescent and radioactive probes are 
known to be more sensitive for detection than biotin (Greenbaum et al., 2002). 
Fluorescently labeled probes contain a reactive group which has the ability to covalently 
attach to a functional group on the molecule to be labelled, which gives the compound a 
detectable property (Probes, 2013). They are suitable for in vitro assay procedures to probe 
particular compounds that can be detected through fluorescence emission (Jeffery & Bogyo, 
2003).  
Mass spectrometry analysis identified tropomyosin, heat shock protein β-1 and nucleolar 
protein 58 as novel protein targets for PSP. Heat shock protein β-1 (also known as HSP-27) is 
a member of small heat shock protein family. These proteins are induced in response to 
stress and are known to have a cardioprotective effect.  At the subcellular level they play an 
important role in preventing apoptosis and necrosis (Mymrikov et al., 2011; Wettstein et al., 
2012). Moreover, they have been found to be associated with the regulation and stability of 
cytoskeleton proteins,  by promoting their structural stability and increasing their resistance 
to stress (Huot et al.,1995; Guay et al.,1997). Based on the results presented in this chapter, 
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it is suggested that  binding of PSP  to HSP27 could lead to changes in its activation status, 
resulting in alterations in its protective function against apoptosis and cardiac toxicity. 
Tropomyosin is known to play a central role as a contractile regulatory protein, which also 
plays an important role in actin stability in muscle and non-muscle cells (Yo & Ono, 2006). In 
vitro studies have suggested that tropomyosin functions to protect actin from actin 
depolymerizing factor proteins (ADF) such as cofilin (Bernstein & Bamburg, 1982; Broschat, 
1990). Actin is known to be a core component of the microfilament network, which  is 
involved in a number of biological function such as regulation of cell motility, contraction 
and cell shape (Khaitlina 2001; Yarar et al, 2005). In vivo studies showed that alteration in 
tropomyosin expression  directly contributes  to significant alteration in cardiac function, 
including  cardiac hypertrophy, ventricular fibrosis and atrial enlargement (Prabhakar et 
al.,2003).  
More interestingly, exposure to PSP (100 µM) induced in vitro cytotoxicity and apoptotic cell 
death mediated by caspase-3 activation in SH-SY5Y human neuroblastoma cells, suggesting 
that activation of caspase-3 is associated with numerous substrate degradation, such as 
actin (Carlson et al., 2000). Later on, exposure to PSP (10 µM) was observed to significantly 
decrease the levels of cellular filamentous actin in human SH-SY5Y neuroblastoma cells 
(Carlson & Ehrich, 2001). Although, all these studies reported the effect of PSP using 
neuronal cells as a model system, none of them used cardiomyocytes. However, It is not 
known whether the changes in actin expression reported in the previous study is a result of 
the direct effect of PSP on actin or an indirect effect from PSP modification of  tropomyosin 
or potentially other actin binding protein. Therefore, it is reasonable to suggest that PSP 
binding to tropomyosin  may affect actin stabilization, which could in turn contribute to the 
development of cardiac toxicity.  
Moreover, it is important to mention that there is clear evidence supporting the link 
between actin stability and apoptosis. For example, drugs that inhibit actin filament 
organization, such as Jasplakinolide, were found to trigger apoptosis in human Jurkat T cells 
(Bubb et al., 1994; Odaka et al., 2000). Thus, changes in actin dynamics are associated with 
different stages of programmed cell death (Desouza et al., 2012). These observations are 
consistent with the possibility that the toxicity of PSP towards differentiated H9c2 may be 
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due to tropomyosin binding affecting actin polymerization, which could alter its activity 
status and induce the activation of downstream caspases that mediate apoptosis. Moreover, 
it is conceivable that PSP binding to tropomyosin attenuates its interaction with other actin 
binding proteins (e.g. cofilin) that are linked to cytoskeleton mediated modulation of 
apoptotic signalling (Desouza et al. 2012).  
Finally, PSP also bound to nucleolar protein 58 which is MSP58 protein is found in the 
microspherules of the nucleolus (Ren et al., 1998) and  required for 60S ribosomal subunit 
biogenesis (Lyman et al. 1999). PSP binding to this protein might impair the translation of 
proteins essential for cell survival; thus, overexpression of MSP58 protein was suggested to 
be associated with alteration in nucleolus size and shape (Ren et al., 1998). However, it 
remains to be established if there is a definitive link between any of these novel protein 
targets and PSP-induced cytotoxicity. 
 
4.12 Conclusion  
In summary the data presented in this chapter indicate marked differences between the 
effects of the tested OPs on mitotic and differentiated H9c2 cells. PSP was shown to be the 
most cytotoxic compound that induced significant increase in LDH release and inhibition of 
MTT reduction, without a major effect on AChE activity. Furthermore, the findings indicate 
that the toxic manifestations induced by PSP administration are associated with activation of 
JNK1/2 and caspase-3. However, the cytotoxic effects of PSP may involve other molecular 
mechanism and biological targets. Therefore, further investigations into the intracellular 
protein targets of PSP are necessary. Mass spectrometry identified tropomyosin, heat shock 
protein β-1 and nucleolar protein 58 as novel binding proteins that may be involved in PSP 
toxicity. PSP binding with such proteins may affect fundamental cardiac function. However a 
number of questions remain unanswered, such as the location and nature of the binding 
sites and whether PSP binding with these protein occur in vivo. Therefore, additional 
experiments are needed to determine the potential significance of these observations and 
whether the biomarkers identified could be of potential value for diagnostic purposes or as 
targets for the development of therapeutic approaches to attenuate OP-induced cardiac 
damage.
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5.1 Introduction 
Organophosphate pesticides and nerve agents are chemical compounds that cause toxicity 
via inhibition of AChE, which results in overstimulation of cholinergic and nicotinic receptors 
in the central nervous system. In turn,  they affects other organs including the heart 
(McDonough & Shih, 1997). In addition to their effects on AChE, such OPs may have direct or 
indirect effects on other target molecules  (Silveira et al., 1990; Jett et al., 1991). For 
example, OPs were found to directly affect cytoskeleton proteins. For example, sublethal 
concentrations of chlorpyrifos oxon were found to bind covalently to tubulin and tubulin-
associated proteins resulting in disruption of microtubule function in neuronal cells (Jiang et 
al., 2010). Organophosphates may also affect proteins involved in the regulation of axonal 
transport in neuronal cells, leading to neuronal dysfunction and cell death (Morfini et al., 
2009). However, no studies conducted so far have examined the effect of sublethal 
concentrations of OPs and their metabolites on cytoskeleton proteins in differentiating H9c2 
cells and on cardiomyocyte-like development. 
Heart structural proteins can be divided into four types: normally contractile proteins, 
sarcomeric skeleton proteins, true cytoskeleton proteins and membrane-associated proteins 
(Kostin et al., 2000). Cytoskeleton proteins, such as myosin, actin, tropomyosin and 
troponins, play a significant role in cardiac contractile function, morphological stability and 
signal transduction (Kostin et al., 2000). Thus, any alterations in these structural and 
functional proteins may result in an increase in mechanical stress and morphological 
alterations in cardiac cells that can cause cardiac dysfunction (Ehler & Perriard, 2000). For 
example, in patients with heart failure, the expression of contractile proteins such as, actin 
and myosin was   downregulated and accompanied by contractile and diastolic dysfunction 
(Kostin et al., 2000). Also, tubulin and desmin expression increased in the early development 
of heart failure in guinea pig hearts, highlighting the importance of cytoskeletal changes 
associated with heart failure (Wang et al., 1999) and over expression of tropomyosin in 
hearts  resulted in dilated cardiomyopathy  (Rajan et al., 2010). Therefore, to study the 
effect of OPs on the development of differentiating H9c2 cells, it is important to evaluate the 
expression of cardiac cytoskeleton proteins, as the expression of these proteins is strongly 
correlated with functional alteration and structural degeneration. At present there are few 
reports on the effects of sublethal concentrations of OPs on cardiac cells. However, a recent 
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in vivo study demonstrated changes in heart rate and anatomical abnormalities in both 
Xenopus and zebrafish following exposure to low concentrations of chlorpyrifos and 
dichlorvos (Watson et al., 2014). Another study also demonstrated that sublethal doses 
methamidophos induced cardiac hypertrophy in rats (Calore et al., 2006). The importance of 
the OPs effect at different  stages of developmental is of concern. For example, amphibian 
species were shown to be more susceptible to sublethal doses of OPs in their early stages of 
development when compared to later stages (van der Schalie et al., 1999). Some toxicity 
studies have found that sublethal doses of OPs cause morphological changes and behaviour 
problems (Zalizniak & Nugegoda, 2006). However, the exact molecular mechanism 
underlying the effect of sublethal concentrations of these compounds on cardiomyocytes is 
still unclear. Therefore, the present study aimed to investigate the sublethal effects induced 
by OPs by monitoring changes in cellular morphology, AChE activity and expression of 
cytoskeletal proteins. 
5.2  Methods 
As described in chapter 2 section 2.3, 2.4, 2.5, 2.6  
5.3 Aims 
This aims of this chapter were to assess the potential effects of sublethal concentrations of 
the OPs chlorpyrifos and diazinon, their corresponding metabolites (chlorpyrifos oxon and 
diazoxon), and PSP on differentiating mouse H9c2 cells, in order to understand the 
molecular basis for the potential long-term toxicity of these compounds. The study focussed 
on the effects of these OPs on morphological features, AChE activity and expression of 
cardiac cytoskeleton proteins. 
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5.4 Results 
The sublethal concentrations of 3 µM and 0.3 µM were selected according to the previous 
result in chapter 4, which demonstrated that OPs compounds at these concentrations had 
no significant effect on MTT reduction or LDH release following 48 h exposure in 
differentiated H9c2 cells. Therefore, these sublethal concentrations 3 µM and 0.3 µM were 
used to investigate if repetitive exposure to sublethal concentrations of OPs can disrupt the 
differentiation of H9c2 cells. In the present study cultured mitotic H9c2 cells were induced to 
differentiate with the desired concentrations of OPs in differentiation medium. Every 48 h 
the differentiation medium was replaced along with the relevant concentration of OPs. 
Then, cells were assessed at days 7, 9 and 13, as shown in Figure 5.1. 
 
 
Figure 5.2 A schematic representation of the experimental procedure in the present 
chapter.  
A) Cultured mitotic H9c2 cells. B) Cells were induced to diffrentiatiate in the presence of the disired 
concentration of OPs for 7 days,  9 days and 13 days . C) Different analyses were performed to study 
the effect of sublethal concentrations of OPs on differentiating H9c2 cells. 
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5.4.1 Effect of sublethal concentrations of OPs on cell morphology  
Initial experiments assessed the effect of sublethal concentrations of OPs on morphological 
changes in differentiating H9c2 cells via Coomassie Brilliant Blue staining following 7, 9 and 
13 day exposure periods. Overall, results showed variation in the size and shape of the cells 
according to the concentration of the OP, and the degree of cell deterioration ranged from 
slight to severe according to the type of OP used.  
Exposure to 3 μM chlorpyrifos was shown to have a moderate effect on the morphology of 
differentiating H9c2 cells, which appeared to be more rounded rather than elongated with 
mild changes at days 7, 9 and 13 when compared to the control (Figure 5.2). By contrast, 
chlorpyrifos oxon proved to have a no observable effect on differentiating H9c2 cells at the 
7-day and 9-day time point, as shown in Figure 5.3a and b. However, chlorpyrifos oxon had 
less observable effect than chlorpyrifos at 13-days as shown in Figure 5.3c.  Exposure to 
diazinon showed similar effects to chlorpyrifos, in that some cells were shown to be to more 
rounded and less elongated at days 7, 9 and 13 when compared to control cells (Figure 5.4). 
More interestingly, the morphological effect of diazoxon was not observed at 7-days 9-day 
time point and at 13-days exposure had less effect than diazinon on differentiating H9c2 
cells as shown in Figure 5.5. 
Exposure of 3 μM PSP to differentiating H9c2 cells induced the most striking effect on cell 
morphology, when compared to other OP compounds (chlorpyrifos, chlorpyrifos oxon, 
diazinon and diazoxon). Cell deterioration was evident, since the PSP-treated cells did not 
exhibit a fibroblast-like structure, elongated spindle shape, or multiple nuclei at days 7, 9 
and 13 (Figure 5.6). Lastly, treatment with 0.3 µM OPs did not cause any observable 
morphological changes and cells appeared to differentiate as normal. Therefore, further 
studies investigated the effects of 3 μM OPs on AChE activity and expression of cytoskeletal 
proteins. 
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Figure 5.3 Effect of sublethal concentrations of chlorpyrifos on differentiating H9c2 cells. 
Mitotic H9c2 cells were induced to differentiate in the presence of 3 µM and 0.3 µM chlorpyrifos for 
A) 7 days B) 9 days and C) 13 days. Following treatment cells were fixed with 90 % (v/v) methanol, 
stained with Coomassie brilliant Blue and then visualised using light microscopy (20x objective lens). 
The black arrow indicates elongated and multinucleated differentiated cells and red arrows indicate 
typical rounded and compact cells. Images presented are from one experiment and representative of 
three independent experiments. Scale bar = 100 µm.  
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Figure 5.4 Effect of sublethal concentrations of chlorpyrifos oxon on differentiating H9c2 
cells.  
Mitotic H9c2 cells were induced to differentiate in the presence of 3 µM and 0.3 µM chlorpyrifos 
oxon for A) 7 days B) 9 days and C) 13 days. Following treatment, cells were fixed with 90 % (v/v) 
methanol, stained with Coomassie Brilliant Blue and then visualised using light microscopy (20x 
objective lens). The black arrow indicates typical elongated and multinucleated differentiated cells 
and red arrows indicate typical rounded and compact cells. Images presented are from one 
experiment and representative of three independent experiments. Scale bar = 100 µm.  
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Figure 5.5 Effect of sublethal concentrations of diazinon on differentiating H9c2 cells.  
Mitotic H9c2 cells were induced to differentiate in the presence of 3 µM and 0.3 µM diazinon for A) 7 
days B) 9 days and C) 13 days. Following treatment cells were fixed with 90 % (v/v) methanol, stained 
with Coomassie Brilliant Blue and then visualised using light microscopy (20x objective lens). The 
black arrow indicates typical elongated and multinucleated differentiated cells and red arrows 
indicate rounded and compact cells. Images presented are from one experiment and representative 
of three independent experiments. Scale bar = 100 µm.  
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Figure 5.6 Effect of sublethal concentrations of diazoxon on differentiating H9c2 cells. 
Mitotic H9c2 cells were induced to differentiate in the presence of 3 µM and 0.3 µM diazoxon for A) 
7 days B) 9 days and C) 13 days. Following treatment cells were fixed with 90 % (v/v) methanol, 
stained with Coomassie Brilliant Blue and then visualised using light microscopy (20x objective lens). 
The black arrows indicate typical elongated and multinucleated differentiated cells and red arrows 
indicate typical rounded  cells. Images presented are from one experiment and representative of 
three independent experiments. Scale bar = 100 µm.  
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Figure 5.7 Effect of sublethal concentrations of PSP on differentiating H9c2 cells.  
Mitotic H9c2 cells were induced to differentiate in the presence of 3 µM and 0.3 µM PSP for A) 7 
days B) 9 days and C) 13 days. Following treatment cells were fixed with 90 % (v/v) methanol stained 
with Coomassie Brilliant Blue and then visualised using light microscopy (20x objective lens). The 
black arrows indicate typical elongated and multinucleated differentiated cells and red arrows 
indicate rounded compact cells. Images presented are from one experiment and representative of 
three independent experiments. Scale bar = 100 µm.  
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5.4.2  Effect of sublethal concentrations of OPs on cell viability  
Under the same experimental conditions as described in section 5.3, the possible long-term 
effects of sub-lethal concentration of OPs on cell viability of differentiating H9c2 cells was 
assessed via MTT and LDH assays.  Chlorpyrifos at a concentration 3 μM had no significant 
effect (p>0.05) on MTT reduction or LDH release following 7, 9 and 13-days exposure. 
Similarly, its acutely toxic metabolite chlorpyrifos oxon at the same concentration had no 
significant effect (p>0.05) on MTT reduction or LDH release following 7-days, 9-days and 13-
days exposure (Figure 5.7). Also, diazinon and its metabolite at a concentration of 3 μM had 
no significant effect (p>0.05) on MTT reduction and LDH release following 7, 9 and 13-days 
exposure (Figure 5.8). Finally, 3 µM PSP had no significant effect on MTT reduction at 7-days. 
However, it had significant effect (p˂0.05) on MTT reduction at 9-days and 13-days 
exposure. PSP had no significant effect (p>0.05) on LDH release following 7-days and 9-days 
exposure. However, it had significant effect (p˂0.05) on LDH release following 13-days 
exposure. Thus, the MTT reduction assay was shown to be more sensitive than the LDH 
release assay for the detection of cytotoxic effects of PSP in differentiating H9c2 cells (Figure 
5.9).  
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Figure 5.8 Effect of chlorpyrifos and  chlorpyrifos oxon on the viability of differentiating 
H9c2 cells monitored by MTT reduction and LDH release.  
H9c2 cells were induced to differentiate for 7 days, 9 days and 13 days in the presence and absence 
of 3 µM chlorpyrifos (A and B) and 3 µM chlorpyrifos oxon (C and D). Following chlorpyrifos and 
chlorpyrifos oxon exposure, cell viability was assessed by measuring the metabolic reduction of MTT 
by cellular dehydrogenases (A and C) and release of LDH (B and D). Data are expressed as a  
percentage of control cell values (= 100%) and represent the mean ± SEM of three independent 
experiments each performed in quadruplicate (MTT) or sextuplicate (LDH). 
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Figure 5.9 Effect of diazinon and diazoxon on the viability of differentiating H9c2 cells 
monitored by MTT reduction and LDH release.  
H9c2 cells were induced to differentiate for 7 days, 9 days and 13 days in the presence and absence 
of 3 µM diazinon (A and B) or 3 µM diazoxon (C and D). Following diazinon and diazoxon exposure, 
cell viability was assessed by measuring the metabolic reduction of MTT by cellular dehydrogenases 
(A and C) and release of LDH (B and D). Data are expressed as a percentage of control cell values (= 
100%) and represent the mean ± SEM of three independent experiments each performed in 
quadruplicate (MTT) or sextuplicate (LDH).  
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Figure 5.10 Effect of PSP on the viability of differentiating H9c2 cells monitored by MTT 
reduction and LDH release.  
H9c2 cells were induced to differentiate for 7 days, 9 days and 13 days in the presence and absence 
of 3 µM PSP. Following PSP exposure, cell viability was assessed by measuring the A) metabolic 
reduction of MTT by cellular dehydrogenases and B) release of LDH. Data are expressed as a 
percentage of control cell values (= 100%) and represent the mean ± SEM of three independent 
experiments each performed in quadruplicate (MTT) or sextuplicate (LDH). *p < 0.05 and **p < 0.01 
versus the control response. 
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5.4.3 Effect of sublethal concentrations of OPs on cellular AChE activity 
Under the same experimental conditions as described in section 5.3, cellular AChE activity 
was measured to determine whether this enzyme was a molecular target of OPs 
(chlorpyrifos, diazinon chlorpyrifos oxon, diazoxon and PSP) at the sublethal concentration 
of 3 µM in differentiating H9c2 cells. Data from these experiments revealed that chlorpyrifos 
and diazinon and their metabolites chlorpyrifos oxon and diazoxon significantly inhibited 
(p˂0.05) AChE activity; this inhibitory effect was observed at days 7, 9 and 13 (Figures 5.10 
and 5.11). In contrast, PSP did not show significant inhibition of AChE activity at days 7, 9 or 
13 (Figure 5.12).  
 
 
 
 
Figure 5.11 Effects of chlorpyrifos and chlorpyrifos oxon on AChE activity in differentiating 
H9c2 cells.  
H9c2 cells were induced to differentiate in the presence of 3 µM  A) chlorpyrifos and B) chlorpyrifos 
oxon for 7 days, 9 days and 13 days. AChE specific activities are expressed as a percentage of control 
cell values (=100%) and represent the mean ± SEM of three independent experiments. ***p ˂ 0.001, 
and ****p ˂ 0.0001 versus the control response. 
 
 
 
Chapter 5 
134 
 
 
 
 
 
 
 
 
 
Figure 5.12 Effects of diazinon and diazoxon on AChE activity in differentiating H9c2 cells.  
H9c2 cells were induced to differentiate in the presence of 3 µM A) diazoxon and B) diazoxon for 7 
days, 9 days and 13 days. AChE specific activities are expressed as a percentage of control cell values 
(=100%) and represent the mean ± SEM of three independent experiments. **p ˂ 0.01, ***p ˂ 0.001, 
and ****p ˂ 0.0001 versus the control. 
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Figure 5.13 Effects of PSP on AChE activity in differentiating H9c2 cells.  
H9c2 cells were induced to differentiate in the presence of 3 µM PSP for 7 days, 9 days and 13 days. 
AChE activities are expressed as a percentage of control cell values (=100%) and represent the mean 
± SEM of three independent experiments.  
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5.4.4 Effect of sublethal concentrations of OPs on cardiac cytoskeleton 
proteins  
In this section the effects of chlorpyrifos, diazinon chlorpyrifos oxon, diazoxon and PSP on 
cytoskeletal protein expression were investigated. Cells were induced to differentiate as 
detailed previously in section 5.3. Cells were exposed to a 3 µM OPs for 7, 9 and 13 days. The 
protein expression levels of cardiac cytoskeleton proteins (troponin 1, tropomyosin and α-
actin) associated with H9c2 differentiation were measured via Western blot analysis. The 
parent compounds chlorpyrifos and diazinon had a significant effect (p˂0.05) on cardiac 
cytoskeletal protein expression, whereas their oxon metabolites did not demonstrate such 
an effect. For example, treatment with chlorpyrifos resulted in a significant decrease 
(p˂0.05)  in troponin 1 levels in differentiating H9c2 cells at 13-days exposure, whereas other 
proteins such as tropomyosin and α-actin were not shown to be affected at 7, 9 or 13-days 
exposure (Figure 5.13). Chlorpyrifos oxon had no significant effect (p>0.05) on the levels any 
of the cytoskeleton proteins examined (Figure 5.14). In contrast, diazinon exposure resulted 
in a significant decrease in the levels of troponin 1 but had no significant effect (p>0.05) on 
tropomyosin or α-actin levels at 7, 9 and 13-days exposure (Figure 5.15). In contrast, its 
acutely toxic metabolite diazoxon had no significant effect (p>0.05) on any of the 
cytoskeleton proteins examined at any exposure time point (Figure 5.16). Finally, exposure 
to 3 µM PSP resulted in a significant decrease (p˂0.05) in the levels of troponin 1, 
tropomyosin and α-actin at 7-days, 9-days or 13-days exposure (Figure 5.17). Table 5.1 
summarizes the effects of OPs used in the present study on cytoskeletal protein expression 
in differentiating H9c2 cells. 
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Table 5.1 Summary of the effects of OPs (chlorpyrifos, diazinon, chlorpyrifos oxon, 
diazoxon and PSP) on cardiac protiens  in differentiating H9c2 cells.   
 
Effects of OPs on cardiac cytoskeleton protein (troponin 1, tropomyosin and α-actin) 
expression in differentiating H9c2 cells. H9c2 cells were induced to differentiate for 7 days, 9 
days and 13 days in the presence of 3 µM OPs. (+) represent a significant (p˂0.05)down 
regulating effect of OPs on cardiac cytoskeleton protiens and (-) represent no significant 
effect (p>0.05)of OPs on cardiac cytoskeleton protiens expression in differentiating H9c2 
cells. These are total data of at least three independent experiments. 
 
 
 
 
 
 
 
 
 
Organophospate 
Cardiac sytoskelton protien 
Troponin Tropomyosin α-Actin 
Exposure time (days) 
7 d 
 
9 d 
 
13 d  7 d 
 
9 d 
 
13 d 7 d 9 d 13 d 
Chlorpyrifos _ _ + _ _ _ _ _ _ 
Chlorpyrifos 
oxon 
_ _ _ _ _ _ _ _ _ 
Diazinon + + + _ _ _ _ _    _ 
Diazoxon _ _ _ _ _ _ _ _ _ 
PSP + + + + + + + + + 
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Figure 5.14 Effects of chlorpyrifos on cardiac cytoskeleton protein expression in 
differentiating H9c2 cells.  
H9c2 cells were induced to differentiate for 7, 9 and 13 days in the presence (+) and absence (-) of 3 
µM chlorpyrifos. Cell lysates (15 µg) were analysed via western blot and probed with antibodies that 
recognise A) cardiac troponin 1, B) tropomyosin and C) α-actin. All values were normalised to GAPDH 
levels and are expressed as mean % control values ± SEM of three independent experiments. ***p ˂ 
0.001 versus the control. 
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Figure 5.15 Effects of chlorpyrifos oxon on cardiac cytoskeleton proteins in differentiating 
H9c2 cells.  
H9c2 cells were induced to differentiate for 7 days, 9 days and 13 days in the presence (+) and 
absence (-) of 3 µM chlorpyrifos oxon. Cell lysates (15 µg) were analysed via western blot and probed 
with antibodies that recognise A) cardiac troponin 1 B) tropomyosin C) α-actin. All values were 
normalised to GAPDH level and are expressed as mean % control values ± SEM of three independent 
experiments.  
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Figure 5.16 Effects of diazinon on cardiac cytoskeleton proteins in differentiating H9c2 
cells. 
 H9c2 cells were induced to differentiate for 7 days, 9 days and 13 days in the presence (+) and 
absence (-) of 3 µM diazinon. Cell lysates (15 µg) were analysed via western blot and probed with 
antibodies that recognise A) cardiac troponin 1 B) tropomyosin C) α-actin. All values were normalised 
to GAPDH level and are expressed as mean % control values ± SEM of three independent 
experiments.  **p ˂ 0.01,  and ***p ˂ 0.001 versus the control. 
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Figure 5.17 Effects of diazoxon on cardiac cytoskeleton proteins in differentiating H9c2 
cells. 
H9c2 cells were induced to differentiate for 7 days, 9 days and 13 days in the presence (+) and 
absence (-) of 3 µM diazoxon. Cell lysates (15 µg) were analysed via western blot and probed with 
antibodies that recognise A) cardiac troponin 1 B) tropomyosin C) α-actin. All values were normalised 
to GAPDH level and are expressed as mean % control values ± SEM of three independent 
experiments.  
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Figure 5.18 Effects of PSP on cardiac cytoskeleton proteins in differentiating H9c2 cells. 
 H9c2 cells were induced to differentiate for 7 day, 9 day and 13 day in the presence (+) and absence 
(-) of 3 µM PSP. Cell lysates (15 µg) were analysed via western blot and probed with antibodies that 
recognise A) cardiac troponin 1 B) tropomyosin C) α-actin. All values were normalised to GAPDH level 
and are expressed as mean % control values ± SEM of three independent experiments. **p ˂ 0.01, 
***p ˂ 0.001, and ****p ˂ 0.0001  versus the control 
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5.4.5 Effect of sublethal concentrations of PSP on the proteome profile of 
H9c2 cells 
The results presented thus far have shown that exposure to 3 µM PSP resulted in a more 
significant effect on cardiac cytoskeleton proteins: troponin1, tropomyosin and α-actin of 
differentiating H9c2 cells when compared to other OPs compound. Therefore, would be of 
interest to identify changes in the levels of other cardiac proteins that may be implicated in 
the toxic effect of PSP on differentiating H9c2 cells. These proteins can be considered as 
novel biochemical changes in H9c2 cells that were induced to differentiate for 7 days in the 
presence of 3 µM PSP. In the present study, 7 days was selected as a preliminary exposure 
period since H9c2 cardiomyoblasts were confirmed to be differentiated at 7-days in to a 
more cardiomyocyte-like phenotype and displayed cardiac-specific characteristics, as shown 
in chapter 3. Thus, long-term incubation such as 9-days and 13- days can be assessed for 
future adverse effect of PSP. 2D gel electrophoresis was performed as described in Chapter 
2. Several protein spots showed a significant reduction in PSP-treated differentiating H9c2 
cells when compared to untreated cells and the significant (p˂0.05) in down regulating 
protein expression was determined by using Progenesis SameSpots software. Five protein 
spots (Spots ID 12, 16 , 14, 27 and 23) were identified as significantly decreased as shown in 
Table 5.2 and were visually distinct for spot picking (Figure 5.18). Protein pots were picked 
from the stained gel and digested with trypsin followed by MALDI-TOF mass spectrometry 
analysis of the peptides produced. Mass spectrometry analysis identified tropomyosin α-4 
and α-actin, which is in agreement with previous findings in described in section 5.3.4. In 
addition, coiled-coil domain containing protein 61 (Ccdc61), calumenin and PDZ-LIM domain 
protein 1 were also identified as novel proteins that showed a significant decrease in density 
in treated differentiating H9c2 cells when compared to untreated H9c2 cells. The identified 
proteins are listed in Table 5.3. The identity of these proteins were also confirmed by 
comparison of their in gel position with their theoretical molecular weights and isoelectric 
point (pI).  
 
 
 
 
Chapter 5 
144 
 
 
Table 5. 2 Progenesis SameSpot analysis represent decrease in density of protein spot in 3 
µM PSP treated cells.  
 
Data table represent a significant decrease in protein spots densities using ANOVA analysis of protein 
spot densities. Data values of 3 accumulated 2D gel electrophoresis, *p < 0.05 was viewed as 
significant.  
 
Figure 5. 19 Representative 2D gel images of PSP effects on cardiac protein expression in 
differentiating H9c2 cells.  
H9c2 cells were induced to differentiate for 7 days in the A) absence and B) presence of 3 µM PSP: 
Cell lysates (300 µg) were analysed by 2D gel electrophoresis using pH 3–10 gradient strips. Gels 
were stained with Proto Blue Safe colloidal Coomassie G-250 stain and gel images analysed using 
Progenesis SameSpots software. Circled spots represent proteins that were significantly down 
regulated when compared to untreated cells. Spot 12, calumenin; spot 14, PDZ-LIM domain protein 
1; Spot 16, coiled-coil domain containing protein 61; spot 23; tropomyosin α-4; spot 27, α- actin. 
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Table 5.3 Identification of proteins affected by sublethal concentrations of PSP in 
differentiating H9c2 Cells 
Spot 
number 
protein accession 
no. 
PMF sequence 
 coverage (%) 
Mascot 
score 
kDa pI Fold 
change 
16 Coiled-coil domain 
containing protein 
61 
A0JPP8 
 
47% 54  57 5.52 11 
12 Calumenin O35783 37% 65 40  4.40 5 
27 α-actin P68035 55% 53 41 4.72 6 
23 Tropomyosin α-4 P09495 45% 68 28.5 4.4 5 
14 PDZ-LIM domain 
protein 1 
P52944 47% 
 
67 35 6.79 2 
 
Mitotic H9c2 cells were induced to differentiate in the presence of 3 µM PSP for 7 days. Cells 
were analyzed by 2D gel electrophoresis. Proteins were identified using MALDI-TOF MS 
(PMF) as described in Materials and Methods. Sequence data were analyzed using Mascot 
software and reported according to percentage sequence coverage (SC%) or Mascot score 
(ion scores for PMF > 51 indicate extensive homology). All identified proteins exhibited 
Mascot scores that were considered statistically significant (*p < 0.05).  
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5.5 Discussion 
The present study examined the morphological, enzymatic and molecular changes induced 
by chlorpyrifos and diazinon, their corresponding metabolites (chlorpyrifos oxon and 
diazoxon), and PSP in differentiating H9c2 cells. Numerous in vivo studies have examined the 
mechanism underlying the toxicity of low doses of OP compounds in the brain; these studies 
have shown that these compounds target neuronal cytoskeleton proteins and cause 
inhibition of neurite outgrowth (Gearhart et al., 2007; Prendergast et al., 2007; Terry et al., 
2007). However, the molecular mechanism underlying the effects of sublethal concentrations 
of OPs on differentiating H9c2 cells were still unknown at the start of the current work. This 
is the first study to demonstrate the effect of OPs on cardiac cytoskeleton proteins in 
differentiating H9c2 cells. Figure 5.19 summarizes the major findings illustrated in the 
present study. Figure 5.20 represents a simple diagram outlining the possible sublethal 
effects of OPs in differentiating H9c2 cells. 
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Figure 5.20 Summary of major finding of sublethal effects of OPs in differentiating H9c2 
cells illustrated in the present study.  
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Figure 5.21 Simple diagrammatic representation of the sublethal effects of OPs 
(chlorpyrifos, diazinon, chlorpyrifos oxon, diazoxon and PSP) in differentiating H9c2 cells. 
OPs may target AChE leading to enzyme activity inhibition and stimulation of myocardial muscarinic 
acetylcholine receptors and contractile dysfunction, resulting in changes in cellular morphology. OP 
exposure may also decrease cardiac cytoskeleton protein expression leading to disruption in cellular 
integrity and cellular morphology. 
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5.5.1 Effect of OPs on the morphological features of differentiating H9c2 cells  
Two major OP concentrations (3 and 0.3 µM) were investigated for toxicity tests in 
differentiating H9c2 cells to determine which concentrations of OPs were harmful and which 
had no apparent effect after long- term exposure. Organophosphates at a concentration of 3 
µM were shown to induce morphological changes in differentiating H9c2 cells, with the 
degree of deterioration ranging from mild to severe, whereas 0.3  µM of all OPs had no 
significant effect on differentiating H9c2 cells.  Chlorpyrifos at a concentration of 3 µM had a 
moderate effect on differentiating H9c2 cells such as cell rounding or irregular cell shape at 
7-days, 9-days and 13-days exposure as shown in Figure 5.2, These data are in agreement 
with previous studies that have reported the morphological change by sublethal 
concentrations of chlorpyrifos. For example, 3 μM chlorpyrifos was able to inhibit the 
outgrowth of axon-like processes in differentiating mouse N2a neuroblastoma (Sachana et 
al., 2001). However, exposure to 3 µM chlorpyrifos oxon did not show major effect on H9c2 
cell viability, and its effect on differentiating cells may be considered as non-cytotoxic (Figure 
5.3).  
Diazinon at a concentration of 3 µM was shown to have a moderate effect on differentiating 
H9c2 cells at 7-days, 9-days and 13-days exposure (Figure 5. 4). This is in agreement with a 
previous study in neuronal cells that showed that exposure to 1-10 μM diazinon induced 
selective inhibition of the outgrowth of neurites in differentiating mouse N2a neuroblastoma 
cells (Flaskos et al., 2007). On the other hand, exposure to 3 µM diazoxon did not show any 
major effect on differentiating H9c2 cells and may be considered as the least toxic (Figure 
5.5). In contrast, 5 µM diazoxon caused significant reductions in the number of axon-like 
processes produced by N2a neuroblastoma cells. This was associated with increased the 
expression of phosphorylated neurofilament heavy chain (NFH) when compared to controls 
(Sidiropoulou et al., 2009).  
The parents compounds chlorpyrifos and diazinon showed an observable effect on cellular 
morphology more than their oxon metabolites, this may be due to their low water solubility 
(lipophilic) and can be readily absorbed by cells (Bowman and Sans, 1983).On the other 
hand, the oxons are often more hydrophilic compounds (Gupta, 2006). Thus, 
Bioaccumulation chlorpyrifos and diazinon in cells of may be considered as an early exposure 
biomarker for adverse effect to toxic substances (Franke et al., 1994). 
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As indicated in Figure 5.6, exposure to PSP induced apparent deterioration in cell shape and 
size. Thus, 3 µM PSP inhibited the differentiation of these cells into a more cardiomyocyte-
like phenotype characterised by an elongated spindle shape and multiple nuclei at days 7, 9 
and 13. These effects are consistent with a previous study showing that 2.5 µM PSP for 24 h 
exposure decreased neurite outgrowth in differentiating N2a cells (Hargreaves et al., 2006). 
Moreover, it is important to note that morphological change may be due to the alteration in 
the basic cell membrane mechanisms by OPs. For example, the OP parathion was found to 
stimulate Ca2+ uptake and ATP hydrolysis via Ca++ pump system in the sarcoplasmic 
reticulum, leading to alterations in cellular ionic balance and affecting myocardial 
conductivity and cellular structure (Ballantyne & Marrs, 1992). Overall, the data presented 
suggest that 3 µM levels of the OPs tested can be considered as sub-toxic toward 
differentiating H9c2 cells. Morphological analysis of the effect of OPs on differentiating H9c2 
cells can be arranged from the most effective to the less effective, as shown PSP > diazinon > 
chlorpyrifos > chlorpyrifos oxon and diazoxon. 
5.5.2 Effect of OPs on cell viability of differentiating H9c2 cells  
Morphological changes are an indicator of OP-induced stress (Atale et al., 2014). The results 
indicated that cell morphology seemed to be affected by sublethal concentrations (i.e. 3 µM) 
of OP. Therefore, it would be of interest to investigate whether longer term exposure to OPs 
are associated with cell death. To the author’s knowledge, no study has been conducted on 
the long- term toxicity of OPs in differentiating H9c2 cells. From the findings in this chapter, 
it is quite clear that chlorpyrifos and its toxic metabolite chlorpyrifos oxon at a sublethal 
concentration 3 μM had no significant effect on MTT reduction or LDH release following 7-
day, 9-day and 13 day exposure (Figure 5.7). This is in agreement with previous study 
showed that sub-lethal concentrations 1–10 μM of chlorpyrifos and chlorpyrifos oxon had no 
effect on the level of MTT reduction in differentiating mouse N2a neuroblastoma 
concomitant with inhibition of the axon-like neurites outgrowth (Sachana et al., 2001; 
Flaskos et al., 2011). Similarly, in the present study, chlorpyrifos treated cells exhibited 
rounded and irregular cell shape.  
Diazinon and its toxic metabolite diazoxon at sublethal concentration 3 μM had no 
significant effect on MTT reduction or LDH release following 7-day, 9-day and 13-day 
exposure (Figure 5.8). In this study this may indicate that diazinon and diazoxon are not 
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cytotoxic under the conditions used. This is consistent with previous findings with 
differentiating mouse N2a neuroblastoma cells and sublethal concentration 1–10 μM 
diazinon and its oxon metabolite diazoxon, no significant MTT reduction. However, they 
inhibited the outgrowth of axon-like neurites (Flaskos et al., 2007; Sidiropoulou et al., 2009).  
PSP exposure showed significant effects on MTT reduction following 9-days and 13 days, 
whereas it showed significant effect on LDH release following 13-days exposure of 
differentiating H9c2 cells. Both exposure periods (9 and 13 days) can be considered as long-
term. However, MTT reduction was shown to be more sensitive than LDH.  This may be 
explained by the cytotoxicity mechanism of each assay. For example, the MTT reduction 
assay assesses cellular mitochondrial function whereas the LDH release assay measures loss 
of cell membrane integrity (Haider & Rauf, 2014). Therefore, the present results may 
possibly suggest that exposure to PSP may lead to impaired mitochondrial function (MTT 
reduction) in differentiating H9c2 cells prior to disturbance of cell membrane and loss of cell 
membrane integrity (LDH release). In a previous study, it has been reported that OPs were 
able to cause disturbance of mitochondrial integrity and permeability and led to the release 
of cytochrome c to the cytosol and ultimately activated caspase-3 and induced apoptosis 
through intrinsic pathway (Razavi et al., 2013). In contrast in a previous study in neuronal 
cells, no cytotoxicity was observed when N2a neuroblastoma cells were exposed to PSP at 
concentrations 3 µM or lower (Harris et al., 2009). The present findings clearly indicate that 
sub-lethal exposure to PSP for 13 days could cause deleterious effects in differentiating H9c2 
cells and may disturb cell survivability and can considered cytotoxic.  
5.5.3 Effect of OPs on AChE activity in differentiating H9c2 cells  
AChE is a key enzyme biomarker of neurotoxicity and is known to be a primary target of OPs. 
Its inhibition can lead to accumulation of ACh and results in hyperstimulation of the 
sympathetic and parasympathetic pathways (Mileson et al., 1998). Therefore, it is important 
to investigate the effects of sublethal concentrations of OPs on AChE activity, as this is 
essential in understanding their cytotoxic effect more fully in differentiating H9c2 cells.  
Chlorpyrifos and its metabolite chlorpyrifos oxon showed significant inhibition of AChE 
activity in differentiating H9c2 cells following 7, 9 and 13 days exposure (Figure 5.10). This is 
in agreement with a previous study showed that 10 µg/ml chlorpyrifos and 10 ng/ml 
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chlorpyrifos oxon caused a significant inhibition in the AChE activity in neuronal cells, 
resulting in significant inhibition of neurite outgrowth in the early differentiation process; 
suggesting that AChE activity is strongly associated with neurite outgrowth (Das & Barone, 
1999).  
In a previous study, chlorpyrifos oxon decreased the activity of AChE with a potency which 
was at least 100-fold higher than that of chlorpyrifos in brain cell cultures (Monnet-Tschudi 
et al., 2000). However such a difference in potency was not observed in the current study. 
One possible explanation is that the surface of the peripheral anionic site of AChE varies 
between different species and cell types, although the esteratic site is similar. This may 
result in variation of the steric attraction of the oxon to the active site of the enzyme in each 
cell line (Kemp & Wallace, 1990). For example, AChE in rainbow trout possesses a smaller 
active site than that for rat AChE, which makes it less accessible than rat AChE to certain 
cholinesterase inhibitors  (Kemp & Wallace, 1990). Thus, AChE in H9c2 cells may have less 
steric attraction for OPs compared to AChE in neuronal cells. Another possibility is that if the 
nucleophilic site of AChE is weak, the acidity of the phosphorus atom of the inhibitor 
determines the rate of phosphorylation of the enzyme and thereby determines the overall 
rate of inhibition (Kemp & Wallace, 1990). This may also determine the spontaneous 
reactivation of the inhibited enzyme, as shown previously in other cell lines using different 
OPs (Wallace & Herzberg, 1988). This raises the possibility that H9c2 cells have a relatively 
weak nucleophilic site in their AChE compared to that of neuronal cells. However, AChE 
characterization in H9c2 cells has not been previously addressed, further work in this area 
could be worthwhile. Onother point of view is that oxons are metabolically converted to less 
toxic compounds via hydrolysis by paraoxonase (A-esterase; Sogorb & Vilanova, 2010). 
Therefore, it can be assumed that the effectiveness of paraoxonase in differentiated H9c2 
cells resulted in increase in oxon hydrolysis. Moreover, studies had indicated that the 
paraoxonase activity between different cell lines exhibit different expression level. Thus cell 
may express high, intermediate, or low paraoxonase activity (Eckerson et al., 1983; Mueller 
et al., 1983). However, expression level of paraoxonase in H9c2 cells have not been 
previously investigated.  
chlorpyrifos and its toxic metabolite have been reported to display neurotoxic effects 
primarily via AChE inhibition, which may persist for days to weeks (McDonough & Shih, 
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1997; Wijeyaratne & Pathiratne, 2006). Although chlorpyrifos and chlorpyrifos oxon showed 
significant inhibition of AChE, they displayed little cytotoxicity against differentiating H9c2 
cells even at very high concentrations (100 µM), as shown in Chapter 4. This may be because 
neuronal cells have higher AChE activity than muscle, eye and heart cells (Miron et al., 2008). 
This may suggest that direct inhibition of AChE activity by chlorpyrifos and chlorpyrifos oxon 
may be associated with the mild to slight morphological changes observed in differentiating 
H9c2 cells. 
The present study also showed that treatment of differentiating H9c2 cells with diazinon and 
its metabolite diazoxon induced significant inhibition of AChE activity in following 7, 9 and 13 
days exposure (Figure 5.11). These results are consistent with a previous study that showed 
that 10 µM diazinon and its metabolite diazoxon inhibited AChE activity in human 
lymphocytes and fibroblast cells (Colovic et al., 2010). Moreover, an in vivo study showed 
that sublethal doses of diazinon had toxic effects in rats which resulted in apoptotic cell 
death, mainly induced by lipid peroxidation, and the induction of oxidative stress (Ogutcu et 
al., 2006). In stark contrast, diazinon and diazoxon did not induce cell death at the sublethal 
concentration of 3 µM in differentiating H9c2 cells, as illustrated in Chapter 4.  One possible 
explanation is that in vivo a number of factors contribute to the development of 
cardiotoxicity and induction of cell death, such as over-activation of the sympathetic and 
parasympathetic nervous systems, hypoxia, acidosis and electrolyte derangement (Karki et 
al., 2004). Differences between in vivo and in vitro experiments are expected, given the 
differences in the physiological characteristics of cells and model animals in both 
experimental conditions (Aronzon et al., 2011; Sztrum et al., 2011; Hutler Wolkowicz et al., 
2014). However, In this study, it may be suggested that significant inhibition of AChE activity 
by sublethal concentrations of diazinon and diazoxon may be correlated with the induction 
of sub-toxic effects that may result from long-term exposure without the induction of cell 
death. In summary, chlorpyrifos and diazinon and their metabolites showed significant 
inhibition of AChE activity in differentiating H9c2 cells. This effect may lead to stimulation of 
myocardial muscarinic acetylcholine receptors. In this respect, muscarinic acetylcholine 
receptors were found to be expressed in H9c2 cells and play an important role in 
cardioprotective mechanism in H9c2 cells (Pan et al., 2012). These receptors are strongly 
associated with dysautonomic symptoms such as decrease in cardiac contractility (Liang-
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Xiong Fu et al., 1995; Goin et al., 1997) and changes in the cardiac response to vagal 
innervation (Chemnitius et al., 1999). Thus, this suggests that reversible or irreversible 
inhibition of AChE may reflect changes in cellular morphology in differentiating H9c2 cells. 
However, researches have shown that cholinergic hyperexcitability is not responsible for all 
of toxic effects of OP poisioning. For example, diazinon was showen to accumulates in 
different tissues leading to histological and biochemical damages (Handy et al.,2002) and 
Intoxication with diazinon was found to be associated with changes haematological 
parameters and induces genotoxicity (Hariri et al., 2010). Changes in cellular morphology 
may also be associated with other non-‎cholinergic molecular targets, which it would be 
worthwhile to investigate in order to assess the long-term effect of sublethal concentrations 
of OPs.  
PSP exposure did not show significant inhibition of AChE activity (Figure 5.12). Therefore, it is 
believed that the cytotoxic effect of PSP in differentiating H9c2 cells is not associated with 
AChE inhibition. However, failure of PSP to interfere significantly with AChE activity indicates 
that alternative proteins targets are involved, which could be useful biomarkers for 
evaluating the cardiac cytotoxicity of PSP. 
5.5.4 Effect of OPs on the cardiac cytoskeleton proteins of differentiating H9c2 
cells 
Certain OPs may have long-term toxic effects and may interfere with brain development by 
binding to molecular targets other than AChE or by affecting neuronal cytoskeletal proteins 
and causing disruption of cellular integrity and cellular structure (Richardson, 1995; 
Crumpton et al., 2000). The current study investigated the possible effects of chlorpyrifos 
and diazinon, their metabolites (chlorpyrifos oxon and diazoxon), and PSP on the cardiac 
cytoskeleton proteins troponin 1, tropomyosin, and α-actin. Changes in the expression of 
these proteins are considered an indicator of cardiac toxicity or cardiac failure (Rajan et al., 
2010). 
The results of the present study showed that treatment with chlorpyrifos at a sublethal 
concentration of 3 µM induced a significant decrease in the expression of troponin 1 at 13 
days exposure in differentiating H9c2 cells, as determined by Western blot analysis (Figure 
5.13 a). Similarly, 3 µM chlorpyrifos exposure was shown to disrupt cytoskeletal protein (NF-
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H; neurofilament heavy chain) in neuronal cells, which suggests that this compound is 
strongly correlated with the inhibition of neurite outgrowth and AChE activity inhibition 
(Schmuck & Ahr, 1997; Flaskos et al., 1998; Li & Casida, 1998, Sachana et al., 2001). In 
cardiac cells, troponin 1 is a sensitive biomarker of cardiac toxicity (O'Brien, 2008). Thus, 
reduction in troponin 1 expression could indicate an early development of a molecular 
lesion, which is directly proportional to the concentration of the toxic given (Ferrans et al. 
1969). Thus, this may be the cause of morphological alterations in differentiating H9c2 cells. 
 The present results showed that chlorpyrifos oxon had no effect on the cardiac proteins 
examined on Western Blots of lysates from differentiating H9c2 cells (Figure 5.14). In 
contrast, 0.03 µM of chlorpyrifos oxon was shown to impair neurite outgrowth in cultures of 
rat PC12 cells (Das & Barone, 1999). Additionally, chlorpyrifos oxon was reported to have a 
more potent effect on differentiation/neurite outgrowth than chlorpyrifos in neuronal cell 
lines (Howard et al., 2005). However, in differentiating H9c2 cells, although chlorpyrifos 
oxon did not show any significant effect on cardiac cytoskeleton proteins, it was shown to 
induce slight morphological changes that may be related to AChE inhibition. A previous study 
on neuronal cells reported that OPs, which interfere with the morphogenic activity of AChE, 
may cause a disruption in axonal outgrowth (Brimijoin & Koenigsberger, 1999). 
In the present study, diazinon was found to have a significant effect on the expression of the 
cardiac cytoskeleton proteins troponin 1 at 7-days, 9-days and 13-days exposure in 
differentiating H9c2 cells (Figure 5.15a). This finding has not been previously reported in 
cardiac-like cells, as the majority of such studies use neuronal cells. For example, a previous 
study reported that sublethal concentrations of diazinon and diazoxon interfered with the 
outgrowth of differentiating mouse N2a neuroblastoma cells after 24 h of exposure (Axelrad 
et al., 2003; Flaskos et al., 2007; Sidiropoulou et al., 2009). Thus, inhibition of neurite 
outgrowth is associated with changes in cytoskeleton proteins e.g. neurofilament heavy 
chain (NFH), microtubule associated protein MAP 1B and heat shock protein 70 (HSP-70; 
Flaskos et al., 2007; Flaskos, 2012). Based on the findings of previous studies, it can be 
assumed that the morphological changes induced by diazinon in differentiating H9c2 cells 
are brought about via its effect on cardiac cytoskeleton proteins.  
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The present data also showed that diazoxon did not have a significant effect on the 
expression of the cardiac proteins examined in differentiating H9c2 cells (Figure 5.16). In 
contrast, it was reported that diazoxon induced a decrease in the expression of cytoskeleton 
proteins such as, tubulin and MAP 1B during the differentiation of rat C6 glioma cells; this 
study also reported a transient decrease in AChE activity, which probably triggers the events 
that later lead to outgrowth impairment (Sidiropoulou et al., 2009). Thus, diazoxon seems to 
have a more potent effect on cytoskeleton proteins in neuronal cells than cytoskeleton 
proteins in cardiac cells or it may affects different proteins to diazinon or it may affects the 
cytoskeleton through different signaling pathways. Such differences between cell lines are 
generally expected (Watson et al., 2014).  
Western Blot analysis indicated that PSP exposure significantly decreased the level of 
troponin 1, tropomyosin and α-actin expression at 7, 9 and 13 days exposure (Figure 5.17). 
The present study, to the best of the author’s knowledge, is the first to report the effect of 
PSP on cardiac cytoskeleton protein expression. In neuronal cells, PSP is believed to induce 
delayed neurotoxicity (Jortner et al., 1999). Sublethal concentrations of PSP were found to 
reduce neuronal cytoskeleton protein expression (neurofilaments), which was found to be 
clearly correlated with the inhibition of outgrowth of axon-like processes (Zhao et al., 2006). 
Cardiac proteins such as troponin 1, tropomyosin and α-actin are proteins associated with 
the normal differentiation process of cardiac muscle contraction (O'Brien, 2008). A decrease 
in the level of these cytoskeleton proteins clearly suggests the presence of an early 
molecular lesion that may interfere with the differentiation of H9c2 cells into 
cardiomyocyte-like cells. This reinforces the idea that the observed effect of PSP may be one 
of the possible factors responsible for its cardiac cytotoxicity. Troponins are globular 
proteins that play an important role in cardiac muscle contraction (O’Brien, 2008). In human 
and animal studies, troponins have been reported to be a sensitive biomarker that is first 
released within minutes in myocardial infarct (Babuin & Jaffe, 2005). Thus, the troponin level 
in blood is not elevated in healthy people (O'Brien, 2008). The effect of OPs on troponin 1 
have been previously studied in vivo. For example, 0.8 g/kg fenthion was found to induce 
myocardial injury and lead to a significant increase in troponin 1 levels in the blood of rats. 
Thus, troponin 1 could be a useful biomarker of OP-induced cardiotoxicity. These findings 
confirm that reduced troponin 1 expression is a key early event following exposure of 
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differentiating H9c2 cells to PSP. Tropomyosin is a central regulator of muscle contraction 
and cellular movement, and it acts in synergy with troponin in actin-myosin interactions 
(Barua et al., 2012). Changes in tropomyosin expression and it’s phosphorylation status play 
an essential role during cardiac development and in response to cardiac hypertrophy and 
heart failure  (Schiaffino et al., 1996). 
 α-actin, a basic regulator of muscle contraction, together with myosin, plays an important 
role in cell migration and cell structure (Pollard & Cooper, 2009). It has been shown that OPs 
such as triphenyl phosphite and parathion can affect the function of the actin cytoskeleton 
(Carlson & Ehrich, 1999; Carlson et al, 2000). More interestingly, caspase activation was 
shown to occur following actin degradation induced by OPs (Carlson et al., 2000).In this 
respect, long term exposure of 3 µM PSP was found to induce cell death in differentiating 
H9c2 cells. Exposure to this concentration in particular involves in α-actin instability and 
cellular structure deterioration leading to cell death. These findings seem to indicate that 
disruption of cardiac cytoskeleton proteins can be a sensitive indicator of PSP-induced 
cytotoxicity in differentiating H9c2 cells. Thus, prolonged exposure to PSP at the sublethal 
concentration of 3 µM may be considered to cause a sub-acute cytotoxic effect. 
5.5.5 Effect of PSP on novel cardiac cytoskeleton proteins expression of 
differentiating H9c2 cells 
It was apparent from blot analysis that sublethal concentrations of PSP induced changes in 
the expression of cardiac cytoskeleton proteins troponin 1, tropomyosin and α-actin. It was 
therefore of interest to further investigate the effects of 3 µM PSP on other cardiac proteins 
expressed in differentiating H9c2 cells. These proteins also may be implicated in the 
mechanisms underlying PSP-induced toxicity. Using 2D gel electrophoresis and mass 
spectrometry the present study identified several novel proteins, specifically coiled-coil 
domain-containing protein 61, calumenin, and PD-LIM domain protein 1, whose expression 
was down regulated in differentiating H9c2 cells in the presence of PSP. These proteins are 
listed in Table 5.3.  
Coiled-coil domain-containing protein 61 (Ccdc61) is present in the centrosomes and plays 
an important role in centrosome function, specifically, in cell division and cell development 
(Kuhn et al., 2014). Ccdc61 connected to the centriole at the centre of the centrosomes and 
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functions as a scaffold and for recruiting various eukaryotic proteins, including kinases and 
phosphatases, thus serving as a signalling centre of multicellular development (Kuhn et al., 
2014).  During the current study, exposure to the sublethal concentration of PSP resulted in 
reduced expression of Ccdc61. This suggests that PSP may affect centrosome function in 
H9c2 cells by disrupting the mitotic spindle of dividing cells and thereby; blocking further 
progress of mitosis. PSP may also promote microtubules disassembly, thereby affecting the 
morphology of the entire cell. Moreover, Ccdc61 was found to play a critical role in the post-
translational modification of proteins (Kuhn et al., 2014); depletion of these proteins thus 
may impair the general structure of H9c2 rat cells during differentiation.  
Calumenin is a calcium-binding protein expressed in various tissues and at particularly high 
levels in heart tissue (Yabe et al., 1997). Calumenin is located in the sarcoplasmic reticulum 
of the mammalian heart (Yabe el al., 1997; Jung & Kim, 2004;). Calumenin has been shown 
to interact with sarco(endo)plasmic reticulum Ca2+ ATPase and ryanodine receptor to 
maintain Ca2+ homeostasis in rat cardiac cell (Sahoo & Kim, 2010). Additionally, extracellular 
calumenin was reported to suppress cellular migration and tumour metastasis by 
inactivating ERK1/2 signalling. Calumenin depletion consequently induced cellular migration 
in hepatocellular and pancreatic carcinoma (Wang et al., 2015). In the present study, a 
sublethal concentration (3 µM) of PSP was shown to down regulate the expression of 
calumenin.  As a result, PSP may alter Ca2+ haemostasis in differentiating H9c2 cells and thus 
also affect muscle contraction (Periasamy & Huke, 2001). Further, depletion of calumenin in 
cardiomyocytes is associated with enhancement of Ca2+ ion transient amplitude in a short 
period to reach peak levels (Koss & Kranias, 1996).  
 
The PDZ-LIM domain protein 1 (PDZLIM 1) is a muscle-specific protein that interacts with the 
α-actin to form the Z-disc structure; disruption in its function results in skeletal myopathy as 
observed in the muscles of male mice (Pashmforoush et al., 2001; Zhou et al., 2001). 
Additional research in mice has revealed increased expression of PDZLIM 1 to be associated 
with the development of malignancy and migration of cancerous cells in the breast, while 
depletion of PDZLIM 1 has been shown to disrupt cell motility and cell migration (Liu et al., 
2015). Thus, PSP may exhibit similar effects in differentiating H9c2 cells, decreasing H9c2 cell 
motility and function.  
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5.6 Conclusion 
The work presented in this chapter shows that exposure to sublethal concentrations of 
chlorpyrifos and diazinon and their metabolites (chlorpyrifos oxon and diazoxon) in 
differentiating H9c2 cells induced significant inhibition of AChE activity, which may be 
strongly associated with the morphological changes in these cells. However, only the parent 
compounds chlorpyrifos and diazinon had a significant effect on cardiac cytoskeleton 
proteins. In contrast, PSP did not show significant inhibition of AChE activity, but it had a 
significant effect on the levels of cardiac cytoskeleton proteins, which is probably closely 
associated with the morphological changes observed. Mass spectrometry data also 
presented novel proteins down regulated in response to PSP. Thus, these findings may 
represent a molecular mechanism for long-term OP-induced cytotoxicity in differentiating 
H9c2 cells.  
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6.1 Introduction 
 Induced pluripotent stem cells are reprogrammed cells generated from differentiated adult 
human somatic cells, which are similar to human embryonic stem cells (Yamanaka, 2007). 
More interestingly, hiPSCs have the ability to form the three primary embryonic germ layers: 
the mesoderm, endoderm and ectoderm, and hence have the potential to differentiate into 
any cell type under certain conditions, including cardiomyocytes (Jq et al., 2003; Yamanaka, 
2007). The ability of immature cells to adopt the features of a mature cardiomyocyte 
provides a promising strategy for various aspects of cardiovascular research including drug 
screening, therapeutic testing and toxicity testing (Ma et al., 2011). Several studies have 
recently evaluated the maturation in vitro of hiPSCs-CMs to the cardiac human phenotype 
(Liu et al., 2009; Sartiani et al., 2007; Foldes et al., 2011). A recent study involving 
ultrastructural analysis of cardiomyocytes derived from hiPSCs showed that they exhibited a 
highly-ordered contractile apparatus similar to that of mature structures of cardiomyocytes, 
such as fascia adherens, dense myofibrils that have clear A and I-bands, gap junctions and 
visible sarcomeres (Lundy et al., 2013). Notably, at the molecular level, cardiomyocytes 
derived from hiPSCs exhibited cardiac structural biomarkers, which were similar to those 
reported in human cardiac myocytes, including connexin-43 and a β-myosin heavy chain 
(Lundy et al., 2013).  
In the previous chapters of this thesis, findings showed significant cytotoxic effects of OPs, in 
particular PSP, on differentiated H9c2 cells. However, an established rodent cell line may 
respond differently to xenobiotic exposure when compared to human cells, due to the 
marked physiological differences between animal and human models (Lewis & Kerry, 2015). 
Therefore, it is essential to assess the cardiotoxic response to OPs on a cellular model that is 
comparable to the functional cardiomyocytes of humans. In this respect, hiPSCs-CMs are 
considered to provide a reproducible, scalable and human-based model applicable for in 
vitro toxicity screening and drug discovery (Burridge et al., 2012). The present study 
employed hiPSCs-CMs as an in vitro model system to assess the effect of OPs on 
cardiomyocytes. This is the first study to explore the toxicological effects of OPs on 
cardiomyocytes derived from hiPSCs; it forms a useful comparison with the toxicological 
effects of OPs that have been previously investigated in differentiated H9c2 cells, and may 
thus represent an opportunity for preclinical evaluation.  
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6.2 Aims 
The aims of this study were to examine the morphological characteristics of mature human-
induced pluripotent stem cell‐derived cardiomyocytes (hiPSCs-CMs), to confirm the 
expression of known specific cardiac markers, such as troponin 1, tropomyosin and α-actin, 
and to validate cytotoxic effects of OPs (chlorpyrifos, diazinon and PSP) observed in earlier 
chapters in a more human-relevant cellular model. 
6.3 Methods 
 As described in chapter 2 section 2.3, 2.4, 2.5. 
 
6.4 Results 
6.4.1 Characterisation of hiPSCs-CMs 
In the present study, hiPSCs-CMs were passaged once and cultured for seven days to enrich 
the contracting cells, as a previous study reported that hiPSCs-CMs start to contract after 7 
days of culture (Burridge et al., 2014). Immunostaining studies were performed to confirm 
cardiomyocyte differentiation and assess the expression of the cardiac-specific proteins in 
myocardial contracting cells. As shown in Figure 6.1, hiPSCs-CMs were positively stained for 
the cardiac troponin 1, tropomyosin and sarcomeric α-actin. The positively-stained 
cardiomyocytes demonstrated mature striated myocytes. Structural examination also 
demonstrated large and elongated cells. This provided additional evidence that the cells had 
gained a mature adult cardiac phenotype.  
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Figure 6.1 Structural characterisation of the hiPSCs-CMs.  
The hiPSCs-CMs were passaged once and cultured for 7 days in cardiac myocyte medium. 
Immunofluorescence staining was performed with antibodies to A) cardiac troponin-1 (green), B) 
tropomyosin (green) and C) α-actin (green). Nuclei were stained with DAPI counterstain (blue). Scale 
bar = 100 μm. The images presented are from one experiment and are representative of four 
experiments.  
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6.4.2 Effects of OPs on the viability of hiPSCs-CMs 
Initial experiments in this study assessed the effect of OP treatment on the viability of 
hiPSCs-CMs and this was investigated via monitoring MTT reduction and the release of LDH 
into the culture medium. Also, the morphological changes of hiPSCs-CMs were assessed via 
Coomassie Brilliant Blue staining following OP exposure. As a starting point, due to the 
limited number of cells, three concentrations of each selected OP (200 µM, 25 µM and 3 
µM) were tested over a 48 h exposure period.  
Chlorpyrifos at 200 µM significantly inhibited MTT reduction and triggered LDH release 
following 48 h exposure (Figure 6.2a and b). Coomassie Brilliant Blue staining, showed that 
cells appeared to be more rounded and compact, rather than elongated when compared to 
the control cells; also at 25 µM and 3 µM morphological changes were observed when 
compared to the control cells (Figure 6.2c).  
Diazinon at a concentration of 200 µM had a significant effect on MTT reduction (Figure 
6.3a), but had no significant effect on LDH release following 48 h exposure (Figure 6.3b). 
Also, at a concentration of 200 µM, stained cells appeared to be more rounded, without an 
appearance of elongated cells. Finally, at concentrations of 25 µM and 3 µM, changes in cell 
morphology suggested toxic effects when compared to control cells (Figure 6.3c).  
PSP had a greater cytotoxic effect when compared to chlorpyrifos and diazinon. At 
concentrations of 200 µM and 25 µM PSP significantly inhibited the reduction of MTT and 
triggered the release of LDH following 48 h of exposure (Figure 6.4a and b). Cell 
deterioration was markedly evident at concentrations of 200 µM and 25 µM, followed by 3 
µM PSP, since cells did not exhibit an elongated spindle shape typically observed in control 
cell cultures (Figure 6.4c). 
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Figure 6.2 The effect of chlorpyrifos on the viability of hiPSCs-CMs monitored by MTT 
reduction and LDH release. 
 hiPSCs-CMs cells were exposed to the indicated concentrations of chlorpyrifos for 48 h. Following 
exposure, cell viability was assessed by measuring the metabolic reduction of MTT by cellular 
dehydrogenases (A) and the release of LDH (B). The data are expressed as a percentage of control 
cell values (=100%) and represent the mean ± SEM of three independent experiments, each 
performed in sextuplicate. **p ˂ 0.01 versus the control response. C) Following chlorpyrifos 
treatment with the indicated concentrations, cells were fixed (90 % (v/v) with methanol, stained with 
Coomassie Blue and then visualised using light microscopy (20x objective lens). The black arrows 
indicate typical elongated differentiated cells and the red arrows point to typical rounded compact 
cells. The images presented are from one experiment and are representative of three independent 
experiments. 
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Figure 6.3 The effect of diazinon on the viability of hiPSCs-CMs as monitored by MTT 
reduction and LDH release. 
 hiPSCs-CMs cells were exposed to the indicated concentrations of diazinon for 48 h. Following 
exposure, cell viability was assessed by measuring the metabolic reduction of MTT by cellular 
dehydrogenases (A) and the release of LDH (B). Data are expressed as a percentage of control cell 
values (=100%) and represent the mean ± SEM of three independent experiments, each performed in 
sextuplicate. **p ˂ 0.01 versus the control response. C) Following diazinon treatment with the 
indicated concentrations, cells were fixed (90 % (v/v) with methanol, stained with Coomassie Blue 
and then visualised using light microscopy (20x objective lens). The black arrow indicates typical 
elongated differentiated cells and the red arrows point to typical rounded compact cells. The images 
presented are from one experiment and are representative of three independent experiments.  
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Figure 6.4 The effect of PSP on the viability of hiPSCs-CMs monitored by MTT reduction 
and LDH release.   
Following exposure, cell viability was assessed by measuring the metabolic reduction of MTT by 
cellular dehydrogenases (A) and the release of LDH (B). Data are expressed as a percentage of control 
cell values (=100%) and represent the mean ± SEM of three independent experiments, each 
performed in sextuplicate. **p ˂ 0.01, ***p ˂ 0.001 versus the control response. C) Following PSP 
treatment with the indicated concentrations, cells were fixed (90 % (v/v) with methanol, stained with 
Coomassie Blue and then visualised using light microscopy (20x objective lens). The black arrows 
indicate typical elongated differentiated cells and the red arrows point to typical rounded compact 
cells. The images presented are from one experiment and are representative of three independent 
experiments.   
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6.4.3 Phenyl Saligenin Phosphate induced Apoptosis in hiPSCs-CMs 
From the previous results it was confirmed that PSP significantly induced hiPSCs-CMs cell 
death at concentration 25 µM and 200 µM. Therefore it is worth to assess whether PSP 
induce cell death via caspase-3 activation. Caspase-3 activation was monitored via 
immunocytochemistry at different time periods (eg, 1, 2 and 4 h). As evident in Figure 6.5, 
treatment of  hiPSCs-CMs with 25 µM PSP triggered a significant activation of caspase-3 at 2 
and 4 h of exposure. 
 
 
Figure 6.5 PSP-induced caspase-3 activation in hiPSCs-CMs.  
hiPSCs-CMs were induced to differentiate for 7 days, then cells were exposed  to 25 μM PSP for A) 
1h, B) 2 h and C) 4 h. Following PSP exposure, caspase-3 activation was assessed via 
immunocytochemistry using an anti-active caspase-3 antibody (green) and DAPI counterstain for 
nuclei visualization (blue). Scale bar = 100 μm. The images presented are from one experiment and 
are representative of three. Quantified data are expressed as a percentage of control cell values and 
represent the mean ± SEM of four independent experiments. **p < 0.01 and ****p < 0.0001 versus 
the control.  
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6.4.4 The Effect of sublethal concentrations of PSP on hiPSCs-CMs 
Previous results in chapter 5 showed 3 µM PSP caused a significant decrease in the 
expression level of cardiac cytoskeleton proteins; troponin 1, tropomyosin, and α-actin in 
differentiated H9c2 cells. Therefore it was worthwhile to assess if similar effect would apply 
with differentiating hiPSCs-CMs.  hiPSCs-CMs were induced to differentiated in the presence 
of 3 µM PSP. As shown in Figure 6.6 troponin 1, tropomyosin, and α-actin expression were 
significantly decreased in PSP treated cell when compared to untreated cells. 
 
 
 
Figure 6.6 The effects of PSP on cardiac cytoskeleton protein expression s in differentiating 
hiPSCs-CMs. 
hiPSCs-CMs were induced to differentiate for 7 days in the presence and absence of 3 µM PSP. Cells 
were analysed via immunofluorescence staining using antibodies that recognise A) cardiac troponin 1 
B) tropomyosin C) α-actin (green) and DAPI counterstain for nuclei visualization (blue). Scale bar = 
100 µm. The images presented are from one experiment and are representative of three. Quantified 
data are expressed as a percentage of control cells and represent the mean ± SEM of four 
independent experiments. *p < 0.05 and **p < 0.01 versus the control response.  
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6.5 Discussion 
The current study evaluated the effects of the OPs chlorpyrifos, diazinon and PSP on 
cardiomyocytes derived from hiPSCs since these cells have been demonstrated to be one of 
the best models of choice for studies focusing on cardiac disease and cardiac toxicity (Liang 
et al., 2013). hiPSCs-CMs have gained a high interest due to their superiority over 
heterologous studies and their spontaneous cardiac differentiation, during which they show 
cardiac beating, and their ability to address the effect of chronic exposure to toxic 
compounds in terms of morphological and physiological assessment (Dell’Era et al., 2015). A 
number of studies have investigated the effect of OPs on different stem cell types, such as 
mesenchymal stem cells (Hoogduijn et al., 2006), human umbilical cord blood-derived stem 
cells (hUCBSCs; Kashyap et al., 2013) and adipose tissue-derived stem cells (Zarei et al., 
2015). However, cardiotoxic investigations of OPs on hiPSCs-CMs have not been previously 
assessed. A simple summary comparison between differentiated H9c2 cells and hiPSCs-CMs 
illustrating the major findings is shown in Table 6.1.  
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Table 6.1 Comparison of major findings of significant effect (p˂0.05) of OPs in 
differentiated H9c2 cell and hiPSCs-CMs. 
MTT 
 
LDH 
Differentiated 
H9c2 cell 
3 µM 
- 
 
25 µM 
PSP 
200 µM 
   CPF 
   PSP 
3 µM 
- 
25 µM 
PSP 
200 µM 
   CPF 
   PSP 
hiPSCs-CMs 
 
 
- 
 
      PSP 
   CPF 
   PSP 
  Diazinon 
 
- 
 
    PSP 
    CPF 
     PSP 
Caspase-3 activation (25 µM PSP) 
Differentiated 
H9c2 cell 
1 h 
- 
 
2 h 
 
4 h 
 
hiPSCs-CMs 
 
- 
 
 
 
 
 
Sublethal effect of 3µM PSP on cardiac protein  
Differentiated 
H9c2 cell 
Troponin 
 
Tropomyosin 
 
α-actin 
 
hiPSCs-CMs 
 
   
  
                        represents a significant increase;       represents significant decrease 
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6.5.1 Morphological characterisation of hiPSCs-CMs 
The present findings showed that reproducibly differentiated cardiomyocytes derived from 
hiPSCs-CMs cells have the ability to express cardiac markers, such as troponin 1, 
tropomyosin and α-actin (Figure 6.1). Indeed, similar cardiac markers were shown to be 
expressed in adult human cardiomyocytes (Braam et al., 2010). This is also in agreement 
with a study showing that hiPSCs-CMs displayed morphological maturation that involved 
expression of cardiac structural proteins, most notably troponin and α-actin (Zwi et al., 2009; 
Ma et al., 2011) Similar expression levels of these proteins were found in adult human heart 
(Lundy et al., 2013). Moreover, the ultra-structural analysis provided additional evidence of 
cardiac maturation with cells displaying the appearance of highly ordered, dense filaments 
and long myotubes. Moreover, similar structural properties were shown in cultured adult 
human cardiomyocytes (Olivetti et al., 1996). 
6.5.2 The Effect of OPs on the viability of hiPSCs-CMs 
Previous results demonstrated the effect of OPs on differentiated H9c2 cells, as shown in 
Chapter 4. Here, the effects of OPs were assessed on hiPSCs-CMs.  Initial experiments 
assessed the effect of OPs on cell viability of hiPSCs-CMs by monitoring MTT reduction and 
LDH release. Interestingly, cell viability results for hiPSCs-CMs displayed a similar pattern to 
that observed in differentiated H9c2 cells. In the present study on hiPSCs-CMs, chlorpyrifos 
showed cytotoxicity at the highest concentration 200 µM, and Coomassie Blue staining 
indicated that they were more rounded and compact cells at 200 µM, 25 µM and 3 µM  
(Figure 6.2). Diazinon at concentration 200 µM caused significant inhibition of MTT 
reduction but had no significant effect on LDH release, suggesting that the former assays 
more sensitive than the latter (Figure 6.3a and b). This may be due to the earlier onset of 
metabolic effects than membrane leakage, consistent with the suggestion that MTT is a 
better predictor of cytotoxicity as observed in a previous study (Fotakis & Timbrell, 2006). 
Coomassie Blue Brilliant stain at 200 µM, 25 µM and 3 µM  revealed the appearance of 
rounded rather than elongated cells when compared to the control cells (Figure 6.3c).  
In comparison with differentiated H9c2 cells, chlorpyrifos induced cytotoxic effects at a 
concentration > 100 µM, whereas diazinon did not show any cytotoxicity effects at a 
concentration 200 µM. It is possible that hiPSCs are slightly more sensitive to OP toxicity 
than differentiated H9c2 cells due to the physiological differences between animal and 
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human models. Consequently, different responses may be observed, particularly in toxicity 
screening (Lewis et al., 2013). However, stained cell images of chlorpyrifos and diazinon at 
sublethal concentration of 3 µM pointed to the idea that other cardiac parameters may be 
affected that influence cell morphology. Indeed, sublethal toxic effect of chlorpyrifos and 
diazinon towards hiPSCs-CMs cannot be excluded as a recent study showed that in vitro 
exposure to 10 and 200 µM of chlorpyrifos for 12 h was able to induce a significant gene 
alteration in mouse embryonic stem cells without inducing cell death or changes in the 
cellular structure (Estevan et al., 2013). Moreover, diazinon at concentrations 1 μM and 10 
μM have been shown to decrease axonal cytoskeleton microtubule associated protein 
1B (MAP 1B) expression, that may reflect inhibition of axon outgrowth in neuronal cells 
(Flaskos et al., 2007). Also, in the current study sublethal concentrations of chlorpyrifos and 
diazinon (3 μM) significantly decreased the cardiac specific marker troponin 1 in 
differentiating H9c2 cells. This observations suggests that sublethal concentrations of 
chlorpyrifos and diazinon may interfere with myocellular contraction. In the muscle 
contraction process both troponin 1 and tropomyosin  block the binding of actin to myosin 
preventing muscle contraction.  At higher Ca2+ concentration, Ca2+ binds to troponin C, 
leading movement of tropomyosin which allows the myosin head interact with actin thus 
allowing contraction. This demonstrates the critical role of troponin in cardiac function 
(Metzger & Westfall, 2004). Therefore, it is likely that similar parameters may be affected in 
hiPSCs-CMs treated with chlorpyrifos or diazinon, which may subsequently affect cellular 
morphology. It would therefore be of interest in future work to determine if sublethal 
concentrations of OPs interfere with the reported contraction of hiPSCs-CMs. However, 
further work will be required to determine which targets are most altered that may relate to 
disruption of cardiac cellular differentiation or cellular function. 
PSP was shown to be more potent than chlorpyrifos and diazinon in viability assays, since 
PSP cytoxicity was observed at lower concentrations (25 μM) in hiPSCs-CMs. Also, Coomassie 
Blue staining at 200 µM and 25 µM showed cell deterioration. This is strongly in agreement 
with the previous study that demonstrated cytotoxic effect of 25 µM PSP in differentiated 
H9c2 cells. Also, visualisation of Coomassie blue stained cells revealed that 3 µM PSP 
induced morphological changes which were not unexpected. In the previous chapter, it was 
shown that 3 µM PSP significantly down regulated cardiac cytoskeleton proteins, troponin 1, 
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tropomyosin and α-actin in differentiating H9c2 cells. Clinically, cardiac troponins have been 
found to be a sensitive biomarker of drug-induced skeletal muscle and myocardial toxicity 
(Smith et al., 2013). Together, troponin with tropomyosin intertwine with thin filament G-
actin and function to regulate contraction of cardiac muscle mediated by increases in 
intracellular Ca2+ (Barua et al., 2012). Structural instability and conformational changes of 
tropomyosin was found to significantly affect proteins that control Ca2+ flux such as the 
sarcoplasmic Ca2+ ATPase (SERCA2a; Schulz et al., 2012). Also, mutation in tropomyosin was 
found to affect its ability to activate the actin thin filament upon binding of Ca2+ to troponin 
(Mamidi et al., 2013). Thus, functional diversity of actin cytoskeletal is strongly associated 
with alterations of tropomyosin expression (Gunning et al., 2008). Presuming that local 
change of tropomyosin activity by PSP may be sufficient to modulate cardiac contractile 
function. Overall, the data support the idea that PSP exposure is more cytotoxic than the 
other OPs tested as it is observed in both the H9c2 cells (rat) and hiPSCs-CMs. 
6.5.3 PSP-induced caspase activation in hiPSCs-CMs 
In the present study, 25 μM PSP was found to induce a significant increase in caspase-3 
activation at the earlier time point of 2 h exposure (Figure 6.5). This is in agreement with the 
data obtained from studies with differentiated H9c2 cells, in which 25 μM PSP was shown to 
induce apoptosis mediated by significant activation of caspase-3 and JNK1/2. Thus, similar 
molecular mechanisms of PSP-induced cell death in hiPSCs-CMs may be observed. However, 
hiPSCs-CMs appeared to show more sensitivity to PSP than differentiated H9c2 cells, as 
caspase-3 was found to be significantly activated at 2 h, while in differentiated H9c2 cells 
caspase-3 was significantly activated at 4 h. One reasonable explanation for this could be the 
minor variations in DNA repair between mouse embryonic stem cells (mESC) and human 
embryonic stem cells (hESC) which might lead to differences in cell fate during cell 
development (Mahler & Butcher et al., 2011; Arabadjiev et al., 2012). Therefore, it can be 
possible that compounds that may show toxicity towards human cells may not be seen to 
have any toxic effects towards mice cells and vice versa (Xia et al., 2008; Malik et al., 2014). 
However, due to the limited number of hiPSCs-CMs, the present study was not able to 
investigate further the molecular mechanism(s) of PSP toxicity in hiPSCs-CMs. Hence, in 
future work, it would be interesting to validate the human cardiac cellular response against 
PSP and to explore the role of protein kinases e.g. JNK1/2 in the regulation of apoptosis in 
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hiPSCs-CMs. Moreover, the ability to engineer iPSC lines by different techniques makes it an 
advantageous source to study genetic alterations caused by toxic compounds (Zhu et al., 
2011; Zeng et al., 2014).   
6.5.4 The Effect of sublethal concentrations of PSP on hiPSCs-CMs 
The fact that 25 µM PSP was shown to induce apoptotic cell death suggests that it is 
necessary to assess the risk of exposure to sublethal concentrations of 3 µM PSP during the 
development of contracting hiPSCs-CMs. In the present study, PSP was shown to significantly 
decrease the level of troponin 1, tropomyosin and α-actin at 7 days of exposure (Figure 6.6). 
Similarly, in differentiating H9c2 cells, 3 µM PSP was also found to reduce the expression of 
troponin 1, tropomyosin and α-actin at 7 days of exposure. Since, hiPSCs-CMs start to 
contract after 7 days in culture, and troponin 1, tropomyosin and α-actin are important 
myofilament proteins (Burridge et al., 2014;  Kempf et al., 2016), these findings strongly 
support the idea that a non-cytotoxic concentration of PSP may disrupt cardiac development 
processes, such as cell proliferation and differentiation, through direct interference with 
cardiac proteins; thus a decrease in their expression may indicate an early sign of 
cardiotoxicity (Yavuz et al., 2008). 
6.6 Conclusion 
Overall, the work presented in this chapter successfully demonstrated concordance with the 
results presented in chapters 4 and 5 on the effect of chlorpyrifos, diazinon and PSP on 
cardiac stem cells with respect to parameters such as MTT reduction, LDH release and 
caspase-3 pathway activation. The findings of this study revealed the toxic effects of OPs in 
differentiated H9c2 cells was similar to the presently reported hiPSCs-derived 
cardiomyocytes, indicating that hiPSCs-CMs represent a suitable model for in vitro toxicity 
testing although with considerable differences in potency amongst different OPs. The 
evaluation of PSP concentrations lower than 25 µM and their manifestations of effects 
would be very helpful in establishing a basic mechanism of PSP toxicity towards cardiac cell 
proliferation and differentiation. Such types of future testing paradigms could help to 
improve understanding of the possible differences in sensitivity of different cell types after 
exposure to OPs, which could be critical in developing measures or procedures for the 
effective management of OP poisoning cases. 
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7.1 General Discussion 
7.1.1 Differentiation of H9c2 cells 
The present study used H92c cells to investigate the effect of OPs on cardiac myocytes. 
Mitotic H9c2 cells were reported to be suitable for use in the study of cardiac 
ischemia/reperfusion, diabetes and cardiac toxicity (Yu et al., 2011; Zhu et al., 2011). 
However, they were shown to differentiate into more cardiomyocyte-like phenotype cells 
when treated with all-trans-RA (Menard et al., 1999). In both previous studies and in the 
current work, the generation of cardiomyocyte-like phenotype cells was confirmed by 
monitoring the morphological alteration and the expression of a cardiac-specific markers, 
such as troponin 1, which developed over a period of 7 days of cell differentiation. 
Proteomic analysis also showed that differentiated H9c2 cells expressed significantly  higher 
levels of cardiac cytoskeleton proteins, such as tropomyosin and α-actin, when compared to 
undifferentiated H9c2 cells. Thus, the use of differentiated H9c2 cells as an in vitro model 
could provide a potential application in toxicity screening and will aid in understanding the 
molecular mechanisms that contribute to OP-induced cardiotoxicity (Pagano et al., 2004).  
7.1.2 Effect of OPs on differentiated H9c2 cells 
The clinical effects of OP poisoning can range from neurological complications to 
intermediate syndrome and cardiac conduction disorders (Abdollahi & Karami-Mohajeri, 
2012). Most scientific studies have examined the effect of neuropathic OPs on neuronal 
cells. In contrast, the mechanisms underlying cardiotoxicity are not fully known. Therefore, 
the present study assessed the effects of PSP, chlorpyrifos and diazinon and their in vivo 
metabolites (chlorpyrifos oxon and diazoxon) on mitotic and differentiated H9c2 cells. The 
findings revealed considerable differences in potency among the different OPs. Chlorpyrifos 
diazinon and their oxon metabolites, which display acute toxicity in vivo as a result of the 
inhibition of AChE, were shown to have little cytotoxic effect on H9c2 cell cardiomyoblasts. 
Similarly, previous study showed that subacute exposure chronic administration of 15 and 
30 mg/kg  diazinon did not activate caspase-3 and caspase- 9 in diazinon treated rat groups. 
Moreover, no significant changes were observed in Bax and Bcl-2 ratios. Moreover, 
apoptosis induction was not observed in rat brain (Rashedinia et al., 2013).  
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In contrast, PSP (a weak inhibitor of AChE) was shown to have a significant cytotoxic effect 
on both mitotic and differentiated H9c2 cells. 
7.1.3. Cytotoxic effect of PSP on differentiating H9c2 cells 
In the present study, PSP was found to induce a cytotoxic effect in both mitotic and 
differentiated H9c2 cells, as determined by the MTT and LDH assays. In mitotic cells, cell 
death occurred from 4 h exposure to concentrations of 25 µM–200 µM; in differentiating 
cells, cell death occurred from 2 h exposure to concentrations of 25 µM–200 µM. It was also 
determined that 25 µM PSP induced apoptotic cell death independently from AChE 
inhibition. As a previous study showed, the JNK1/2 pathway plays an essential role in the 
apoptotic pathway (Dhanasekaran & Reddy, 2008). Therefore, the present study 
investigated the effect of PSP on protein kinase signalling pathways such as, AKt ERK and 
JNK1/2. It was showen that PSP-induced apoptosis occurs via JNK 1/2 mediated caspase-3 
activation. A similar phenomenon was observed in a previous study, in which PSP (10 and 
100 µM) induced apoptosis in human neuroblastoma SH-SY5Y cells via the activation of 
caspase-3 (Carlson et al., 2000). In agreement with a previous study revealed that some OPs 
such as, chlorpyrifos and dimethoate have an effect on MAPK pathway. Protein kinases like 
the Akt family or ERK was significantly down regulated after OPs poisoning, these proteins 
are essential for cell survival and proliferation (Schafer et al., 2013)  
Pre-treatment with the specific JNK1/2 inhibitor SP 600125 abolished PSP-induced JNK1/2 
activation and was also able to block caspase-3 activation, indicating the involvement of the 
JNK 1/2 pathway. More interestingly, the results showed that other specific kinase inhibitors 
were unable to block the apoptotic pathway induced by PSP, thus excluding the involvement 
of other protein kinases, such as ERK1/2 and PKB. Since ERK1/2 and PKB pathways are 
associated with the regulation of cell survival (Xia et al., 1995; Brunet et al., 2001), it is 
conceivable that increased ERK 1/2 and PKB activation are not essential to PSP-induced cell 
death.  
The current study identified novel non-cholinesterase targets of PSP that may contribute to 
its cytotoxicity, including tropomyosin, heat shock protein β-1 and nucleolar protein 58. 
Tropomyosin is essential to muscle contraction and responsible for regulation of the 
interaction of actin binding proteins, such as myosin, with microfilaments (Yo & Ono, 2006), 
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Variation in tropomyosin expression can be caused by disease-related substitutions or 
naturally occurring amino acid substitutions in tissue-specific tropomyosin isoforms that may 
lead to unlikly physiological functions. Thus, structural instability in the central region of 
tropomyosin modulates cardiac contractile function (Mamidi et al., 2014). In addition, 
Mutations in alpha-tropomyosin, a thin filament protein involved in structural and regulatory 
roles in muscle cells, are associated  with Dilated cardiomyopathy (van de Meerakker et al., 
2013). Dilated cardiomyopathy is characterized by idiopathic dilatation and systolic 
contractile dysfunction of the ventricles leading to an impaired systolic function. Mutation in 
tropomyosin significantly weakens the binding of tropomyosin to actin by 25% (van de 
Meerakker et al., 2013). Suggesting that binding to PSP may affect actin stabilisation, leading 
to impaired cell motility and cell contraction.  
Heat shock protein β-1 is expressed in response to stress to mediate the cytoprotection 
effect that may prevent cell death (Mymrikov et al., 2011). This protein is found to be 
related to stress and metabolism in skeletal muscles (Kim et al., 2010). Thus, the binding of 
heat shock protein β-1 to PSP may impair its ability to promote cell survival. Nucleolar 
protein 58 is located in microspherules in the nucleolus (Ren et al., 1998), which is essential 
for 60S ribosomal subunit biogenesis (Lyman et al., 1999). Therefore, it is suggested that 
binding to PSP may affect the nucleolus and protein translation. 
7.1.4 Sublethal effect of OPs on differentiating H9c2 cells 
A number of toxicity studies revealed that sublethal doses of OPs might cause morphological 
changes and behaviour problems (Zalizniak & Nugegoda, 2006). Therefore, the possible 
ability of sublethal concentrations of OPs to induce long-term toxicity cannot be neglected. 
The experiments performed in this study were designed to determine whether sublethal 
concentrations of OPs might have a measurable effects on the differentiation process of 
H9c2 cells. Mitotic H9c2 cells were induced to differentiate in the presence of 3 µM OPs and 
the effect of OPs was observed at 7, 9 and 13 days. 
Results showed that both chlorpyrifos and diazinon induced morphological changes and 
elicited significant reduction in cardiac specific marker troponin 1. On the other hand, their 
oxon forms did not show any toxic effects toward differentiating H9c2 cells. Simirlay, 
sublethal concentration of 1, 5 and 10 μM diazinon had no effect on the expression of 
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neuronal cytoskeletal proteins β-tubulin in differentiating N2a neuroblastoma cells, it also 
failed to affect the levels neurofilament light (NFL) and neurofilament medium (NFM) chain 
levels (Sachana et al., 2014). Indicating that the parent compounds were potent to interfere 
with H9c2 cell differentiation. Importantly, changes in a such a protein level is applied in 
clinical diagnostic for cardiomyopathies (O’Brien, 2008) and for chemical induced low dose 
toxicity (Reagan et al., 2013). However, troponin 1 cannot alone account for adverse 
consequences of chlorpyrifos and diazinon, particularly following long-term exposure. These 
data suggest that chlorpyrifos and diazinon may affect other cytoskeleton proteins involved 
in the fundamental cardiac contractile function.  
Although both parent compounds chlorpyrifos and diazinon and their metabolites are 
eliminated relatively rapidly in humans (i.e., metabolized and then eliminated primarily 
through the kidneys; Hill et al., 1995), previous studies in rats indicate that chlorpyrifos and 
diazinon are redistributed to adipose tissue, forming a depot for slow release. More 
intristing, sublethal exposures to diazinon interfered with influence on the adipose tissue 
most probably via stimulation of muscarinic receptors (Pakzad et al., 2013). Thus, the OPs 
may be retained for longer periods than is evident using plasma measurements (Gallo & 
Lawryk, 1991; Abu-Quare & Abou-Donia, 2001). Therefore, it is also important to note that 
chlorpyrifos and diazinon itself may have toxic properties in the absence of conversion to 
their oxon metabolites (Terry et al., 2003). More recently, a study has reported lethal cardiac 
complications and severe histological alterations in the cardiac tissue with diazinon- 
chlorpyrifos treated animals. In addition, diazinon and chlorpyrifos tested increased the 
oxidative stress and oxidative modifications in the genomic DNA content of the cardiac 
tissues, data provided possible evidence of the cardiotoxicity mechanism (Zafiropoulos et al., 
2014). This may suggest that chlorpyrifos and diazinon may be stored in cardiac cells 
resulting in a sub lethal effect that may be longer lasting.  
As mentioned previously, PSP was shown to have a potent effect on the viability of 
differentiating cells when compared to chlorpyrifos and diazinon. Interestingly, PSP was also 
found to affect the differentiation of H9c2 cells, as observed using a light microscope at 7, 9 
and 13 days. Thus, cells appeared more rounded following exposure, rather than elongated 
or spindle-shaped. One explanation for this may be is the effect of PSP was also able to 
significantly decrease in the expression of cardiac cytoskeletal proteins, such as cardiac 
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troponin 1, tropomyosin and α-actin, at  7, 9 and 13 days, resulting in the loss of cell integrity 
and morphological alterations, as described above (Hamm & Hinton, 2000; Osterauer & 
Köhler, 2008). Morphological alterations were also induced by PSP in the study of 
Hargreaves et al. (2006), who showed a decrease in neurite outgrowth in differentiating N2a 
cells induced by 2.5 µM PSP. The attenuation of these cytoskeleton protein levels might 
reflect early molecular lesions in cardiac cells (O’Brien, 2008). Therefore, it is conceivable 
there is a continuous reduction in cell integrity and cardiac cytoskeletal protein expression 
resulting in PSP-induced cell death of differentiating H9c2 cells after 13 days.  
A proteomic investigation revealed the first report on the effect of sublethal PSP exposure 
on novel protein expression in differentiating H9c2 cells when compared to control. 
Identified proteins included, coiled-coil domain-containing protein 61, calumenin, and PDZ-
LIM domain protein 1.  
Coiled-coil domain-containing protein 61 is abundant in the centrosomes and acts as a 
scaffold to recruit various eukaryotic proteins, such as kinases and phosphatases into the 
centrosomes for vital multicellular development (Kuhn et al., 2014). A sublethal 
concentration of PSP was shown to induce a significant reduction in coiled-coil domain-
containing protein 61 expression that may affect centrosome in H9c2 cells, thus affecting cell 
division and cell differentiation.  
Calumenin is a Ca2+-binding protein located in the endo/sarcoplasmic reticulum of 
mammalian hearts and regulates Ca2+ homeostasis in hearts (Sahoo & Kim, 2010). It is highly 
expressed during the early developmental stage of the heart and regulates the activity of 
sarco/endoplasmic reticulum Ca2+-ATPase and of the ryanodine receptor in the endoplasmic 
reticulum (Sahoo & Kim, 2010). Therefore, calumenin is a Ca2+ sensor, which folds into a 
compact structure, capable of interacting with its molecular partners, when Ca2+ 
concentration within the ER reaches the millimolar range. (Mazzorana et al., 2016). In 
addition, previous study showed that overexpression of calumenin decreased ER stress and 
reduced ER-initiated apoptosis neonatal rat ventricular cardiomyocytes. Thus, calumenin 
may serve as a therapeutic target against various heart diseases (Lee et al., 2013). Thus, 
changes in the expression of calumenin could alter Ca2+ cycling (Sahoo & Kim, 2008). 
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Therefore, a decrease in calumenin expression induced by PSP in cardiomyocytes may 
disturb Ca2+ regulation and thus interferes with heart contraction.  
PDZ-LIM domain protein 1 is a protein expressed in the early stage of heart development 
(Kotaka et al., 2001). Furthermore, it is implicated in cytoskeleton organization and plays an 
important role in myofibrillogenesis (Kotaka et al., 2001). PDZLIM1  binds to α-actinin and 
transfers as PDZLIM1/α-actinin complex to the newly formed actin cytoskeleton during 
migration and contraction of endothelial cells (Bauer et al., 2000). PDZLIM1 is one of the 
proteins that found to increase its expression dramatically in breast cancer cell progression, 
thus disruption in the PDZLIM1/α-actinin complex may significantly affect signaling pathways 
which are relevant to cell migration and invasion (Liu et al., 2014). The observed decrease of 
PDZLIM1 expression in PSP-treated cells point to the idea that PSP is a developmental 
toxicant that may interfere with the early developmental process of cardiomyocytes. 
However, further work is required to validate the effect of PSP on the expression levels of 
these novel identified proteins and to establish the consequences of PSP interaction on their 
biochemical properties/function.  
7.1.5 Effects of OPs on cardiomyocyte derived from human-induced 
pluripotent 
The present study investigated the effect of OPs on differentiating H9c2 cells, which were 
derived from an embryonic rat. However, it is possible that cells derived from a human 
model when compared to cells derived from animals may respond differently, due to the 
physiological differences between the two species (Lewis & Falconer, 2015). Therefore, 
hiPSCs-CMs were used in the later stages of the current work to provide a model more 
similar to the functional cardiac cells in humans (Burridge et al., 2012). A recent study 
charecterized the biophysical and pharmacological properties of hiPS-CMs. the Na+ and Ca2+ 
channels were evaluated and a pattern of increasing Na+ and L-type Ca2+ current density in 
hiPSCs-CMs was observed with increasing time in cell culture. hiPSCs-CMs also exhibited 
action potential heterogeneity, likely reflecting cell types (atrial, ventricular, and pacemaker) 
and a range of cellular maturation in the culture. hiPSCs-CMs showed prominent diastolic 
depolarization and action potentials spontaneously. hiPS-CMs are immature cells that 
proven with time in culture can progressively develop to a more mature phenotype without 
signs of dedifferentiation (Rashedinia et al., 2013). 
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Initial experiments assessed the effect of chlorpyrifos, diazinon and PSP on the cell viability 
of hiPSCs-CMs at three different concentrations (3, 25 and 200 µM).  
The findings revealed that chlorpyrifos and diazinon induced toxicity at a high concentration 
(200 µM), while PSP also showed a potent cytotoxic effect at a lower concentration (25 μM) 
in hiPSCs-CMs. Thus, the cell viability changes were comparable with the cytotoxic effect of 
25 µM PSP on differentiated H9c2 cells. However, morphological changes at sublethal 
concentrations of chlorpyrifos, diazinon and PSP cannot be ruled out, as visualised stained 
cells appeared to be compact rather that elongated cells. This may reflect their toxic effects 
at sublethal concentration in hiPSCs-CMs as shown with differentiated H9c2 cells. 
Chlorpyrifos and diazinon exposure significantly reduced troponin 1 expression in 
differentiated H9c2 cells. However, other proteins and signaling pathways may be involved 
in OP-induced cardiotoxicity. For example, histological and morphometric studies in rats 
showed the development of hypertrophy in cardiac muscular cells exposed to OPs (Calore et 
al. 2007). Previous studies have shown that calcineurin may play a critical role in the 
signaling of cardiac hypertrophy in many experimental models (Kamiya et al., 2001). 
Cardiotrophin-1 (CT-1), a member of the IL-6 family of cytokines that induces hypertrophy of 
cardiac myocytes in vitro. Furthermore, levels of CT-1 are elevated in the serum of patients 
with ischemic heart disease and valvular heart disease (Freed et al., 2003). Therefore, it may 
be of value to study these biochemical pathways in chlorpyrifos and diazinon induced 
sublethal effect in hiPSCs-CMs.  
More interestingly, 25 µM PSP was shown to induce apoptotic cell death mediated by 
caspase-3 activation in differentiated H9c2 cells, which provided further validation of the 
results obtained in hiPSCs-CMs. The current study also investigated the effect of a sublethal 
concentration of 3 µM PSP on the cardiac cytoskeletal proteins troponin 1, tropomyosin and 
α-actin in hiPSCs-CMs that may contribute to PSP toxicity. Exposure to PSP was shown to 
decrease significantly the expression of troponin 1, tropomyosin and α-actin at 7 days 
exposure, and this was consistent with the findings shown in differentiating H9c2 cells. 
These findings showed that sublethal exposure to PSP might affect the cardiac development 
processes and may interfere with cardiac function. On this basis, it can be confirmed that 
PSP exhibited cardiotoxicity, and this highlights concerns regarding human cardiomyocytes. 
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7.2 Concluding Remarks 
The present research provides valuable insights into the effect of OPs on cardiac cells. PSP 
was found to have a potent cytotoxic effect on rodent and human cardiomyocyte-like cells 
when compared to other compounds, and to induce apoptosis in differentiating cells in a 
JNK1/2 activation related manner. Novel binding proteins (e.g. tropomyosin) were identified 
for PSP that may contribute to its cytotoxicity. Furthermore, long-term exposure to sublethal 
concentrations of chlorpyrifos, diazinon and PSP was able to attenuate the expression of 
cardiac cytoskeletal proteins that are important in cardiac differentiation, proliferation and 
migration. The data from the present study will help to establish a basic mechanism of 
cardiotoxicity following exposure to OPs. Figure 7.1 summaries the present study. 
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Figure 1.7  summary of results in the present study. 
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7.3 Future work 
 As some organophosphates showed severe cholinergic toxicity resulting from the 
inhibition of acetylcholinesterase and butyrylcholinesterase and leading to an 
enhanced activation of the autonomic pathways (Lyzhnikov et al., 1975, Ludomirsky 
et al., 1982, Anand et al., 2009), an evaluation of the effects of chlorpyrifos, diazinon 
and PSP on butyrylcholinesterase activity levels could help to further elucidate 
targets in differentiated H9c2 cells that may be involved in cardiac cytotoxicty.  
 Organophosphates are highly reactive compounds and can interact with proteins at 
very low (nanomolar range) concentrations, as determined in vitro (Huff et al., 1994; 
Howard & Pope, 2002). Further research is needed to investigate lower 
concentrations of PSP that can bind to cardiac-specific proteins and whether similar 
binding occurs in vivo.  
 The type of PSP binding to proteins and the possible motifs involved could be 
identified by mass spectrometry, in particular, with low concentration toxicity. Thus, 
the effect of a concentration less than 3 µM might be examined to identify a new 
molecular mechanism and provide novel strategies to control cardiac toxicity. 
 In vivo models, such as mouse, rat, porcine and rabbit are available for toxicity 
screening and were proven to address similar cardiovascular complications in 
humans (Zaragoza et al., 2011). Thus, such types of future testing paradigms could 
also help in the understanding of possible differences in sensitivity between different 
species and their physiological behaviours after exposure to OPs, which could be 
critical in developing measures or procedures in the effective management of OP 
poisoning cases. 
 Further studies are also required to establish time course and dose effects of OPs in 
vivo. It would also be worth determining the lethal dose of OPs, as the LD50 of some 
OPs were reported to be very low (1 mg/kg) in rats (Klaassen, 2007). Thus, this dose 
may evoke adverse consequences in humans and might likely lead to the 
development of cardiotoxicity. 
 Understanding the molecular mechanisms associated with gene expression 
alterations or DNA damage in response to OPs exposure. Further experiments could 
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explore genetic biomarkers that can be detected following early exposure. Thus, this 
would improve the diagnostic tool and clinical treatment. 
 Future studies should focus on the identification of possible non-cholinergic targets 
of OP compounds, which will help to increase understanding of the molecular 
mechanisms of OP-induced toxicity. 
 General physiological studies to provide substantial evidence of that the two cardiac cells 
H9c2 and hiPSCs-CMs such as calcium channels and potassium channels. 
 Measuring gene expression of cardiac proteins including calcium, potassium and sodium 
transport (channel proteins, SERCA, RyR ect) 
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